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ABSTRACT 
An essential element of a modern biorefinery is the enzymatic conversion of biomass to soluble 
sugars.  Although the optimization of this process has been pursued by both academia and 
industry for decades, it still represents a bottleneck in the biorefinery concept.  Recent 
discoveries of a lytic polysaccharide monooxygenase (LPM) activity among members of family 
33 of carbohydrate binding modules (CBM33), boosting the degradation of recalcitrant 
polysaccharides, have given more insight to the degradation of complex polysaccharides in 
nature that could be adapted for biorefining processes.  These findings have also prompted an 
effort in cloning, expressing and characterizing a wide variety of CBM33s in order to get 
information on CBM33-family diversity in terms of function and mechanism.   
The genome of the Gram negative soil bacterium Cellulomonas flavigena encodes four CBM33s 
(CfCBM33s), all possessing C-terminal CBM2a domains, indicating substrate specificity 
towards either cellulose or chitin.  The bacterium is previously known to metabolize cellulose 
and xylan.  Conversely, results from binding and activity assays performed with two of the 
CfCBM33s (CfCBM33A-N and CfCBM33B-N) in this study show no specificity towards either 
of these substrates.  However, both show affinity for chitin, which is intriguing as the genome of 
C. flavigena contains no identified chitinases.  In addition to the unexpected binding affinity 
towards chitin, CfCBM33B-N shows lytic chitin monooxygenase activity and is also able to 
boost the degradation of β-chitin by chitinase A, B and C from Serratia marcescens.  Moreover, 
intriguingly, CfCBM33B-N generates partly deacetylated products from the oxidation of β-chitin 
possibly showing a new function or binding specificity not previously reported for LPMs. 
Finally, a CBM33 containing a CBM20 (indicating binding affinity for starch) from the fungus 
Aspergillus terreus was successfully cloned and expressed in Pichia pastoris.  Preliminary 
binding experiments using isothermal titration calorimetry indicate that AtCBM33A binds 
specifically to starch.  Analysis of LPM activity was prevented by the time restrains of this 
study, but will be the focus of consecutive work.  A starch active LPM would be completely new 
to the field and could be an important finding for the starch processing industry.  
  
SAMMENDRAG 
Enzymatisk nedbrytning av biomasse er en viktig prosess innen det moderne 
bioraffinerikonseptet.  På tross av at både den akademiske verden og industrien har jobbet 
målrettet for å optimalisere denne prosessen i tiår, er den fullstendige nedbrytningen til løselige 
sukker fremdeles flaskehalsen i bioraffinerien.  Nylige oppdagelser viser en lytisk polysakkarid 
monooksygenase (LPM)-aktivitet blant medlemmer i familie 33 av karbohydratbindende 
moduler (CBM33) som øker nedbrytningshastigheten av gjenstridige polysakkarider.  Disse 
oppdagelsene har gitt større innsikt i den naturlige nedbrytningen av komplekse polysakkarider 
som kan benyttes i bioraffineringsprosessen.  I tillegg er det nå økt interessen for å klone, 
utrykke og karakterisere ulike CBM33er for å kartlegge ulike funksjoner og mekanismer innad i 
familien. 
Genomet til den Gram-negative jord bakterien Cellulomonas flavigena koder for fire CBM33 
(CfCBM33) med C-terminale CBM2a-domener som indikerer substratspesifisitet mot cellulose 
eller kitin.  Bakterien har tidligere vist å metabolisere cellulose og xylan.  Resultater fra 
bindings- og aktivitetsstudier med CfCBM33A-N og CfCBM33B-N viser derimot ingen 
spesifisitet for disse substratene.  Derimot viser de affinitet for kitin, noe som er svært interessant 
siden genomet til C. flavigena ikke inneholder identifiserte kitinaser.  I tillegg til denne uventede 
substratspesifisiteten utøver CfCBM33B-N lytisk kitinmonooxygenase aktivitet og øker 
nedbrytningshastigheten av β-kitin i synergi med chitinase A, B og C fra Serratia marcescens.  I 
oksidasjon av β-kitin genererer CfCBM33B-N delvis deacetylerte produkter, en funksjon som 
tidligere ikke er beskrevet for LPM. 
I tillegg ble en CBM33 fra soppen Aspergillus terreus (AtCBM33A) suksessfullt klonet og 
uttrykt i Pichia pastoris.  AtCBM33A inneholder et CBM20 domene som indikerer 
bindingsaffinitet for stivelse, som også ble observert ved innledende bindings eksperimenter 
utført ved hjelp av isotermisk titrerings-kalorimetri.  Studiets tidsbegrensing hindret videre 
analyser av AtCBM33As LPM-aktivitet, men oppfølgende studier vil fokusere på dette.  
Stivelseaktive LPMer er ikke tidligere beskrevet i litteraturen og vil være svært betydningsfullt 
for industrielle prosesser hvor nedbrytning av stivelse er nødvendig.   
  
ABREVIATIONS 
aa Amino acids 
AtCBM33A A CBM33 protein from Aspergillus terreus 
BHI Brain Heart Infusion 
BMGY/ BMMY Buffered Complex Glycerol/ Methanol Medium 
CAZY Carbohydrate-Active Enzymes 
CBM Carbohydrate Binding Module 
CBM33 Carbohydrate Binding Module of family 33 
CBP Chitin Binding Protein 
CfCBM33A, -B, -C, -D CBM33 proteins from Cellulomonas flavigena, full-length protein 
CfCBM33A-N, -B-N, -C-N, D-N CBM33 proteins from Cellulomonas flavigena, truncated version 
ChiA/ ChiB/ ChiC ng a CBM20 (indicating binding affi 
dH2O Sterile water (Milli-Q) 
dNTP Deoxynucleoside triphosphate 
EC Enzyme Commission 
g gravity 
GH Glycosyl Hydrolase 
GlcN β-glucosamine 
GlcNAc N-acetyl-β-glucosamine 
ITC Isothermal titration calorimetry 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
kb Kilobases 
kDa Kilo Dalton 
LB Luria Bertani 
LPM Lytic Polysaccharide Monooxygenase 
MALDI-TOF Matrix-Assisted Laser Desorption and Ionization Time Of Flight 
MS / MS/MS Mass spectrometry / Tandem mass spectrometry 
OD600 Optical density at 600 nanometer 
PCR Polymerase Chain Reaction 
rpm Rotations per minute 
SDS-PAGE Sodium Dodecyl Sulphate PolyacrylAmide Gel Electrophoresis 
TB Terrific Broth 
UV Ultraviolet 
v/v Volume/volume 
w/v Weight/volume 
YPDS/ YPD Yeas Extract Peptone Dextrose with/or without Sorbitol 
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1 INTRODUCTION 
1.1 Polysaccharides  
A carbohydrate is an organic compound with the formula Cm(H2O)n.  Carbohydrates represent 
one of the most common biomolecules in nature and possess important roles including roles in 
cell signalling and energy storage to structural roles, e.g. as components of the cell wall. 
Carbohydrates are divided into four groups: i) monosaccharides, which form the basic 
carbohydrate unit, ii) disaccharides, which are composed of two monosaccharides, iii) 
oligosaccharides, typically composed of two to ten monosaccharides, and iv) polysaccharides, 
that are long carbohydrate polymers with structures ranging from linear to highly branched.  
Mono-, di-, and oligosaccharides are important in cell signalling and metabolism, while 
polysaccharides function as structural components (e.g. cellulose, xylan, and chitin) and in 
energy storage (e.g. glycogen and starch). 
In carbohydrate polymers the monosaccharides are covalently joined by glycosidic bonds.  A 
glycosidic linkage is formed between the hemiacetal group in one saccharide and the hydroxyl 
group of another saccharide.  A glycosidic bond can either have α− or β-conformation depending 
on the axial or equatorial orientation, respectively, of the bond (Figure 1.1).  Different 
conformations of glycosidic linkages combined with the large amount of different 
monosaccharides enable the enormous molecular diversity seen among polysaccharides (Vaaje-
Kolstad 2005).    
       
Figure 1.1.  Glycosidic linkages.  Glycosidic linkages can either be in α-conformation as in maltose (a), or in β-
conformation, as in lactose (b).   
Figure source: http://chem-guide.blogspot.com/2010/04/carbohydrates.html. 
The annual production of polysaccharides in nature is dominated by cellulose, hemicellulose 
(with xylan as main component) and chitin.  Their main function is to protect the organism or 
cell from mechanical and chemical stress, by forming rigid insoluble and sometimes crystalline 
structures that are insoluble and difficult to degrade chemically.    
b) 
a) 
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1.1.1 Cellulose 
The cell wall of plant is a complex structure made up of several layers of microfibrils of 
cellulose in a crosshatched pattern, impregnated with other polysaccharides (hemicellulose, 
pectin), lignin, and some proteins; alltogether known as lignocellulose (Lynd et al. 2002).  The 
main component, cellulose, is a linear polymer of β-1,4 linked D-glucose  with the consecutive 
monomers rotated 180 degrees to each other(Figure 1.2).  Thus, the repeating units of the 
cellulose chain are the disaccharide cellobiose.  Parallel chains of cellulose are connected 
through hydrogen bonds, forming a microfibril network with great mechanical strength (Viëtor et 
al. 2000).  These microfibrils are crystalline and non-soluble.  
 
Figure 1.2.  The structure of cellulose. Cellulose consists of β-1,4 linked D-glucose.  Note that the repeating unit of 
the cellulose chain is a glucosamine-dimer as every monosaccharide unit is rotated 180° in relation to the next unit.  
Figure source: http://www.scientificpsychic.com/fitness/carbohydrates1.html. 
Crystalline cellulose is found in two forms, Iα and Iβ (Iβ being the major type of cellulose found 
in plants), while other types (i.e. type II, III and IV) of crystalline cellulose can be gained by pre-
treatment (chemically or enzymatically).   
1.1.2 Xylan 
Besides cellulose, the plant cell wall is composed of other polysaccharides generically termed 
hemicelluloses, a collectively name for various non-cellulose polysaccharides.  The predominant 
component of hemicellulose in grasses, angiosperms and hardwood is the polysaccharide xylan, 
which is also found in the cell walls of green algae.  Xylan has a backbone of β-1,4 linked D-
xylopyranosyl residues (1.3) which are pentose sugars (whereas glucose is a hexose).  This 
backbone often has side chain substitutions and may be decorated with α-L-D-
glucuronopyranosyl, 4-O-methyl-α-D-glucuronopyranosyl, α-L-arabinofuranosyl, O-acetyl, 
feruloyl or coumaroyl residues.   
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Figure 1.3.  The structure of xylan.  The backbone of xylan is made up of D-xylopyranosyl residues connected by β-
1,4 linkages.  Figure source: http://www.scientificpsychic.com/fitness/carbohydrates1.html. 
1.1.3 Starch 
Starch is present in all green plants as energy storage of glucose derived from carbon dioxide 
through photosynthesis.  Starch is stored in semi-crystalline granules the shape and size of which 
vary between plant organs and species (Smith 2001).  The two major polysaccharides in starch 
are amylose and amylopectin, with a relative weight percentage ranging from 72% to 82% for 
amylopectin and from 18% to 28% for amylose (Buléon et al. 1998).  The most abundant 
compound in starch granules, amylopectin (Figure 1.4), is a large molecule with a main chain 
composed of α-1,4 linked D-glucopyranosyl residues which is heavily branched through α-1,6 
linkages.   
 
Figure 1.4. The branched nature of amylopectin.  Amylopectin has a main-chain of 1,4-linked α-D-glucopyranosyl 
residues and is heavily branched with α-1,6 linkages.   
Figure source: http://www.scientificpsychic.com/fitness/carbohydrates1.html. 
Amylose is a relatively long and linear chain of α-D-glucopyranosyl units connected through α-
1,4 linkages (Figure 1.5) with few α-1,6 linkages (Buléon et al. 1998).   
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Figure 1.5.  The structure of amylose.   Αmylose consists of α-1,4 linked D-glucopyranosyl units. 
Figure source: http://www.scientificpsychic.com/fitness/carbohydrates1.html. 
Both the amylose chains and some exterior chains of amylopectin can form double helices 
which, in turn, may associate to form crystalline domains.  Starch is biosynthesized as semi-
crystalline granules, and the varying content of amylopectin and amylose in the granules gives 
varying degrees of crystallinity (Buléon et al. 1998).   
1.1.4 Chitin 
Chitin is an important structural biopolymer that functions as the main component of the cell 
walls of fungi, the exoskeletons of arthropods such as insects and crustaceans (e.g. crabs and 
shrimps) (Rinaudo 2006) as well as in molluscs (Peters 1972) and algae(Jeuniaux 1972).  Chitin 
is a linear insoluble homopolymer of β-1,4 linked N-acetyl-β-D-glucosamine (GlcNAc) 
(Blackwell 1988) as shown in Figure 1.6.  The repeating disaccharide units of the unbranched 
chitin chain contain two GlcNAcs that are rotated 180o relative to each other.    
 
Figure 1.6.  The structure of chitin.  The repeating units in chitin are disaccharides with the subsequent monomers 
of β-1,4 linked N-acetylglucosamine (GlcNAc) rotated 180oC to each other. 
Figure source: http://www.scientificpsychic.com/fitness/carbohydrates1.html. 
Chitin is similar to cellulose, only differing by the acetamido group on C2 in GlcNAc being 
replaced by a hydroxyl group in cellulose.  Like cellulose, chitin chains also form rigid crystal 
structures by intermolecular bonding.  However, because of the presence of the acetamido group, 
the structure of chitin is somewhat more open than the structure of cellulose (Eijsink et al. 2008)  
In nature, crystalline chitin is found in three different polymorphic forms dependent on the 
orientation of the GlcNAc-chains; α-chitin has an anti-parallel arrangement of the individual 
chains (Minke & Blackwell 1978) while the chains in β-chitin have a parallel arrangement 
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(Gardner & Blackwell 1975).   The least frequent form of chitin, γ-chitin, has a repeating 
structure of two parallel and one single anti-parallel chain.  
The α-form is the most rigid and abundant chitin polymer and the anti-parallel packing of the 
chains is stabilized by a high number of intra- and intermolecular hydrogen bonds (Carlström 
1957).  This arrangement contributes to the mechanical strength and stability seen in α-chitin 
containing organisms such as crustaceans and insects.  The crystal structure of β-chitin shows 
looser packing of the chains and fewer interchain hydrogen bonds, which is reflected in the 
ability to accommodate water molecules and results in a more flexible chitinous structure 
(Merzendorfer & Zimoch 2003).  β-chitin is frequently found in squid pen, a rigid internal body 
part found in some squids, and in certain phytoplankton (Blackwell 1988). 
Figure 1.6 above shows the fully acetylated form of chitin, however, deacetylation by 
concentrated NaOH or enzymatic hydrolysis yields a water-soluble copolymer of GlcNAc and 
D-glucosamine (GlcN) referred to as chitosan (Horn et al. 2006a).  Chitosans may differ in their 
degree of acetylation and solubility.     
The annual production of chitin in nature is estimated to be 1010- 1011 tons (Gooday 1990).   In 
principle, chitin is available in considerable amounts as underutilized waste product from e.g. the 
shrimp and crab industry.  Currently, only a small part of this biopolymer is utilized for the 
production of glucosamine and chitosan for use in e.g. water treatment, agriculture, food and 
paper industry, and personal-care products (Ravi Kumar 2000).  There are several other potential 
applications for chitin or chitosan based materials with both antibacterial and antifungal effects 
(Hoell et al. 2010). Alternatively, the polymers can be converted to bioactive oligomeric 
compounds or building blocks for bioactive glycol-conjugates (Aam et al. 2010).  However, lack 
of efficient enzyme technology is a hinder for the optimal degradation and utilization of chitin 
(Horn et al. 2006a). 
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1.2 Microbial degradation of polysaccharides 
As mentioned, the annual production of polysaccharides in nature is dominated by cellulose, 
hemicellulose and chitin.  Their main use is to protect the organism or cell from mechanical and 
chemical stress, thus forming rigid crystalline structures that are insoluble and difficult to 
chemically degrade.  In nature, however, there is no long term accumulation of these abundant 
polysaccharides, indicating efficient break down by microorganisms.  Bacterial and fungal 
degradation of complex polysaccharides is performed by extracellular enzymes which are either 
released in the surroundings or remain associated with the cell surface.  Secreted enzymes act 
synergistically to hydrolyse crystalline substrates into soluble mono-and oligosaccharides 
(Merino & Cherry 2007) which can be taken up by the organism and further processed.   
1.2.1 Degradation of cellulose 
Cellulose is degraded by bacteria and fungi which secrete cellulolytic enzymes (cellulases).  
Cellulases (EC 3.2.1.4) are found in family 5-10, 12, 18, 19, 26 44, 45, 48, 51, 61, 74 and 124 of 
glycoside hydrolases (GH; for details on the classification of carbohydrate active enzymes see 
section 1.3.1).  They are divided into exoglucanases/ cellobiohydrolases and endoglucanases.  
Synergistic cooperation of these enzymes is required for efficient cellulose degradation (Kurašin 
& Väljamäe 2011).  Endoglucanases are non-processive enzymes and cleave at random positions 
along the crystalline cellulose, thereby generating new chain ends for the processive 
cellobiohydrolases to attach to and continue degradation, releasing cellobiose units (Kurašin & 
Väljamäe 2011).  β-glucosidases (EC 3.2.1.21, found in GH family 1, 3, 5, 9, 30, 116) finally 
hydrolyse cellobiose into single glucose units. 
In recent years (Forsberg et al., 2011; Quinlan et al., 2011) it has become clear that microbial 
degradation of cellulose involves at least one additional class of (oxidative) enzymes known as 
lytic polysaccharide monooxygenases (LPMs); this is discussed in more detail in section 1.3.4. 
1.2.2 Starch degradation 
The hydrolysis of starch is performed by α-amylases (EC 3.2.1.1), belonging to GH families 13, 
14, 57 and 119.  Various physical and structural features influence the degradation of starch 
granules.  The main parameter determining degradation efficiency is granule crystallinity, 
depending on the extent of helix formation in amylose and amylopectin.  However, also granular 
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size, phosphorous contents, and complex formation between amylose and lipids affect the 
enzymatic degradation (Asare et al. 2011).    
1.2.3 Chitin degradation 
Two major are known.  The first pathway encompasses the deacetylation of chitin to chitosan by 
chitin deacetylases (EC 3.5.1.41, belonging to family 4 of carbohydrate esterase), followed by 
hydrolysis of the β-1,4 glycosidic bond in chitosan by chitosanases (EC 3.2.1.132, belonging to 
GH families 5, 7, 8, 46, 75 and 80)  (Hoell et al. 2010).  The other pathway, the chitinolytic 
pathway, involves initial hydrolysis of the β-1,4 glycosidic linkages in chitin by chitinases (EC 
3.2.1.14) belonging to GH families 18 and 19 (Henrissat 1991; Henrissat & Davies 1997).  This 
hydrolysis results in production of mainly dimers of GlcNAc that are subsequently degraded to 
GlcNAc monomers by  family 20 glycoside hydrolases called chitobiases (EC 3.2.1.29).  Like 
for cellulose, microbial degradation of chitin also involves LPMs (see section 1.3.4) (Vaaje-
Kolstad et al. 2010). 
Chitinolytic degradation is achieved in a synergistic manner by mixtures of hydrolytic exo- and 
endo-acting enzymes  (Horn et al. 2006b), similar to what is seen for cellulose degradation.  
These enzymatic machineries have the potential to convert the biomass to fermentable sugars, 
and are therefore of great interest for industrial purpose   Enzymes involved in degradation of 
crystalline polysaccharides have to be able to associate with the insoluble substrate, disrupt the 
polymer packing, and guide a single polymer chain into the catalytic centre (Eijsink et al. 2008).    
1.2.4 Biomass degrading microorganisms relevant for this study 
1.2.4.1 Serratia marcescens 
One of the most efficient chitin degraders described is the Gram-negative enterobacterium S. 
marcescens.  The bacterium is commonly found in soil, water and plants.   
The chitinolytic machinery of S. marcescens is induced by chitin (Brurberg et al. 1995; Monreal 
& Reese 1969) and consists of three family 18 chitinases, two processive enzymes working in 
opposite directions called ChiA and ChiB, and a non-processive endochitinase called ChiC, an 
LPM known as CBP21 (CBP for chitin binding protein; see section1.3.4 for more details), and a 
family 20 chitobiase (Brurberg et al. 1994; Brurberg et al. 1995; Fuchs et al. 1986; Horn et al. 
2006b).  
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1.2.4.2 Cellulomonas flavigena 
C. flavigena (Bergey et al. 1923) is an aerobic Gram-positive non-motile bacterium with 
snapping division (a post fission movement after rapid horizontal division of the cell resulting in 
an angular (V-) arrangement of the daughter cells before complete separation (Krulwich & Pate 
1971)).  C. flavigena’s preferred habitats are cellulose enriched environments such as soil, bark, 
wood, and sugar fields.  The bacterium secretes amylases   in addition to multiple enzymes for 
utilization of different lignocellulosic substrates (Sanchez-Herrera et al. 2007). Members of the 
genus Cellulomonas are known to degrade cellulose, xylan and starch (Abt et al. 2010).  The 
genome of C. flavigena encodes four family 33 carbohydrate-binding modules (CBM33s) all 
connected to a CBM2 domain (see section 1.3.5.1) and these proteins’ substrate specificity and 
function as putative lytic polysaccharide monooxygenases (LPMs, described further in section 
1.3.4) were the prior focus of this study. 
1.2.4.3 Aspergillus terreus 
The Aspergillus species are adapted for the degradation of complex plant polymers by secreting 
acids and enzymes into the surrounding environment, and are thus found in various terrestrial 
habitats.  A. terreus is a filamentous fungus that produces statins, clinically relevant secondary 
metabolites used in cholesterol-lowering drugs, and toxins associated with aspergillosis of the 
lungs and/ or disseminated aspergillosis (Bennett 2010).  The genome of A. terreus encodes one 
CBM33 connected to a CBM20 domain (see section 1.3.6.3.1) ant the substrate specificity and 
putative LPM-activity of this protein were the second focus of this study. 
1.3 Enzymes and binding modules involved in the degradation of 
polysaccharides 
1.3.1 Classification of carbohydrate active enzymes 
All enzymes are provided with an Enzyme Commission (EC) number by the Nomenclature 
Committee of the International Union of Biochemistry and Molecular Biology representing the 
reaction catalyzed and the substrate specificity of the enzyme.  However, this coding fails to 
identify enzymes with multiple substrate specificities and does not account for evolutionary 
relationships provided through sequence and structure data.  In 1991, Henrissat et al introduced a 
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new classification system to improve the classification of glycoside hydrolases  This system is 
based on amino acid sequence similarities (Henrissat 1991; Henrissat & Davies 1997) and 
formed the basis of the Carbohydrate-Active Enzymes (CAZY) database.  Today, an extended 
version of CAZY describes different families of structurally related enzymes that degrade, 
modify or create glycosidic bonds, and their carbohydrate-binding modules (Cantarel et al. 
2009).  As of June 2012 the, the database includes 130 families of glycoside hydrolases, 94 
families of glycosyl transferases, 22 families of polysaccharide lysases, 16 families of 
carbohydrate esterases and 64 families of carbohydrate-binding modules.     
1.3.2 Glycoside hydrolases 
Glycoside hydrolases (GHs, EC 3.2.1.-) are enzymes catalyzing the hydrolysis of glycosidic 
bonds in di-, oligo- or polysaccharides.  GHs acting on polysaccharides can be either exo-acting, 
cleaving the substrate from one end or endo-acting, only cleaving interior bonds in the substrate 
chain (Dilokpimol 2010).  GHs have a high structural diversity but the shape of the active site is 
more conserved and can be divided into three general classes: (i) pocket, (ii) cleft, and (iii) 
tunnel (Davies & Henrissat 1995).     
A deep cleft or a tunnel topology allows the enzyme to remain attached to the substrate during 
saccharification and degrade the substrate in a processive manner.  Processivity is a common 
feature of glycosidases that degrade crystalline polysaccharides such as cellulose and chitin.  As 
the process of gaining access to a single polymer chain is energetically unfavorable for an 
enzyme, a processive mechanism is thought to be beneficial for degradation of crystalline 
substrates.  However, the same properties that make an enzyme processive, may contribute to a 
reduced enzyme efficiency for certain substrates as processive enzymes tends to “get stuck” on 
their substrates. 
1.3.3  A closer view at GH18 chitinases and the chitinolytic machinery of S. 
marcescens 
One of the best-studied enzyme systems for the degradation of recalcitrant polysaccharides is the 
chitinolytic system from S. marcescens (Eijsink et al., 2008). The lytic polysaccharide 
monooxygenases, which are the main topic of the present study (see below), where originally 
discovered in this bacterium (Vaaje-kolstad et al., 2005a,b, 2010).  
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As stated in section 1.2.4.1, S. marcescens produces three GH18 chitinases when grown on 
chitin; ChiA, ChiB, and ChiC.  All these chitinases employ a substrate-assisted double 
displacement catalytic mechanism and contain the diagnostic sequence motif D-X-X-D-X-D-X-
E (D corresponds to aspartic acid, E to glutamic acid and X can be any amino acid), where the 
final glutamate in the motif acts as the catalytic acid (Durand et al. 2005). Crystal structures of 
both ChiA (Papanikolau et al. 2003; Perrakis et al. 1994) and ChiB (van Aalten et al. 2000) 
reveal deep “tunnel-like” substrate-binding clefts having a path of aromatic residues extending 
over the surface of the substrate-binding domain (Figure 1.7) (Perrakis et al. 1994; van Aalten et 
al. 2000).  In ChiB, this substrate-binding domain, a carbohydrate-binding module family 5 
(CBM5)-domain, extends the cleft on the side where the reducing end of the substrate binds, 
where in ChiA another type of substrate-binding domain, a fibronectin III-domain ( see section 
1.3.6.2), extends the cleft towards where the non-reducing end of the substrate binds.  The deep 
substrate-binding clefts in both ChiA and ChiB underpin the notion that these enzymes work in a 
processive manner.   
Glycosidases acting processively on non-soluble polysaccharides share a common feature of 
having aromatic residues, particularly tryptophans, lining the substrate-binding cleft.  Together 
with hydrogen bonding, aromatic residues are the dominant interaction in protein-carbohydrate 
complexes (Sørlie et al. 2012).  The impact of aromatic residues near the catalytic centres of 
ChiA and ChiB was demonstrated by Zakariassen et al. (2009) and Horn et al. (2006a), 
respectively.  In the former study, it was shown that by mutating two tryptophan residues near 
the catalytic centre (Trp167  Ala and Trp275  Ala, see Figure 1.7) ChiA showed a decrease in 
the processive degradation of crystalline β-chitin.  However, the loss of processivity resulted in 
increased activity towards chitosan, indicating that the rate-limiting step of the reaction depends 
on the solubility of the polymeric substrate (Zakariassen et al. 2009, (Zakariassen et al. 2009; 
Zakariassen et al. 2010).  Similar observations have been made for ChiB (Horn et al. 2006a). 
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Figure 1.7.  Crystal structures of ChiA (left, PDB: 1ctn) and ChiB (right, PDB: 1e15).  The catalytic acids, ChiA-
Glu315 and ChiB-Glu144, are colored blue and the aromatic residues involved in substrate binding are highlighted and 
numbered.  Note that the catalytic domains are oriented in a similar manner and that they are extended by CBMs in 
opposite directions (to the “non-reducing side” in ChiA, and to the “reducing side” in ChiB.  Protein structure 
graphics were made using PyMol (DeLano 2002). 
While both ChiA and ChiB are processive, exo-acting enzymes, the third chitinase expressed in 
S. marcescens, ChiC, is a non-processive endo-chitinase.  Judged from sequence alignments with 
ChiA and ChiB, ChiC has a much more open substrate binding groove (Suzuki et al. 1999). ChiC 
randomly hydrolyzes the polymer and yields longer chitooligosaccharides as products (Baban et 
al. 2010; Horn et al. 2006b).   It has two extra domains; one fibronectin III-like domain and one 
CBM12 domain, both with chitin-binding properties.  ChiC often occurs in two forms in cultures 
of S. marcescens; the complete protein, referred to as ChiC1, and a proteolytically truncated 
variant, called ChiC2, lacking the two chitin-binding domains (Horn et al. 2006b; Suzuki et al. 
1999). 
ChiA and ChiB degrade chitin chains from opposite ends, ChiA from the reducing end and ChiB 
from the non-reducing end (Baban et al. 2010; Horn et al. 2006b).  When including the non-
processive endo-acting ChiC, the three S. marcescens chitinases show strongly synergistic 
effects in degradation of different chitinous substrates (Brurberg et al. 1996; Hult et al. 2005; 
Suzuki et al. 2002).  The available data convincingly show that the three chitinases have different 
and complementary activities and directionalities, which explains the synergism (Horn et al. 
2006b).  Still, the picture is not completely clear, as ChiB and ChiC show little synergy in the 
hydrolysis of powdered chitin, while ChiA in combination with either ChiB or ChiC, show a 
clear synergy on the same substrate (Suzuki et al. 2002).  Recent findings on the role of CBP21 
from S. marcescens, which disrupts and depolymerizes the structure of crystalline chitin by an 
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oxidative mechanism, and thereby potentiates the chitinase activity (Vaaje-Kolstad et al. 2005a; 
Vaaje-Kolstad et al. 2010)  suggest other explanations for the synergistic effects as discussed in 
section 1.3.4). 
1.3.4 Lytic Polysaccharide Monooxygenases 
It has recently been discovered that enzymes now called lytic polysaccharide monooxygenases 
(LPMs) contribute to the depolymerization of polysaccharides. These enzymes are currently 
represented by two families in CAZY, carbohydrate-binding module family 33 (CBM33) and 
GH family 61 (GH61); both these families await re-classification).  The first structure of LPMs 
to be solved was of a CBM33, the chitin-binding protein CBP21 from S. marcescens (Figure 1.8) 
(Vaaje-Kolstad et al. 2005b).  In 2005 Vaaje-Kolstad et al (2005a; 2005b) discovered that 
CBP21 increases chitinase efficiency in degradation of certain forms of crystalline chitin.  At the 
time it was thought that the binding of CBP21 to crystalline chitin somehow led to changes in the 
substrate structure and increased substrate accessibility.  It was shown that CBP21 promoted 
hydrolysis of β-chitin by ChiA and ChiC, while it was essential for full degradation by ChiB.  In 
2010, Vaaje-Kolstad et al. revealed that CBP21 is a metal-dependent enzyme which generates 
chain breaks and oxidizes chain ends on the surface of crystalline chitin, thereby depolymerizing 
the substrate and making it more available for degradation by chitinases.   
Similar activities have been observed for members of the GH family 61 (GH61) (Phillips et al. 
2011; Quinlan et al. 2011; Westereng et al. 2011).  The GH61 enzymes share structural 
similarity with CBM33s (Fig. 1.8), but share a sequence identity of less than 10%.  The GH61 
family consists of fungal proteins up regulated during growth on cellulose and other 
polysaccharides from plant biomass (Hori et al. 2011).  They were originally classified as 
glycoside hydrolases in the CAZy database on the basis of weak endo-1,4-β-D-glucanase activity 
detected for one of the family members.  However, Harris et al. (2010) concluded that GH61 
proteins are unlikely to be classical glycoside hydrolases based on the lack of the characteristics 
of a glycosidase hydrolase.  Like CBM33s, GH61s have a remarkably flat substrate-binding 
surface and lack catalytic residues that are typical for glycoside hydrolases. Furthermore, unlike 
GHs, CBM33s and GH61 require divalent metal ions for optimal activity.   Harris et al. (2010) 
also described synergistic effects of GH61 and cellulases in hydrolyzing lignocellulose, 
indicating that GH61 activity corresponds to the activity of CBP21 (Harris et al. 2010).  In their  
paper on the discovery of the lytic oxidative properties of CBP21, Vaaje-Kolstad et al. (2010) 
pointed out that GH61s were likely to carry out the same chemistry, as suggested by conserved 
13 
 
active site architectures (Fig 1.8) and as later confirmed experimentally (Phillips et al. 2011; 
Quinlan et al. 2011; Westereng et al. 2011).   
 
Figure 1.8. Crystal structure of CBP21 (left, PDB ID: 2BEM) and GH61E from Thielavia terrestris (right, PDB ID: 
3EII).  The side chains of conserved histidine residues in the active site involved in binding of divalent copper are 
coloured in magenta in both models. Note that His28 and His19 in the left and right panels, respectively, are the N-
terminal residues of correctly processed secreted proteins.  Protein structure graphics were made using PyMol 
(DeLano 2002). 
In 2011, the oxidative properties and direct degradation of cellulose by a GH61 from 
Thermoascus aurantiacus (TaGH61) were described (Quinlan et al. 2011).  TaGH61’s oxidative 
activity was proven to be copper-dependent.  The copper binds to a type II copper site involving 
the methylated N-terminal histidine of the enzyme that acts as a metal-coordinating residue 
(Quinlan et al. 2011).  A similar activities were detected for PcGH61D, a GH61 from 
Phanerochaete chrysosporium (Westereng et al. 2011) and for Cdh-1, from Neuropora crassa 
(Phillips et al. 2011).  The GH61s cleave cellulose at the glycosidic bond and oxidize one of the 
new chain ends.  This is analogous to what has been described for the chitin-active CBM33s 
CBP21 (Vaaje-Kolstad et al. 2010) and CBM33A from Enterococcus faecalis (Vaaje-Kolstad et 
al. 2012) and the cellulose-active CBM33 CelS2 (Forsberg et al. 2011) Importantly, while data 
indicate that CBM33s and PcGH61D exclusively oxidize C1 in the scissile C1-C4 bond, it seems 
that other GH61 oxidize C4 in the scissile bond and perhaps even C6 at the newly generated non-
reducing end.  
Available data show that the activity of CBM33s and GH61s is increased by the presence of 
external electron donors such as ascorbic acid (Quinlan et al. 2011; Vaaje-Kolstad et al. 2010; 
Westereng et al. 2011), while Langston et al. (2011)and Phillips et al. (2011) showed the same 
using an electron donating enzyme, cellobiose dehydrogenase (enzymes oxidizing cellobiose to 
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the corresponding 1-5-δ-lactone).  Furthermore, after some initial confusion (Harris et al. 2010; 
Vaaje-Kolstad et al. 2010), several studies have convincingly shown that CBM33s and GH61s 
are copper dependent oxidases (Aachmann et al. 2011; Phillips et al. 2011; Quinlan et al. 2011; 
Westereng et al. 2011). Details of the catalytic mechanism remian to be unravelled but reaction 
mechanisms and names for these novel enzymes have been proposed.  One proposed reaction 
mechanism proposed by Phillips et al. (2011) is shown in  
Figure 1.9. Possible names for these enzymes include polysaccharide monooxygenase (PMO) or 
the name adapted in this report, lytic polysaccharide monooxygenase (LPM).  In their 2011 
paper presenting a possible mechanism for GH61s, Phillips et al. (2011) only consider C1- or 
C4- oxidation generating a lactone or a ketoaldose, respectively.  
 
Figure 1.9. PMO/LPM reactions and proposed mechanism. (Top) Type 1 PMOs abstract a hydrogen atom from 
carbon 1 leading to the formation of a sugar lactones, which will be spontaneously hydrolyzed to aldonic acids, 
depending on pH. Type 2 PMOs catalyze hydrogen atom abstraction from carbon 4 leading to formation of 
ketoaldoses. (Bottom) PMO mechanism: an electron, in this case from a heme domain of the cellobiose 
dehydrogenase, reduces the PMO Cu(II) to Cu(I) so O2 can bind.  By internal electron transfer, a copper superoxo 
intermediate is formed, which then abstracts an H• from C1 or C4 on the carbohydrate. A second electron from the 
cellobiose dehydrogenase leads to a cleavage of the Cu-bound hydroperoxide. The copper oxo-species (Cu–O•) then 
couples with the substrate radical, hydroxylating the substrate. Addition of the oxygen atom destabilizes the 
glycosidic bond and leads to elimination of the adjacent glucan (Phillips et al. 2011).  The Figure is from Phillips et 
al. (2011).  
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CBM33s and GH61s are not active on soluble cello- or chito-oligosaccharides (Vaaje-Kolstad et 
al., 2010; Westereng et al., 2011) and their flat active site surfaces (Fig. 1.8), suggest that these 
enzymes are optimized for interacting with ordered substrate surfaces as in crystalline substrates.  
Interestingly, the chromatographic profiles of products generated by oxidation of various 
cellulose or chitin substrates (PASC, Avicel, cellulose nanofibrils) differ from each other in 
terms of the dominance of even-numbered products.  This might reflect different binding modes 
towards different substrates with varying degree of crystallinity (Vaaje-Kolstad et al. 2010; 
Westereng et al. 2011).  Westereng et al. (2011) point out that putative functional difference 
between cellulolytic GH61s and CBM33s may yield synergistic effects when combining several 
of these proteins working on the same substrate.  This is interesting, as the genomes of most 
biomass-degrading microorganisms contain multiple genes encoding CBM33s or GH61s.  
Recently, Medie et al. (2012) introduced these enzymes as lytic oxidases, a name that is broad as 
oxidases covers all oxidizing enzymes and more informative than “PMO” as it indicates bond 
cleavage (“lytic”).  However, as monooxygen is incorporated into the product of the 
CBM33/GH61 catalyzed reaction (convincing experimental evidence from both Vaaje-Kolstad et 
al. (2010) and Beeson et al (2012)), the optimum name that would cover all aspects of the 
mechanism would be lytic polysaccharide monooxygenase (LPM), which is the name adopted in 
this report.  An overview of the degradation of cellulose by the synergistic action of LPMs, 
endoglucanases and cellobiohydrolases is shown in Figure 1.10. 
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Figure 1.10.  An overview of the enzymatic degradation of cellulose in presence and absence of LPMs (referred to 
as “lytic oxidizes” in the Figure). a)  Endoglucanases catalyze hydrolytic chain cleavage, resulting in non-oxidized 
chain ends (blue hexagons).  LPMs introduce chain cleavages on the crystalline substrate, resulting in oxidized chain 
ends (red hexagons).  Cellobiohydrolases are processive enzymes, and hydrolyze the cellulose into cellobiose.  β-D-
glucosidases can then further cleave the cellobiose to glucose monomers.  b) In the absence of oxidative cleavage, 
endoglucanases and processive cellobiodydrolases degrade the cellulose, but the rate limiting step is the numbers of 
chain ends (Medie et al. 2012).  The Figure is from Medie et al. (2012). 
1.3.5 Carbohydrate-binding modules 
Carbohydrate-binding modules (CBMs) are non-catalytic domains with a carbohydrate-binding 
activity that enhance the activity of many enzymes acting on complex carbohydrates (Cantarel et 
al. 2009).  CBMs are usually small and occur as clearly distinguishable domains separate from 
the catalytic domains of hydrolytic enzymes (Sorimachi et al. 1997).  They are thought to 
enhance the catalytic efficiency of the enzyme towards insoluble substrates by bringing the 
catalytic module in intimate contact with the substrate (Hashimoto et al. 2000), thus increasing 
the local concentration of substrate.  There are indications that certain CBMs may have a 
substrate-disrupting effect (Eijsink et al. 2008).  The CBM33s discussed above are no true CBMs 
but enzymes and will be re-classified in the near future. 
1.3.6 Carbohydrate-binding modules 
Carbohydrate-binding modules (CBMs) are non-catalytic domains with a carbohydrate-binding 
activity that enhance the activity of many enzymes acting on complex carbohydrates (Cantarel et 
al. 2009).  CBMs are usually small and physically separate from the catalytic domains of 
hydrolytic enzymes (Sorimachi et al. 1997).  They are thought to enhance the catalytic efficiency 
of the enzyme towards insoluble substrates by bringing the catalytic module in intimate contact 
with the substrate (Hashimoto et al. 2000
1.3.6.1 CBM2 
CBM family 2 (CBM2) contains members that primarily bind cellulose (CBM2a) and xylan 
(CBM2b), and in some instances chitin
8-residue loop in CBM2a that is absent from CBM2b 
surface-exposed tryptophan residues, forming a planar binding surface 
1.11) ideal for binding to the planar surface of crystalline cellulose. 
(W17 in Figure 1.11, left) is located 
conserved surface-exposed tryptophan residues, and one of these (W259 in 
rotated by 90o compared  to its corresponding position in CBM2a (W17 in 
(Simpson et al. 2000).  In crystalline xylan, the subsequent 
each other and the orientation of the surfa
Figure 1.11, right) favours binding
second pyranose ring of xylan.  
 
Figure 1.11. Crystal structure of the CBM2a of 
domain of xylanase D (Cfixyn11A, PDB ID: 1XBD
The surface exposed tryptophans involved in substrate binding are shown i
specificity-determining residues, Glycine in Xyn10A and Arginine in Xyn11A
but not labeled. Protein structure graphics
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Figure
Figure
pyranose rings are
ce exposed trytophans in CBM2b (W291 and W259 in 
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, right) both found in the genome of Cellulumonas flavigena
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 were made using PyMol (DeLano 2002). 
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Regarding the substrates, the only difference between glucose and xylose (see 
Figure 1.3) is the presence of a CH
(2000) describes how a mutation of an arginine near the rotated tryptophan in 
(Uniprot ID: P54865) to a glycine resulted in loss of affinity for
binding properties.  They conclude that the arginine holds the tryptophan in an orientation 
favorable for xylan-binding (Figure
nuclear magnetic resonance, supports thi
protein (Simpson et al. 200). 
Figure 1.12.  Cartoon and stick representation of the major functional difference between CBM families 
The representation shows a zoom-in showing the orientation of the 
Cfixyn11A (right) and the residue determining the conformation of this tr
in CBM2b).  Protein structure graphics were
1.3.6.2 Fibronectin III-like domain
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bacterial genomes (Perrakis et al. 1997
similar to fibronectin type III domains.
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Both ChiA and ChiC contain an N-terminal domain that has an immunoglobulin-like fold, both 
structurally similar to fibronectin III domains.  However, the N-terminal chitinase domains share 
no sequence similarity with fibronectin III domains (Perrakis et al. 1997).  Perrakis et al. (1997) 
proposed that such fibronectin III-like domains in chitinases are involved during catalysis by 
forming interactions with the chitin chain. The role of these domains in chitin-hydrolysis has 
been confirmed by several experiments (Watanabe et al. 1994). 
1.3.6.3 Starch binding domains  
Starch binding domains (SBDs) are present in approximately 10% of amylases and are usually 
located at the C-terminal end of the enzyme.  Starch binding domains are classified in CBM 
families 20, 21, 25, 26, 34, 41, 45, 48 and 53 in the CAZy database (Christiansen et al. 2009b).  
These domains mainly act on the surface of crystalline starch, allowing the enzyme to degrade 
whole starch granules (Morris et al. 2005).  Morris et al. (2005) also showed that proteolytic 
removal of the starch binding domain from an Aspergillus niger glucoamylase led to a dramatic 
reduction in activity towards granular starch, whereas this modification did not affect the activity 
towards soluble starch and oligosaccharides.  
1.3.6.3.1 CBM20 
Among the SBDs, the CBM family 20 (CBM20) is the best-studied family.  CBM20s are found 
in archaea, bacteria and eukaryotes, mainly linked to amylolytic enzymes (Christiansen et al. 
2009a).  The structure of the CBM20 of glucoamylase 1 (1,4-α-D-glucan glucohydrolase, EC 
3.2.1.3) from Aspergillus niger has been determined both when free in solution (Sorimachi et al. 
1996) (right in Figure 1.13) and when bound to β-cyclodextrin, an analogue of starch (Sorimachi 
et al. 1997) (left in Figure 1.13).   
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thought to lock the substrate into position for catalysis.  A flexible loop associated with binding 
site 2 (Fig. 1.13) allows binding of the SBD to starch strands in a variety of orientations 
(Sorimachi et al. 1997).   
CBM20 domains are proposed to play two roles in starch degradation. Firstly, they help enzymes 
to attach to granular starch and to increase the enzyme concentration at the substrate surface 
(Morris et al. 2005). Secondly, they “unwind” α-glucan helices on the granule surface, enhancing 
the cleavage by the catalytic domain (Southall et al. 1999). 
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1.4 Goal of this study 
The aim of this study was to provide more insight into the roles of different putative lytic 
polysaccharide monooxygenases (LPMs) from the family 33 of carbohydrate binding modules.  
These LPMs are of great interest both for the understanding of microbial polysaccharide 
degradation as well as for industrial purposes, to facilitate the degradation of crystalline 
substrates.  The main objective has been to clone, express, purify and characterize CBM33s from 
two different organisms, the bacterium C. flavigena, the primary target being CBM33s with 
activity on chitin or cellulose, and the fungus A. terreus, with the primary target being CBM33s 
with activity on starch. 
The first issue to be addressed was the characterization of the four CBM33s in the genome of C. 
flavigena (CfCBM33A, CfCBM33B, CfCBM33C and CfCBM33D; UniProt IDs are listed in 
Table 3.1).  The intention was to clone, express and purify all four CfCBM33s to study whether 
the CfCBM33s have different substrate specificities, if they work synergistically in substrate 
degradation, and whether or not the C-terminal CBM2 present in all four CfCBM33s is required 
for substrate specificity and degradation. 
The second part of this study was focused on a putative CBM33 from A. terreus (AtCBM33A; 
UniProt ID in Table 3.1). This CBM33 is of great interest as it is linked to a CBM20 domain, 
suggesting specificity towards starch.  So far, nothing is known about the starch degrading 
properties of CBM33s.  Since LPMs have proven to boost the degradation of chitin and 
cellulose, two recalcitrant crystalline structures, it is conceivable that CBM33s from a starch 
degrading fungus such as A. terreus work on starch.  Notably, there are no published data on 
CBM33s from fungi. 
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2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals 
Chemical Supplier 
2,5-Dihydroxybenzoic acid (DHB)  Bruker Daltonics 
Acetic acid 99.8 % VWR 
Acetonitrile (CH3CN) Fulltime 
Agar bacteriological (Agar No. 1) Oxoid 
Agarose, SeaKem® Lonza 
Albumin, bovine serum (BSA), Fraction V Sigma-Aldrich 
Ammonium bicarbonate (NH4HCO3) Sigma-Aldrich 
Ammonium chloride (NH4Cl) Fluka/ Sigma-Aldrich 
Ammonium sulphate (NH4 )2SO4 Merck 
Ampicillin Sigma-Aldrich 
Ascorbic acid Sigma-Aldrich 
Bacto™ Peptone Becton, Dickinson and Company 
Bacto™ yeast extract Becton, Dickinson and Company 
Bacto™Tryptone Becton, Dickinson and Company 
Biotin Sigma-Aldrich 
Bis-Tris (C8H19NO5) Sigma-Aldrich 
Brain heart infusion (BHI) Oxoid 
Calcium chloride (CaCl2) Sigma-Aldrich 
Calcium sulphate (CaSO4) Sigma-Aldrich 
Coomassie Brilliant Blue R250 Merck 
D(+)-Glucose monohydrate VWR 
DL-Dithiothreitol (DTT) Sigma-Aldrich 
D-Sorbitol Sigma-Aldrich 
Ethanol 96 % (v/v) Arcus 
Ethidium bomide, ultrapure Bioreagent J.T. Baker 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich 
Ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA-Na2) Sigma-Aldrich 
Gallic acid Sigma-Aldrich 
Glycerol 85 % (w/v) Merck 
Hepes (C8H18N2O4S) Sigma-Aldrich 
Hydrochloric acid (HCl) Merck 
Imidazole Sigma-Aldrich 
24  
 
Iodoacetamide Sigma-Aldrich 
Isopropyl β-D-1-thiogalactopyranoside Sigma-Aldrich 
L-Gluthation, reduced Sigma-Aldrich 
Magnesium chloride (MgCl2) Qiagen 
Magnesium sulphate (MgSO4) Merck 
Magnesium sulphate heptahydrate (MgSO4) x 7H2O Merck 
MES (C6H13NO4S ) hydrate Sigma-Aldrich 
Methanol, HPLC grade LAB-SCAN 
N-Acetyl-D-glucosamine Sigma-Aldrich 
Phenylmethanesulfonylfluoride (PMSF) Sigma-Aldrich 
Phosphoric acid (KOH) 85 % (w/v) Merck 
Potassium chloride (KCl) Merck 
Potassium dihydrogen phosphate (KH2PO4) Merck 
Potassium phosphate dibasic (K2HPO4) Sigma-Aldrich 
Potassium sulphate (K2SO4) Sigma-Aldrich 
Simply Blue SafeStain Invitrogen 
Sodium acetate (C2H3NaO2) Sigma-Aldrich 
Sodium acetate (CH3COONa) Sigma-Aldrich 
Sodium chloride (NaCl) Sigma-Aldrich 
Sodium hydroxide (NaOH) 50 % (w/v) J.T. Baker 
Sodium sulphate (Na2SO4) Sigma-Aldrich 
Sodium phosphate dibasic heptahydrate (Na2HPO4 x 7H2O) Sigma-Aldrich 
Sodiumdodecylsulfate (SDS) Bie & Berntsen 
Sulphuric acid (H2SO4) Sigma-Aldrich 
Thiamine Sigma-Aldrich 
Trifluoro acetic acid (TFA) Sigma-Aldrich 
Tris(hydroxymethyl)aminomethan (Tris-HCl) Sigma-Aldrich 
Yeast extract Remel 
Yeast Nitrogen Base (YNB) Fluka 
Zeocin™ Invitrogen 
α-cyano-hydroxy-cinnamic acid (CHCA), 97 % (w/v) Aldrich 
Β-lactoglobulin from Bovine Milk, 90 % (w/v) Sigma-Aldrich 
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2.1.2 Carbohydrate substrates 
Table 2.1.  Polysaccharide substrates used for cultivation experiments, binding assays and degradation experiments. 
Note that only some of the substrate specifications are known. 
Substrate Origin Specifications provided by supplier Supplier 
α-chitinA Shrimp shell Dried  and milled  Hov Bio, Tromsø, Norway 
α-chitinB Crab shell Dried  and milled Y. Nakagawa, Japan 
α-chitinC Crab shell Milled by cutter mill 60 sec, 88 % 
crystallinity  
Y. Nakagawa, Japan 
α-chitinD Crab shell Ball mill 30 min,  30% crystallinity Y. Nakagawa, Japan 
α-chitinE Nanofiber  S. Ifuku, Japan
 
β-chitinA Squid pen  dried  and milled France chitin, France 
β-chitinB Squid pen  dried  and milled Y. Nakagawa, Japan 
β-chitinC Squid pen  Cutter mill 60 sec, 78 % 
crystallinity  
Y. Nakagawa, Japan 
β-chitinD Squid pen  Ball mill 60 min, 32 % crystallinity  Y. Nakagawa, Japan 
β-chitinE Nanofiber  S. Ifuku, Japan 
CelluloseA Avicel ~50 µm particle size  PH101Sigma-Aldrich 
CelluloseB PASC Phosphoric acid swollen cellulose  K. Igarashi 
CelluloseC Filter paper 0.5 mm Whatman no. 1 
Xylan Birchwood xylan  Roth, Karlsruhe, Germany 
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2.1.3 Primers 
Table 2.2. Primers by name and sequence. 
Primer name Primer sequence (5’  3’) 
InFCf33AF CGCAACAGGCGAATGCTCACGGCTCCGTCACCGACCC 
InFCf33AR1 CAGCCGGATCAAGCTTTCAGGCCGCGGTGCAGGT 
InFCf33AR2 CAGCCGGATCAAGCTTTTACGCGGTCCCGTTGATGTT 
InFCf33BF CGCAACAGGCGAATGCTCACGGTGCCGTGTCCGACC 
InFCf33BR1 CAGCCGGATCAAGCTTTCAGGCGGCTGCGCAGGT 
InFCf33BR2 CAGCCGGATCAAGCTTTTAGCCACCGAAGGTCAC 
InFCf33CF CGCAACAGGCGAATGCTCACGGGTGGATCTCCGACC 
InFCf33CR1 CAGCCGGATCAAGCTTTCAGGCGGCCGCGCAGGT 
InFCf33CR2 CAGCCGGATCAAGCTTTTAGCCACCGGGCGTGATGT 
InFCf33DF CGCAACAGGCGAATGCTCACGGCGGTCTGACGAACCC 
InFCf33DR1 CAGCCGGATCAAGCTTTCAGCGGACGATGCAGGGCT 
InFCf33DR2 CAGCCGGATCAAGCTTTTAACCACCGAAGTCCACGT 
Seq1Cf33A CATCAACGGGACCGCGCCGACGCAG 
Seq2Cf33A CCGCCTGGTAGAGACCGGTCGTGCC 
Seq1Cf33B TGACCTTCGGTGGCGGTGGGACGCC 
Seq2Cf33B TGCTTCGTCACGTAGATCTTCAGGT 
Seq1Cf33C CACCGCGACGTTCAAGACGAACAAC 
Seq2Cf33C CTCGGGCAGGTTGTTGATCGTGTGC 
Seq1Cf33D CGTTCTACAACTGCGTCGACGTGGA 
Seq2Cf33D CTTGCCGCTCTTGTTCGACGGCAGC 
3320_XhoI_SP ATAACTCGAGAAAAGAGAGGCTGAAGCTCACGGCTACTTGACTATTC 
3320_XbaI_ASP GCGTCTAGATCAACGCCAAGAAGCGGCTG 
pRSET-B SeqF GATCTCGATCCCGCGAAATT 
pRSET-B SeqR TGTTAGCAGCCGGATCAAGC 
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Table 2.3. Primers by name and description.  
Primer name Primer description 
InFCf33AF Cfcbm33A, forward cloning primer 
InFCf33AR1 Cfcbm33A, reverse cloning primer, full-length protein 
InFCf33AR2 Cfcbm33A-N, reverse cloning primer, N-terminal domain 
InFCf33BF Cfcbm33C, forward cloning primer 
InFCf33BR1 Cfcbm33C, reverse cloning primer, full-length protein 
InFCf33BR2 Cfcbm33C-N, reverse cloning primer, N-terminal domain 
InFCf33CF Cfcbm33D, forward cloning primer 
InFCf33CR1 Cfcbm33D, reverse cloning primer, full-length protein 
InFCf33CR2 Cfcbm33C-D, reverse cloning primer, N-terminal domain 
InFCf33DF Cfcbm33B, forward cloning primer 
InFCf33DR1 Cfcbm33B, reverse cloning primer, full-length protein 
InFCf33DR2 Cfcbm33B-N, reverse cloning primer, N-terminal domain 
Seq1Cf33A Cfcbm33A, forward sequencing primer (annealing in the middle of the gene) 
Seq2Cf33A Cfcbm33A, reverse sequencing primer (annealing in the middle of the gene) 
Seq1Cf33B Cfcbm33C, forward sequencing primer (annealing in the middle of the gene) 
Seq2Cf33B Cfcbm33C, reverse sequencing primer (annealing in the middle of the gene) 
Seq1Cf33C Cfcbm33D, forward sequencing primer (annealing in the middle of the gene) 
Seq2Cf33C Cfcbm33D, reverse sequencing primer (annealing in the middle of the gene) 
Seq1Cf33D Cfcbm33B, forward sequencing primer (annealing in the middle of the gene) 
Seq2Cf33D Cfcbm33B, reverse sequencing primer (annealing in the middle of the gene) 
3320_XhoI_SP Atcbm33A, forward cloning primer  
3320_XbaI_ASP Atcbm33A, reverse cloning primer  
pRSET-B SeqF pRSET-B, forward sequencing primer   
pRSET-B SeqR pRSET-B, reverse sequencing primer   
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2.1.4 Bacterial strains and plasmids 
Table 2.4. Bacterial strains 
Strain Source 
Escherichia coli DH5α Invitrogen 
Escherichia coli TOP10 Invitrogen 
Cellulomonas flavigena (DSM 20109) ATCC (http://www.lgcstandards-atcc.org/) 
Pichia pastoris X-33 Invitrogen 
 
Table 2.5. Plasmids 
Plasmid Source or reference 
pPICZα-A Invitrogen (vector map is shown in Appendix D, Fig D.1) 
pRSET-B/cbp21 (Vaaje-Kolstad et al. 2012) (pRSET-B vector map retrived 
from Invitrogen is shown in Appendix D, Fig D.2) 
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2.2 Cultivation of microorganisms 
2.2.1 Agars, cultivation media and substrates 
All medium and agar solutions were autoclaved on liquid cycle at 15 psi (1 bar) and 121oC for 
20 minutes. 
2.2.1.1 Luria Bertani (LB) 
Liquid medium 
10 g Bacto Trypton 
5 g Bacto yeast extract 
10 g NaCl  
After carefully mixing and dissolving the ingredients, the volume was adjusted to 1 litre with 
dH2O and the medium was autoclaved. If the medium was used to select for positive 
transformants, 50 µg/ml ampicillin was added prior to cultivation. 
Agar plates 
15 g/liter agar was added to the LB medium before autoclaving.  After cooling to ~55oC and, if 
selecting for transformants, addition of 50 µg/ml ampicillin; the medium (1 liter) was distributed 
on 20 Petri dishes. After cooling for 20 minutes the plates were stored wrapped in plastic at 
+4oC.  
2.2.1.2 Low salt LB 
Liquid medium 
10 g Bacto Tryptone 
5 g Bacto yeast extract 
5 g NaCl 
After carefully mixing and dissolving the ingredients with 900 ml dH2O the pH was adjusted to 
7.5 using 1 M NaOH.  The volume was adjusted to 1 liter with dH2O before autoclaving.   Prior 
to use, ZeocinTM was added to 25 µg/ml final concentration.   
 
Agar plates 
15 g/liter agar was added to the low salt LB medium before autoclaving.  After cooling to 55oC, 
ZeocinTM was added to 25 µg/ml final concentration and the medium (1 liter) was distributed on 
20 petri dishes.  After cooling for 20 minutes, the plates were wrapped in foil and stored at 4oC. 
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2.2.1.3 Terrific broth (TB) 
10 x TB salts:  
23.12 g KH2PO4 
125.41 g K2HPO4 
The chemicals were carefully mixed, and dissolved in dH2O to a final volume of 1 liter and 
autoclaved. 
Liquid medium   
12 g Bacto Trypton 
24 g Bacto yeast extract 
4 g glycerol 
All ingredients were carefully mixed and dissolved in dH2O to a final volume of 900 ml before 
autoclavation.  After autoclavation the medium was added 100 ml 10 x TB salts. 
 
2.2.1.4 Brain Heart Infusion (BHI) 
Liquid medium 
37 g BHI 
BHI was completely dissolved in dH2O to a final volume of 1 liter and autoclaved. 
 
2.2.1.5 Yeast extract Peptone Dextrose (YPD) 
Liquid medium 
10 g yeast extract 
20 g peptone 
100 ml 20% (w/v) glucose, filter-sterilized 
Yeast extract and peptone were dissolved in dH2O to a total volume of 900 ml and autoclaved; 
after cooling down glucose was added.  When selecting for transformants of P. pastoris 
ZeocinTM was added to the medium to a final concentration of 1µg/ml right before use. 
 
Agar plates 
20 g agar was added per 1 liter final volume of medium before autoclaving. After cooling to 
below 60oC, glucose and 1 µg/ml ZeocinTM were added before spreading on plates.  Plates 
containing ZeocinTM were stored in the dark at 4oC.   
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2.2.1.6 Yeast extract Peptone Dextrose medium with Sorbitol (YPDS) 
Liquid medium 
10 g yeast extract 
20 g peptone 
182.2 g sorbitol 
100 ml 20% (w/v) glucose, filter-sterilized 
Yeast extract, peptone and sorbitol were dissolved in dH2O to a total volume of 900 ml and 
autoclaved; after cooling down glucose was added. When selecting for transformants of P. 
pastoris, ZeocinTM was added to the medium to a final concentration of 1 µg/ml right before use. 
 
Agar plates 
For agar plates, 20 g agar was added per 1 liter final volume of medium before autoclaving.  
After cooling to below 60oC, glucose and 1 µg/ml ZeocineTM were added before spreading on 
plates.  Plates containing ZeocinTM were stored in the dark at 4oC.    
 
2.2.1.7 Buffered complex media 
1M potassium phosphate buffer, pH 6.0: 
66 ml 1M K2HPO4  
434 ml 1M KH2PO4 
The solutions were mixed together and the pH assured to be 6.0 before autoclaving.   
 
2.2.1.8 Buffered complex glycerol medium (BMGY): 
10 g yeast extract 
20 g peptone 
100 ml 1M potassium phosphate buffer, pH 6.0 
100 ml 13.4 % (w/v) YNB  
2 ml 0.02 % (w/v) Biotin 
100 ml 10 % (w/v) Glycerol 
Yeast extract and peptone were dissolved in 700 ml dH2O and autoclaved.   After cooling to 
room temperature, potassium phosphate buffer and filter-sterilized YNB, biotin and glycerol 
were added. 
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2.2.1.9 Buffered complex methanol medium (BMMY) 
The recipe for BMGY was followed but instead of glycerol 100 ml 5 % (v/v) methanol was 
added as carbon source. 
2.2.2 Antibiotics used for selective growth of microorganisms 
Zeocin™ 
Zeocin™ (Invitrogen) is an antibiotic isolated from the bacterium Streptomyces verticillus.   It 
shows strong toxicity against bacteria, fungi (including yeast), plants and mammalian cell lines.  
It binds to DNA and introduces nucleotide-specific DNA cleavage (Bostock et al. 2003).  
Organisms with the Shble gene (Streptoalloteichus hindustanus bleomycin gene) incorporated in 
their genome are resistant to Zeocine™.  Bleomycine-protein binds stoichiometrically to 
Zeocin™ and inhibits its activity.  In this study, Zeocin™ was used in selecting for positively 
transformed E. coli and P. pastoris, carrying the pPICZα-A vector containing the Shble-gene and 
the gene of interest. 
Ampicillin 
Ampicillin (Sigma-Aldrich) is a beta-lactam antibiotic active against both Gram-negative and 
Gram-positive bacteria.  Ampicillin is commonly used as a selective marker in routine 
biotechnology.  The β-lactamase (bla) promoter in pRSET-B allows expression of the ampicillin 
resistance gene, β-lactamase, which, in turn, allows selection of the plasmid in Escherichia coli. 
2.2.3 Cultivation of bacterial strains 
All reagents and media used for cultivation were sterilized either by autoclaving or sterile-
filtration (0.45 µm pore size).  All culturing work was performed in sterile conditions.  To start a 
new culture, a single colony from an agar plate or a piece of glycerol stock (see section 3.3) was 
inoculated in 5 ml medium of choice in culture tubes and incubated overnight at 30°C or 37°C 
with shaking at 220 rpm as described in further detail below.  For media recipes, see section 
2.2.1. Growth of microorganisms was monitored by measuring optical density at a wavelength of 
600 nm (OD600).  
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C. flavigena strain DSM 20109 (TaxID: 446466) was cultivated in LB-medium, either on solid 
agar plates or in liquid medium, both without antibiotics, at 30°C in a heating cabinet overnight.   
Liquid cultures were incubated with shaking at 220 rpm.   
E. coli is the most used model organism in prokaryotic genetics, physiology and biochemistry, 
and the most used bacterium in production of heterologous proteins.  The Gram-negative, rod-
shaped bacterium is typically present in the lower intestine of humans.   Most E. coli strains have 
a generation time of about 20 minutes. 
E. coli strains without antibiotic resistance were cultivated on LB- agar plates or in liquid LB- 
medium at 37°C in a heating cabinet overnight.   Cultures in liquid LB were incubated with 
shaking at 220 rpm.   
E. coli TOP10 cells (Invitrogen) carrying plasmids encoding ampicillin resistance were 
cultivated in liquid LB-medium supplemented with 50 µg/ml ampicillin or on LB- agar plates 
supplemented with 100 µg/ml ampicillin. 
E. coli Bl21 Star™ (DE3) cells (Invitrogen) carrying plasmids encoding ampicillin resistance 
were cultivated in LB- medium supplemented with 50 µg/ml ampicillin or on LB-agar plates 
supplemented with 100 µg/ml ampicillin.  For optimal expression of CfCBM33 (see below), 
cells were grown in TB-medium supplemented with 50 µg/ml Ampicillin at 25°C for 3 days. 
E. coli XL gold cells (Stratagene) carrying plasmids encoding ZeocinTM resistance were 
cultivated in Low Salt LB- media or on Low Salt LB- agar plates, both containing 25 µg/ml 
ZeocinTM.  It is necessary to use a low salt medium with neutral pH because both high ionic 
strength and acidity or basicity inhibits the antibiotic activity of Zeocin™.   
2.2.4   Cultivation of Pichia pastoris  
The yeast P. pastoris is frequently used as a protein expression system.  It combines important 
properties of higher eukaryotic systems related to protein processing, protein folding and post 
translational modifications, with being almost as easy to grow and manipulate as E. coli or 
Saccharomyces cerevisiae.    
P. pastoris strain X-33 was cultivated in yeast extract peptone (YPD)-medium or on YPD-agar 
plates.  To start a new culture, a single colony from an agar plate was inoculated in 5 ml YPD-
medium in culture tubes and grown at 30°C overnight with shaking at 220 rpm.  P. pastoris X-33 
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has a generation time of about 2.7 hours when grown on YPD-medium and an OD600 of 1 
corresponds to a cell density of 5 x 107 cells/ ml (M. Abou Hachem, personal communication). 
For selection of positive transformants of P. pastoris, the culture was cultivated in YPD-medium 
(liquid or agar plates) supplied with Zeocin™ accordign to section 2.2.2. 
For protein expression, P. pastoris was grown in buffered complex methanol medium (BMMY) 
with methanol as the sole carbon source.  Every day methanol was added to a final concentration 
of 0.5 % (v/v) to compensate for consumption and, to some extent, evaporation.   
2.2.5   C. flavigena cultivation experiments 
As noted in section 1.2.4.2, C. flavigena is reported to use both xylan and cellulose as carbon 
source.  Previous studies have shown successfully growth of C. flavigena with xylan and 
cellulose as sole carbon source (Sanchez-Herrera et al. 2007).  To examine C. flavigena’s 
metabolic adaptation, the bacterium was cultivated in minimal medium supplied with different 
substrates with glucose as a control. 
Materials 
o M9-salts:   
64 g Na2HPO4×7H2O 
15 g KH2PO4  
2.5 g NaCl 
5.0 g NH4Cl 
All ingredients were dissolved in dH2O to a final volume of 1 liter and autoclaved. 
o 1M MgSO4 
o 1M CaCl2 
o Autoclaved dH2O 
o Substrates (see section 2.1.2, Table 2.1): 
- CelluloseA 
- Xylan 
- α-chitinA  
- β -chitinA  
- Glucose  
o 0.1 mg/ml Biotin  
o 10 mg/ml Thiamine   
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Procedure 
For each culturing flask, minimal medium was made by mixing 30 ml M9-salts, 0.3 ml 1M 
MgSO4 and 15 µl 1M CaCl2 with 116,7 ml dH2O.   A 5 ml overnight inoculum of C. flavigena 
(prepared according to section 2.2.3) was centrifuged and the pellet resuspended in 1 ml minimal 
medium.   Out of this suspension, 150 µl was transferred to each culturing flask (1 litre) 
supplemented with 10 µg/L biotin, 1 mg/L thiamine, and 1% (w/v) substrate (all final 
concentrations).   As a control, one culture was set up in minimal medium containing 0.2 % 
(w/v) glucose.  All cultures (total volume 250 ml) were incubated at 30°C with shaking at 220 
rpm for a total of 7 days.  Each day, 10 ml of each culture was taken out. After removing the 
cells by centrifugation the culture supernatants were concentrated by the use of Amicon Ultra 
centrifugal filter units with 10 kDa cut-off (Millipore) and analyzed by SDS-PAGE according to 
section 2.18.  
2.3 Long-term storage of microorganisms 
For long term storage of microorganisms, glycerol was added as a cryoprotectant in order to 
ensure the survival of most cells.  Cultures of the different microorganisms, containing different 
constructs, were preserved by glycerol as follows: 
o 1 ml overnight bacterial or yeast culture  
o 300 µl glycerol (85 % (w/v), sterile) 
After carefully mixing the culture with glycerol in a cryo-tube, the glycerol stock was kept at -
80°C.   Inoculations of new cultures were made by scraping small amounts of the frozen stock 
with a toothpick and inoculating tubes containing 5 ml appropriate growth medium including 
antibiotics when required. Alternatively, the cells were first inoculated on an agar plate for 
obtaining single colonies. 
2.4 Extraction of chromosomal DNA from C. flavigena 
Materials 
o TE-buffer pH 7.0:  
1 ml 1M  Tris-HCl (final concentration 10 mM) 
0.2 ml 0.5 M EDTA (final concentration 1 mM) 
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Tris-HCl and EDTA were completely dissolved in dH2O to a total volume of 60 ml and the 
pH regulated to 7.0 with 6 M HCl.  Finally, the volume was adjusted to 100 ml with dH2O. 
o E.Z.N.A.®  Bacterial DNA Kit (Omega Bio-Tek) 
- Lysozyme Solution 
- BTL Buffer 
- Proteinase K 
- RNaseA 
- DBL Buffer 
- DNA Wash Buffer 
- Elution Buffer, preheated to 65°C 
- HiBind DNA columns, collection tubes  
o 96% Ethanol 
 
Procedure 
Extraction of the chromosomal DNA from C. flavigena was performed according to the 
E.Z.N.A.®  Bacterial DNA Kit, spin protocol: 
2 ml C. flavigena overnight culture was harvested by centrifugation at 4,000 x g for 10 min at 
room temperature.  After completely removing the medium, cells were resuspended in 100 µl TE 
buffer before 10 µl 50 mg/ml lysozyme solution was added.   The sample was incubated at 37°C 
for 10 minutes for lysozyme digestion of the cell wall.  To digest proteins in the mixture, and 
thereby incapacitate any DNases, 100 µl BTL buffer and 20 µl 2 mg/ml proteinase K were added 
to the sample.   After incubation at 55°C in a water bath for 1 hour, 5 µl RNaseA was added and 
the tube that was immediately inverted at least 6 times, followed by 5 minute incubation at room 
temperature.  220 µl DBL buffer was added, and after vortexing the sample was incubated at 65° 
C for 10 min.  To ensure optimal binding of sample DNA to the column, 220 µl 96% ethanol 
was added and the sample vortexed for 20 seconds (no precipitation was observed).  The sample 
was transferred to a HiBind DNA column placed in a collection tube and centrifuged at 10,000 x 
g for 1 minute.  The flow-through was discarded and two wash steps were performed each with 
700 µl DNA wash buffer.  All flow-through was discarded.   The HiBind DNA Column was then 
dried by centrifugation at max speed for 2 min and then placed in a nuclease-free 1.5 ml 
microfuge tube.  50 µl elution buffer preheated to 65°C was then applied to the HiBind matrix 
followed by a 3 minute incubation room temperature.  The DNA was eluted by centrifugation at 
10,000 x g for 1 min.   For maximum yield, the elution step was repeated once.   
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2.5 Polymerase Chain Reaction 
The Polymerase chain reaction (PCR) is an in vitro technique used for amplification of specific 
nucleotide sequences.  The reactions require both sequence specific oligonucleotide primers 
complementary to the sequence of interest, dNTPs, and a thermo-stable DNA polymerase.    
2.5.1 PCR using Phusion™ High-Fidelity DNA Polymerase  
Phusion™ High-Fidelity DNA Polymerase (Finnzymes) works fast and generates long DNA 
molecules with a high accuracy.  In this study, the polymerase was used for three purposes: i) 
Amplification of putative LPM-genes Cfcbm33A, Cfcbm33B, Cfcbm33C, and Cfcbm33D from C. 
flavigena, all without the signal sequence and in two variants, one with and one without the C-
terminal CBM2-domain.  ii)Amplification of the codon optimized and synthetically made  
putative LPM-gene Atcbm33A from A. terreus NIH2624 (Taxid: 341663; see 
www.genescript.com/ for details on codon optimization algorithms and gene synthesis protocol).  
iii) Verification of transformed P. pastoris X-33 cells carrying the Atcbm33A gene in the 
genome. 
Materials 
o Phusion™ High-Fidelity DNA Polymerase (Finnzymes): 
- dNTP mix, 10 mM 
- 5x Phusion™ GC Buffer 
- Phusion™ DNA polymerase (2 U/µl) 
o Primers (see section 2.1.3, Table 2.2 and 2.3) 
o Nuclease-free dH2O 
Procedure 
PCR reactions (50µl) were set up on ice in 0.2 ml PCR tubes according to table 2.6.   Reaction 
mixes were placed in a Master cycler gradient 120V (Eppendorf) and amplification was carried 
out using the settings shown in table 2.7. 
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Table 2.6. Reaction setup for PCR using Phusion™ High-Fidelity DNA Polymerase 
Reagents Volume (Final concentration) 
dNTPs 10 mM 1 µl (2 mM) 
5x Phusion™ HF / GC buffer* 10 µl 
DNA Template 2 µl (approximately 80 ng) 
Forward primer 1 µl ( 0.5 µM) 
Reverse primer 1 µl (0.5 µM) 
dH2O 34.5 µl 
Phusion™ DNA Polymerase 0.5 µl (1 U) 
*5x Phusion HF- buffer was used in PCR reactions with Atcbm33A as template, whereas the GC-buffer was used in 
reactions with Cfcbm33’s because of a high GC- content in the C. flavigena genome. 
 
Table 2.7.  Cycling parameters for PCR using Phusion™ High-Fidelity DNA Polymerase. 
Step Temperature Time (minutes:seconds) Number of cycles 
Initial denaturation 98°C 1:30  1 
Denaturation 98°C 0:10  
25 Annealing 60°C 0:30  
Elongation 72°C 3:00  
Final elongation 72°C 5:00  1 
 
After amplification, the PCR products were analyzed by agarose gel electrophoresis, described in 
section 2.5.3.  The appropriate DNA band was cut from the gel and the DNA fragment purified 
as described in section 2.5.4 . 
2.5.2 PCR using Red Taq DNA Polymerase Master Mix 
Red Taq DNA Polymerase Master Mix (VWR) contains Taq polymerase, dNTPs and 
magnesium chloride.  This mix was used in PCR reactions to verify transformed products. 
Materials  
o Red Taq DNA Polymerse Master Mix (VWR) 
o Primers (see section 2.1.3, Table 2.2) 
o dH2O 
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Procedure 
PCR reactions were set up on ice in 0.2 ml PCR tubes following table 2.8.  The reaction mixes 
were placed in a Master cycler gradient 120V (Eppendorf) and the amplification was carried out 
according to table 2.9.  
Table 2.8. PCR reactions set up using Red Taq DNA Polymerase Master Mix. 
Reaction Component Volume 
Forward sequencing primer for pRSET-B  5 µl (50 pmol) 
Reverse sequencing primer for pRSET-B 5 µl (50 pmol) 
Template DNA 1/5 of a colony with transformed cells dissolved in 5 µl dH2O 
dH2O 10 µl 
Red Taq DNA Polymerase Master Mix 25 µl 
 
Table 2.9. Program for the thermal cycler when using Red Taq DNA Polymerase Master Mix. 
Step Temperature Time (minutes:seconds) Number of cycles 
Initial denaturation 64°C 6:00 1 
Denaturation 95°C 0:30 
25 Annealing 60°C 0:30 
Elongation 72°C 0:30 
Final Elongation 72°C 5:00 1 
 
After amplification, the PCR product was analyze by agarose gel electrophoresis as described in 
section 2.5.3. 
2.5.3 Agarose gel-electrophoresis 
The final PCR products were verified by separation on a 1% agarose gel.  Linear DNA 
molecules are charged and, when subject to an electric field in a gel matrix they are separated 
according to size.  For DNA visualization, ethidium bromide was added to the gel.  Ethidium 
bromide intercalates between the stacked nucleotide bases and because of its fluorescent 
properties, DNA binding ethidium bromide can be visualized under a UV lamp.  The size of the 
DNA molecules is determined by comparison to a DNA ladder comprised of DNA fragments of 
known size.   
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Materials 
o Agarose 
o 1x TAE-buffer:  
4.85 g Tris-base 
1.14 ml Acetic acid, 99.8% (v/v) 
2 ml 0.5 M EDTA, pH 8.0 
Dissolved and mixed in 1 liter dH2O, yielding a final pH of 8.5. 
o Ethidium bromide, 10 mg/ml 
o 10x loading buffer (Takara)  
o 1 kb DNA ladder (Fermentas) or 100 bp DNA ladder (New England Biolabs) 
Procedure 
1 % (w/v) agarose gels were made by dissolving 0.5 g agarose in 50 ml 1xTAE-buffer by careful 
heating in a microwave-oven.  The solution was cooled to below 60°C before 1 µl Ethidium 
bromide was added.  The gel solution was poured into the gel-chamber of a Mini-Sub Cell GT 
cell with a UV-transparent gel casting tray (Bio-Rad) with a 15-wells spacer, and left to solidify.  
After 30 minutes the, spacer was removed and the gel transferred to an electrophoresis chamber.  
1xTAE- buffer was added to the chamber covering the gel completely.  Both the 1 kb DNA 
ladder and samples were added 0.1 volumes 10x loading dye and applied to the gel.  The gel was 
run for 40 minutes at 90 volt using PowerPac Basic™ power supply (Bio-Rad) and DNA-bands 
were visualized by UV light. 
2.5.4 Extraction of DNA fragments from agarose gels 
Materialer 
o NucleoSpin® Extract II kit (Macherey-Nagel) 
- Solubilisation-binding NT buffer 
- Wash- buffer NT3 
- Elution buffer NE 
- NucleoSpin® Extract II columns and 2 ml collection tubes 
o Scalpel 
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Procedure 
Extraction of verified PCR products from the agarose gel was done using the NucleoSpin® 
ExtractII- kit.  All centrifugations were carried out at room temperature for 1 minute at 11,000 x 
g using a Centrifuge 5415R (Eppendorf). 
The DNA fragment was excised from the agarose gel by cutting carefully around the band with a 
clean scalpel.  The weight of the gel piece was determined and for every 100 mg of agarose gel, 
200 µl NT buffer were added, followed by incubation at 50°C until the gel slice was completely 
dissolved.  The sample was then loaded onto a NucleoSpin® Extract II column placed in a 2 ml 
collecting tube and centrifuged.  The flow-through was discarded and the column washed with 
600 µl NT3 buffer by centrifugation.  After discarding the flow-through, remaining liquid was 
removed from silica membrane by re-centrifugation.  The NucleoSpin® Extract II column was 
placed into a clean 1.5 ml micro centrifuge tube and added 25 µl elution buffer NE.  After 
incubation at room temperature for 1 minute, the DNA was eluted by centrifugation.  The elution 
step was repeated once to increase the yield of eluted DNA. 
2.6 Plasmid isolation from E. coli 
2.6.1 Plasmid isolation using NucleoSpin® Plasmid kit 
The vector used in cloning of all Cfcbm33 genes was a pRSET-B-based expression construct 
used for production of CBP21(Vaaje-Kolstad et al. 2005b), referred to here as pRSET-B/cbp21.  
Materials 
o NucleoSpin® Plasmid/Plasmid (NoLid) kit (Macherey-Nagel) 
- NucleoSpin® Plasmid/Plasmid (NoLid) Column 
- Collection tubes (2 ml) 
- Resuspension buffer A1 
- Lysis buffer A2 
- Neutralization buffer A3 
- Wash buffer A4 
- Elution buffer AE 
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Procedure 
pRSET-B/cbp21 was isolated from E. coli TOP10 cells following the protocol for plasmid DNA 
preparation with the NucleoSpin® Plasmid/Plasmid (NoLid) kit.  All reaction steps were carried 
out at room temperature and all centrifugations were done at 11,000 x g using a Cetnrifuge 
5415R (Eppendorf).   
From an E. coli overnight culture, 2 ml was harvested by centrifugation for 30 seconds.  The 
medium was completely removed before resuspending the pellet in 250 µl resuspension buffer 
A1.  For cell lysis, 250 µl lysis buffer A2 was mixed into the sample by inverting the tube 6-8 
times.  The sample was then incubated until the lysate appeared clear.  Maximum incubation 
time was 5 minutes.  Lysis was stopped by adding 300 µl neutralization buffer A3 and inverting 
the tube 6-8 times before the lysate was centrifuged for 5 minutes.  The clear supernatant (750 
µl) was loaded onto a NucleoSpin® Plasmid/Plasmid (NoLid) column placed in a 2 ml collection 
tube and spun down for 1 minute.  The flow-through was discarded.  Washing of the column was 
performed by adding 600 µl wash buffer A4 to the column and centrifuging for 1 minute.  The 
flow-through was discarded and remaining liquid was removed by an additional 2-minute 
centrifugation.  Prior to elution, the NucleoSpin® Plasmid/Plasmid (NoLid) column was placed 
in a 1.5 ml micro centrifuge tube followed by addition of 50 µl elution buffer AE.  After 1 
minute incubation the DNA was eluted by centrifugation for 1 minute.    
2.6.2 Plasmid isolation using GeneJET™ Plasmid Miniprep kit 
The cloning vector used for transformation in P. pastoris was the expression vector pPICZα-A 
previously transformed into E. coli DH5α.  pPICZα-A was isolated by the use of GeneJET™ 
Plasmid Miniprep kit (Fermentas).   The same procedure was also used for isolation of pPICZα-
A/Atcbm33A from transformed E. coli XL Gold. 
Materials: 
o GeneJETTM Plasmid Miniprep Kit (Fermentas) 
- Resuspension solution 
- Lysis solution 
- Neutralization solution 
- Wash solution 
o Nuclease-free dH2O 
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Procedure: 
Plasmids were isolated from 5 ml overnight culture of transformed E. coli.  All steps were 
carried out at room temperature.  
E.coli cells from a 5 ml overnight culture were harvested by centrifugation at 6,800 x g for 2 
minutes using a Centrifuge 5415R (eppendorf).  After decanting the supernatant the pellet was 
completely resuspended in 250 µl resuspension solution and transferred to a micro centrifuge 
tube.  To the resuspended cells, 250 µl lysis solution was added and the solutions were mixed 
carefully by inverting the tube 6 times.  When the solution became viscous and slightly clear, 
350 µl neutralization solution was added.  The reagents were mixed by inverting the tube 6 
times, followed by 5 minutes centrifugation at 10,000 x g.  The supernatant was transferred to 
the supplied GeneJETTM spin column by decanting, followed by centrifugation at 10, 000 x g for 
1 minute.    
After discarding all flow-through, the column was placed back into the same collection tube and 
washed by adding 500 µl wash solution followed by centrifugation as above.  This was repeated 
once and, after discarding flow-through the second time, the column was centrifuged again to 
remove residual wash solution.  To elute the plasmid DNA, the GeneJETTM spin column was 
transferred to a fresh 1.5 ml micro centrifuge tube and 50 µl nuclease-free dH2O was applied to 
the centre of the column membrane.  Subsequent to 2 minutes incubation, the eluent was 
separated from the column by a 2 minute centrifugation at 10,000 x g.  This elution step was 
repeated once with 30 µl nuclease-free dH2O.    
The DNA concentration was measured for a 20 x diluted sample in a quartz cuvette with 10.0 
mm path using an Ultrospec 2100 pro spectrophotometer (GE Healthcare) at 280 nm.   
2.7 Restriction digestion 
Restriction endonucleases are sequence-specific enzymes that cleave DNA molecules at 
particular sites, producing a double-stranded break in the DNA strand.   Cleavage may form 
blunt ends, meaning that both strands are cut at the same position, or overhanging (cohesive) 
ends, meaning that the two strands are cut at slightly different positions.  Different restriction 
enzymes may require different reaction conditions for optimal digestion. 
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2.7.1 Double restriction digestion of Atcbm33A and pPICZα-A 
The expression vector pPICZα-A was prepared for cloning by a double restriction digestion, 
using XhoI and XbaI.  These restriction enzymes form cohesive ends and to promote integration, 
Atcbm33A was also double-digested with XbaI and XhoI.   
Materials 
o Restriction enzymes  
- XhoI, 10 U/µl (Fermentas) 
- XbaI, 10 U/µl (Fermentas) 
o Buffers 
- 10 x Buffer R (Fermentas) 
- 10 x Buffer Tango™ (Fermentas) 
o Nuclease-free dH2O 
Procedure 
Both pPICZα-A and Atcbm33A was first cut by the restriction endonuclease XhoI.  A 50 µl 
reaction was set up with 5 µl 10 x buffer R mixed with 5 µl XhoI and a total of 1 µg DNA diluted 
in nuclease-free dH2O.  For optimal digestion, the reaction was incubated at 30°C for 16 hours, 
followed by 20 minute incubation at 80°C to inactivate the enzyme.   
To remove the inactivated XhoI enzyme and buffer components, purification was performed 
according to section 2.7.4.  For digestion using XbaI, a total of 1 µg DNA diluted in nuclease-
free dH2O was mixed with 5 µl buffer Tango and 5 µl of XbaI restriction enzyme in a total 
volume of 50µl.  The reaction was incubated at 37°C for 3 hours before inactivation of the 
enzyme by incubation at 65°C for 20 minutes, and finally the digested DNA was purified 
according to section 2.7.4.  Atcbm33A was then cloned into pPICZα-A (pPICZα-A/Atcbm33A) 
according to section 2.10.2. 
2.7.2 Plasmid preparation of pRSET-B 
To remove the protein-coding sequence of cbp21 and enable insertion of Cfcbm33-genes, 
pRSET-B/cbp21 extracted from E. coli TOP10 (section 2.6.1) was digested with HindIII and 
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BsmI.  By doing so, the signal peptide of CBP21 remains part of the construct and will drive the 
translocation of the inserted CfCBM33. 
Materials 
o Restriction enzymes 
- HindIII, 20 U/µl (New England Biolabs) 
- BsmI, 10 U/µl (New England Biolabs) 
o NEbuffer2 (New England Biolabs) 
o dH2O 
Procedure 
For restriction cutting, 8 µl plasmid extract (see section 2.6.1) was mixed with 6 µl of dH2O and 
4 µl NEBuffer before addition of 2 µl HindIII restriction endonuclease.  The digestion reaction 
mixture was incubated for 2.5 hours at 37°C in a water-bath.  After incubation with HindIII, 2.2 
µl BsmI was added directly to the reaction and the mixture was incubated for 3.5 hours at 65°C in 
a water-bath.  The high temperature inactivates HindIII.  BsmI was finally inactivated by 
incubating the reaction mixture for 20 minutes at 80°C in a water-bath.   
The digested plasmid was visualized on an agarose gel as described in section 2.5.3 and was 
extracted from the gel as described in section 2.5.4. 
2.7.3 Linearization of pPICZα-A/Atcbm33A 
Prior to transformation into P. pastoris, to stimulate recombination, pPICZα-A/Atcbm33A 
(cloned according to 2.10.2) was linearized within the 5’AOX1-region using the SacI 
endoglucanase.     
Materials 
o 10 x buffer SacI (Fermentas) 
o SacI 10 U/µl (Fermentas) 
o Nuclease-free dH2O 
Procedure 
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Reactions were set up on ice according to Table 2.10 and the linearization was done by 3 hour 
incubation at 37°C followed by an inactivation of SacI by incubation at 65°C for 20 minutes.    
Table 2.10.  Reaction set up for linearization of pPICZα-A/Atcbm33A. 
Reaction component Volume 
Purified plasmid 30 µl (approximately 0.5 - 1 µg DNA) 
10 x Buffer SacI 4 µl 
Nuclease-free dH2O 2 µl 
SacI 4 µl 
 
2.7.4 PCR purification 
Restriction digested DNA and PCR-products were purified by the use of GeneJETTM PCR 
Purification Kit (Fermentas).  This removes primers, dNTPs, enzymes and salts from the reaction 
mixture.    
Materials 
o GeneJET™ PCR Purification Kit (Fermentas) 
- Binding buffer 
- Eluation buffer, preheated to 45°C 
- Wash buffer 
- GeneJETTM Purification Columns and collection tubes 
o 3M sodium acetate 
o Ethanol, 100 % (v/v) and 80 % (v/v) 
o 2 mM Tris-HCl 
Procedure 
The GeneJETTM PCR Purification Kit’s protocol was followed.  All purification steps were 
carried out at room temperature and all centrifugations at 13,000 x g for 1 minute. 
The DNA was mixed thoroughly with 1 volume of binding buffer and transferred to a 
GeneJET™ purification column.  After centrifugation of the column, the flow-through was 
discarded and the column was washed by adding 700 µl wash buffer followed by centrifugation.  
All flow-through was discarded and the silica membrane dried by another centrifugation.  Then 
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the column was transferred to a clean 1.5 ml micro centrifuge tube and purified DNA was eluted 
by centrifugation in two steps with a total of 70 µl pre-heated elution buffer.  Eluted DNA was 
precipitated according to section 2.9. 
2.8 DNA sequencing 
Plasmids generated according to section 2.10 and isolated from E. coli according to section 2.6.1 
and 2.6.2, were sequenced to check for mutations before transformation of plasmids into an 
expression host.  For plasmids carrying bacterial genes, the BigDye® Terminator v3.2 Cycle 
Sequencing Kit (Applied Biosystems) was used for sequencing.  Plasmids containing a fungal 
gene were sent to Eurofins (www.eurofins.com) for sequencing.   All data analysis of sequences 
was performed using GENtle (Manske 2003). 
2.8.1 BigDye® Terminator v3.1 Cycle Sequencing Kit, Sequencing PCR 
During DNA sequencing by chain-termination, the same principle as for PCR is used, only with 
the addition of dideoxynucleotides (ddNTPs).  ddNTPs lack the 3’ hydroxyl group and addition 
of a ddNTP instead of a dNTP to the growing 3’- end results in termination of the elongation.  
The four different ddNTPs have different fluorescent tags, absorbing light at different wave-
lengths.  After amplification, every base from the DNA-strand can be visualized by separating all 
possible sequence lengths and measuring the absorbance for each amplicon.  An ABI Prism 
3100- genetic analyzer and BigDye® Terminator Cycle Sequencing Kit v3.1sequencing were 
used for dye terminator sequencing.    
Materials 
o BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) 
- Ready Reaction Premix 
- BigDye Terminator v1.1/3.1 Sequencing Buffer (5x) 
o Sequencing primers (see section 2.1.3) 
o dH2O 
Four reactions were set up for sequencing, one using the forward pRSET-B-primer, one with the 
reverse pRSET-B-primer, one with the gene-specific forward and the final with the reverse 
sequencing primer; the last two annealing in the middle of the gene.  Both reactions were set up 
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on ice in 0.2 ml PCR tubes according to table 2.11.  The reaction tubes were placed in a Master 
cycler gradient 120V (Eppendorf) and the reactions carried out using settings shown in table 
2.12. 
Table 2.11. Reaction mixture for DNA sequencing. 
Reagent Quantity 
Template 250 ng 
Primer 3.2 pmol 
BigDye Sequencing Buffer 2 µl 
dH2O To a final reaction volume of 20 µl 
Ready Reaction Premix 4 µl 
 
Table 2.12. Thermal cycling conditions for DNA sequencing 
Reaction step Temperature Time (minutes:seconds) Number of cycles 
Initial Denaturation 96°C 1:00 1 
Denaturation 96°C 0:10 
25 Annealing 50°C 0:05 
Elongation 60°C 4:00 
 
After sequencing, the products were precipitated using Pellet Paint®, as described in section 2.9. 
2.9   Ethanol Precipitation of DNA using Pellet Paint® 
Ethanol precipitation is commonly used for concentrating nucleic acid (DNA or RNA) 
preparations.  DNA has a highly charged phosphate backbone, making the molecule polar and 
thus soluble in water.  A salt is added to the sample to neutralize these charges, in this case 
sodium acetate.  The positively charged sodium ions neutralize the negative charges in DNA but 
due to the high dielectric constant of water the ionic interactions are weak.  To strengthen these 
interactions ethanol, which has a lower dielectric constant, is added and the DNA is precipitated.  
The Pellet Paint® Co-Precipitant (Novagen) is a visible dye-labeled carrier formulated 
specifically for alcohol precipitation of nucleic acids.  In this study, precipitation was used for 
concentrating DNA samples and for precipitating PCR products for sequencing.    
Materials 
o 3 M sodium acetate pH 5.2 
o Ethanol, 96% (v/v) and 70 % (v/v) 
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o Pellet Paint® Co- Precipitant (Novagen) 
Procedure 
All reactions were carried out at room temperature and all centrifugations were at 14,000 x g for 
5 minutes using Centrifuge 5415R (Eppendorf). 
The nucleic acid sample was mixed with 2 µl Pellet Paint® and 0.1 volumes 3 M Na Acetate 
(both at room temperature) and the solution was mixed briefly.  After adding 2 volumes 96 % 
ethanol the sample was mixed and incubated for 2 minutes at room temperature.  Subsequent to 
centrifugation, a pink pellet was visible in the bottom of the tube and the supernatant was 
removed.  To wash the pellet, 4 volumes 70 % ethanol were added and the sample was vortexed 
and centrifuged.  After removal of the supernatant the pellet was rinsed in 100 % ethanol and 
centrifuged again.  The final supernatant was removed and the pellet was air-dried on the bench 
for 30 minutes.  
2.10  Cloning 
2.10.1  In-Fusion™ Cloning of Cfcbm33-genes into pRSET-B 
In-Fusion™ Advantage PCR Cloning Kits (Clontech) are designed to combine multiple pieces of 
DNA without the use of restriction enzymes, ligase or phosphatise, and are typically used to 
clone PCR products into vectors.  In-fusion is a PCR based DNA cloning procedure used for 
cloning a gene directly into a linearized vector. Primers used for the PCR amplification of the 
gene for insertion extends the gene with 15 base pairs in each end, overlapping each end of the 
insertion site.  The linearized vector and the gene of interest are mixed and incubated with an In-
Fusion™ enzyme that creates single-stranded regions at the ends of the vector and the PCR 
product.  These regions are then fused because of the 15 bp of complementary bases. In this 
work, InFusion™ cloning was used for cloning the Cfcbm33-genes, lacking the native signal 
peptide, into pRSET-B by annealing it to the cbp21 leader peptide (pRSET-B/Cfcbm33). 
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Figure 2.1. The principle of In-fusion™ cloning.  The gene of interest is amplified by PCR using primers extending 
the gene with 15 base pairs in each end, identical with each end of the linearized vector. During 30 minutes of 
incubation, the In-Fusion™ enzyme generates single-stranded regions at the end of both the insert and the vector.  
The insert is then ligated with the vector because of the 15 bp complementary regions of the insert and vector.  The 
construct is then transformed into bacterial strains for selective growth of positive transformants (type of selection 
depends on the vector’s specificities).  For more information, see www.clontech.com.  Figure source: 
http://openwetware.org/wiki/In-fusion_biobrick_assembly.   
Materials 
o TE-buffer 8.0:  
157.6 mg Tris-HCl 
29.2 mg EDTA 
Dissolved in 60 ml dH2O, adjusted to pH 8.0 with 6 M HCl and finally adjusted to 100 ml 
with dH2O.  
o 5x In-Fusion™ Reaction Buffer (Clontech) 
o In-Fusion™ Enzyme (Clontech) 
o Nuclease free dH2O 
Procedure 
In this case, Protocol II called “In-Fusion™ Cloning Procedure W/Spin-Column Purification” 
was used.   For maximum cloning efficiency, a 2:1 molar ratio of insert vs. vector was used.   
Reactions were set up according to table 2.13 and incubated initially for 15 minutes at 37°C 
followed by 15 minutes at 50°C, after which the reaction mixtures were placed on ice.  Before 
transformation, the reaction volume was brought up to 50 µl with TE buffer (pH 8.0).   Only 
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Cfcbm33A-N and Cfcbm33B-N were successfully cloned into pRSET-B, generating pRSET-
B/Cfcbm33A-N and pRSET-B/Cfcbm33B-N. 
Table 2.13. Reaction set up for In-Fusion™ cloning of Cfcbm33 into pRSET-B generating p-PICZα-A/Cfcbm33-
constructs. 
Reaction Component Cloning Reaction Negative Control Positive Control 
Purified PCR insert, Cfcbm33 2 µl (50 ng) - 2 µl2 
Linearized vector,  pRSET-B 2 µl (100 ng) 1 µl1 1 µl1 
5x In-Fusion™ Reaction Buffer 2 µl 2 µl 2 µl 
In-Fusion™ Enzyme 1 µl 1 µl 1 µl 
Deionized water 3 µl 6 µl 4 µl 
1: linearized pUC19 Control vector (50 ng/µl) included in the kit. 
2: 2 kb Control insert (40 ng/µl) included in the kit. 
2.10.2  Cloning into pPICZα-A 
Atcbm33A and pPICZα-A both had cohesive ends as a result of the double restriction digestion 
performed according to section 2.7.1, and was cloned by using T4 DNA ligase (New England 
Biolabs) in a ligation reaction with molar vector vs. insert ratio of 3:1. 
Materials 
o T4 DNA ligase (New England Biolabs) 
o 10 x T4 DNA ligase reaction buffer (New England Biolabs) 
o Nuclease-free dH2O 
Procedure 
Reactions were set up according to Table 2.14 and incubated for 24 hours at 16°C.  The DNA 
ligase was subsequently inactivated by incubating the reactions at 65°C for 10 minutes. 
Table 2.14. Reaction set up for cloning of Atcbm33A into pPICZα-A (generating pPICZα-A/Atcbm33A). 
Reaction Component Cloning Reaction Negative Control 
Restriction digested Atcbm33A 5.5 µl (approximately 150 ng) - 
Linearized vector, pPICZα-A 4 µl (100 ng) 4 µl 
10 x T4 DNA ligase reaction buffer 2 µl 2 µl 
T4 DNA ligase 1,5 µl 1,5 µl 
Nuclease-free dH2O 7 µl 13,5 µl 
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2.11 Transformation of E. coli  
Materials 
o Super Optimal Broth (SOC) medium:    
2g Bacto tryptone 
0.5g Bacto yeast extract 
0.057g NaCl 
0.019g KCl 
0.247g MgSO4 
All chemicals were dissolved in dH2O to a total volume of 90 ml before autoclaving. After 
cooling to room temperature 1 ml 2 M glucose (sterile filtered) was added and the medium 
was stored at 4°C. 
o OneShot® TOP10 chemically competent E. coli cells (Invitrogen) 
o OneShot® BL21 Star (DE3) chemically competent E. coli cells (Invitrogen) 
o XL10- Gold® Ultracompetent E. coli cells (Stratagene) 
Procedure 
OneShot® TOP10 chemically competent E. coli cells were used for plasmid amplification of p-
RSET-B constructs, OneShot® BL21 Star (DE3) chemically competent E. coli cells were used 
for periplasmic expression of CfCBM33A-N and CfCBM33B-N while E. coli XL10- Gold® 
cells were used for plasmid amplification of pPICZα-A/Atcbm33A. 
For transformation, a 2.5 µl ligation-mixture was added to 25 µl competent cells in sterile cell 
culturing tubes followed by incubation on ice for 30 minutes. After a heat-shock at 42°C for 30 
seconds the cells were cooled on ice for 1 minute.  To recover the cells after transformation, 250 
µl SOC medium heated to room temperature was added and the transformation mixture was 
incubated for 1 hour at 37°C with shaking at 220 rpm.   Following centrifugation at 6000 rpm 
and 30°C, the cells were resuspended in 100 µl SOC medium and spread out on preheated LB-
agar plates supplied with ampicillin.  After overnight incubation at 37°C, pre-cultures of clones 
were made by inoculation of overnight cultures with transformants as described in 2.2.3.  
Glycerol stocks of the transformed cells were made according to section 2.3. 
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To verify that the transformation was successful, a PCR using Red Taq DNA Polymerase Master 
Mix was set up according to section 2.5.2 using the corresponding sequencing primers listed in 
section 2.1.3.   
2.12  Transformation of P. pastoris 
Transformants of P. pastoris were generated by homologous recombination between pPICZα-
A/Atcbm33A and regions with homology in the genome.   
2.12.1  Preparation of electro-competent P. pastoris 
Materials 
o dH2O 
o 1 M sorbitol 
o YPD- medium (see section 2.2.1) 
Procedure 
From a P. pastoris X-33 overnight culture, 1 ml was transferred to a 250 ml baffled cell culture 
flask containing 20 ml YPD- medium.  The culture was grown overnight in an incubator at 30°C 
while shaking at 200 rpm.  The next day, the overnight culture was transferred to a 2 liter baffled 
cell culture flask containing 500 ml YPD medium.  After 18 hours (approximately 7 generation 
times) with incubation at 30°C and shaking at 160 rpm, the culture had reached an OD600= 1.4 
(measured with Spectrophotometer, Ultraspec 2100 (GE Healthcare)).  The culture was 
transferred to a 500 ml centrifugal bottle and harvested by a 5 minute centrifugation at 1,500 x g 
and 0°C using a Sorvall centrifuge RC-5C, with rotor F10S-6*500Y (Thermo scientific).  The 
pellet was resuspended in 500 ml ice-cold (0°C) sterile water, centrifuged as above and 
resuspended in 250 ml ice-cold water followed by another centrifugation and resuspension in 20 
ml ice-cold 1 M sorbitol.  The sorbitol is needed to stabilize the osmotic pressure in the cells. 
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2.12.2  Electroporation of P. pastoris  
Transformation of pPICZα-A/Atcbm33A into P. pastoris was performed by electroporation. 
Materials 
o 1 M sorbitol 
o YPDS- plates supplemented with 100 µg/ml Zeocin™ (see section 2.2.2, preheated to 30°C 
Procedure 
During transformation, all work was carried out on ice and all solutions and materials used were 
ice-cold (0°C). 
Electro-competent P. pastoris X-33 cells, approximately 7*107 cells (prepared according to 
section 2.12.1), were collected by centrifugation and resuspended in 1 ml ice-cold 1 M sorbitol.  
From the resuspended cells, 80 µl were mixed with approximately 8 µg linearized pPICZα-
A/Atcbm33A dissolved in 2 µl of nuclease-free water in an ice-cold 2 mm gap electroporation 
cuvette (Molecular Bioproducts) and incubated for 30 minutes on ice.  Transformation was 
performed by use of a Micopulser (Bio-Rad) giving 2kV for 5.4 milliseconds.  A control without 
added plasmid was treated in the same way.  After the pulse, 1 ml ice-cold 1 M sorbitol was 
added followed by careful mixing by inverting the cuvettes 4-6 times; the cuvette contents were 
then transferred to falcon tubes.  The transformed cells were incubated at 30°C without shaking.  
After 1 hour incubation, 1 ml YPD was added to both tubes and the incubation was continued for 
2 more hours.   
For selective growth of transformed cells, the cell suspension was spread on 3 YPDS plates 
supplemented with 100 µg/ml of Zeocin™ with varying amount of cells on each plate.  500 µl of 
the control was spread on one YPDS- plate supplemented with Zeocin™, and all plates were 
wrapped in aluminum foil and incubated at 30°C for 4 days. 
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2.12.3  Control of transformation 
To check if the gene was incorporated in P. pastoris’ genome, a PCR was conducted using 
Zymolyase (Seikagaku Corporation) digested cells.  Zymolyase is a β-glucanase that breaks 
down the cell wall, thus lysing the yeast cells and thereby allowing direct PCR on chromosomal 
DNA.   
Materials 
o dH2O 
o Zymolyase  
Procedure 
A small part of a colony with transformed P. pastoris X-33 cells was dissolved in 100 µl dH2O 
containing 0.5 mg/ml zymolyase and incubated at 35°C for 1.5 hours.  Following inactivation of 
the enzyme at 65°C, the lysate was centrifuged for 5 minutes at 8,000 x g.  The viscous 
supernatant was used as template for Phusion™ High Fidelity PCR according to section2.5.1 
using the cloning primers 3320_XhoI_SP and 3320_XbaI_ASP (see section 2.1.3).  The PCR 
product was visualized on an agarose gel according to section 2.5.3. 
2.13  Protein expression 
2.13.1  Cultivation of transformed E. coli BL21 for optimal expression of 
CfCBM33B-N 
For optimal expression of CfCBM33A-N and CfCBM33B-N, E. coli Bl21 Star™ (DE3) 
harboring pRSET-B/Cfcbm33A-N and pRSET-B/Cfcbm33B-N were cultivated in different media 
(LB, TB, BHI; section 2.2.1) and different cultivation conditions (temperature and length of 
cultivation) were tested.   
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2.13.2  Induction of the lac-operon by IPTG 
Expression of the gene of interest from pRSET-B is controlled by the strong phage T7 promoter 
(indicated in the vector map in appendix D, Figure D.1) that drives expression of downstream 
genes, including the multiple cloning site with the inserted gene.  The T7 promoter is transcribed 
by T7 RNA polymerase and the transcription of this polymerase is controlled by an isopropyl β-
D-thiogalactoside (IPTG)-inducible promoter.  Therefore, for optimal expression of the inserted 
gene, T7 RNA polymerase production was induced by addition of 0.5 mM IPTG.   
Materials 
o 1 M IPTG, sterile filtered 
Procedure 
5 ml overnight culture was transferred to a culture flask containing 300 ml medium 
supplemented with 50 µg/ml ampicillin followed by incubation at 37°C with shaking at 220 rpm 
until OD600 reached 0.6.  OD600 was measured using Biophotometer (Eppendorf).  Then, gene 
expression was induced by adding IPTG to a final concentration of 0.5 mM.   After cultivation 
for 4 more hours, the culture was harvested and a periplasmic extract was made according to 
section 3.4. 
The T7 RNA polymerase promoter in pRSET-B/cbp21, and therefore also pRSET-B/Cfcbm33A-
N and pRSET-B/Cfcbm33A-N, is leaking and IPTG induction has no effect (results not shown).  
IPTG induction was thus only used in expression of ChiC that is cloned into a pRSET-B-vector 
from another origin. 
2.13.3  Protein expression in P. pastoris; screening for positive transformants. 
P. pastoris is a methylotropic yeast, which implies that it is capable of using methanol as its sole 
carbon source, in a process that is carried out in the peroxisomes by alcohol oxidases and uses 
molecular oxygen.  Two genes code for these alcohol oxidases, aox1 and aox2, both tightly 
regulated and induced by methanol.  Gene products of AOX1 accounts for the majority of alcohol 
oxidase activity in the cell and, since the gene of interest is inserted downstream of the methanol 
regulated AOX1 promoter, the gene of interest is also produced in large quantities subsequent to 
methanol induction (Macauley-Patrick et al. 2005).  In Pichia, heterologously expressed proteins 
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can end up either in the intracellular space or be secreted.  The major advantage by secretion is 
that P. pastoris secretes very low levels of native proteins, meaning that secreted heterologous 
proteins are relatively pure 
Prior to fermentation, a screening for transformants with the Atcbm33AHis incorporated (verified 
by PCR, see section 2.5.1, and agarose gel electrophoresis, see section 2.5.3) was performed. 
This was done by growing several transformants on methanol as the sole carbon source and then 
analyzing the medium for the secreted protein of interest. 
Materials 
o BMGY, see section 2.2.1 
o BMMY, see section 2.2.1.72.2.1 
o 100 % (v/v) Methanol, sterile- filtered 
Procedure 
Colonies with transformed P. pastoris X-33 (as verified by PCR) were inoculated in 10 ml 
BMGY in 50 ml tubes and incubated overnight at 30°C, with shaking at 250 rpm, until the OD600 
was approximately 3 (measured with Ultraspec 2100 pro (GE Healthcare)).  P. pastoris X-33 
harbouring a pPICZα-A vector with the GH61- gene from Aspergillus nidulans (gh61) integrated 
was used as a positive control, whereas the negative control was native P. pastoris X-33. 
The next day, cells were harvested by centrifugation at 3,000 x g for 5 minutes at room 
temperature using Centrifuge 5430R (Eppendorf).  The supernatant was decanted before the 
pellet was resuspended in 1 ml BMMY and used to inoculate 25 ml BMMY containing 0.5% 
(v/v) methanol for protein expression.   The culture was incubated at 22°C for 96 hours with 
shaking at 150 rpm.  Each 24th hour methanol was added to a final concentration of 0.5 % (v/v) 
to compensate for consumption and, to some extent, evaporation.  Both at the start of the 
incubation and after 96 hours, 0.5 ml of the expression-cultures was collected and after 
centrifugation at 5,000 x g the supernatants were concentrated 10 times using Amicon Ultraspin 
columns containing a cellulose filter with a 10kDa cut-off (Millipore).  An SDS-PAGE was then 
performed according to section 2.18 to identify transformants expressing AtCBM33AHis.   
58  
 
2.13.4  Large scale expression of AtCBM33AHis  
For large scale expression, materials and procedures were as in 2.13.3 with some exceptions.  
The overnight pre-culture was set up in 2 liter baffled cell culture flasks containing 0.5 liter 
BMGY and inoculation of the production culture was performed by transferring the concentrated 
cells from the overnight culture (in 10 ml BMMY) to 2 liter baffled cell culture flasks containing 
1 liter BMMY.  Induction was carried out for 96 hours at 22°C with shaking at 150 rpm.  Each 
24th hour, starting at 0 hours of induction, the OD600 of the culture was measured and the 
expression culture was added methanol to 5% final concentration and 50 ml BMMY to 
compensate for consumption and evaporation.  Also, each 24th hour, 0.5 ml of the expression 
culture was collected and, following centrifugation at 5,000 x g, the supernatant was stored at -
20°C.  After 96 hours of incubation, all supernatants collected were concentrated 10 times using 
Amicon Ultraspin columns containing cellulose filter with a 10kDa cut-off (Millipore) and 
analyzed by SDS-PAGE according to section 2.18. 
2.13.5  Fermentation of P. pastoris 
P. pastoris is well-suited for fermentative growth and has the ability to reach high cell density 
during fermentation.  This may improve overall protein yields.  Fermentation of P. pastoris for 
protein expression in a bioreactor has three stages: (i) a glycerol growth phase for generation of 
biomass; (ii) a growth phase with a growth-limiting feed-rate of glycerol, for controlled biomass 
generation and derepression of the alcohol oxidase promoter, AOX1; and (iii) a methanol feed 
phase, inducing expression of the AOX1-controlled genes.  The fermentation was carried out in a 
5 liter Biostat B plus bioreactor equipped with an additional feed pump, gas mixer, dissolved 
oxygen tension polarographic electrode and a water cooler.  During fermentation, parameters 
listed in Table 2.15 were monitored and controlled.     
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Table 2.15. Parameters that should be monitored and controlled during fermentation according to Invitrogen’s 
Pichia-fermentation protocol. 
Parameter Reason 
Temperature (28.0°C when grown on glycerol and 
22.0°C when grown on methanol) 
Growth above 32°C is detrimental to protein 
expression 
Dissolved oxygen (>20%) 
Pichia needs oxygen to metabolize glycerol and 
methanol 
pH (5.0-6.0) 
Important when secreting protein into the medium and 
for optimal growth 
Agitation (500 to 1500 rpm) Maximizes oxygen concentration in the medium 
Aeration (0.1 to 1.0 vvm* for glass fermenters) Maximizes oxygen concentration in the medium  
Antifoam (minimum needed to eliminate foam) 
Excess foam may cause denaturation of your secreted 
protein and it also reduces headspace 
Carbon source (variable rate) 
 
Must be able to add different carbon sources at 
different rates during the course of fermentation 
* Volume of oxygen (litres) per volume of fermentation culture (litres) per minute 
 
The dissolved oxygen concentration is the relative per cent of oxygen in the medium (O2-
saturated medium has a concentration of dissolved oxygen of 100%).  P. pastoris consumes 
oxygen during growth, whether it grows on methanol or glycerol, thereby keeping the dissolved 
oxygen concentration low.  Thus, the dissolved oxygen-values give information about the health 
and state of the culture.  When switching from glycerol to methanol as carbon source, close 
monitoring of the dissolved oxygen-values is of great importance to determine whether all the 
glycerol is consumed by the culture prior to induction.  Shutting off the carbon source should 
cause the culture to decrease its metabolic rate, and the dissolved oxygen to rise (spike).    
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Materials 
o PTM, trace salts:   
3.0 g Copper (II) sulphate- 5H2O 
0.04g Sodium iodide 
1.50 g Manganese sulphate- H2O 
0.1 g Sodium molybdate-2 H2O 
0.01 g Boric acid 
0.25 g Cobalt chloride 
10.0 g Zinc chloride 
37.5 g Ferrous sulphate- 7H2O 
0.1 ml Biotin 0.02 % (w/v) 
2.5 ml Sulphuric acid  
All ingredients were thoroughly mixed and dissolved in dH2O to a final volume of 0.5 liters 
before the solution was filter- sterilized.  PTM is light sensitive and was stored in the dark at 
room temperature. 
o 500 ml Glycerol feed:   
494.2 ml 50 % (w/v) glycerol 
4.8 ml PTM 
1 ml 0.02 % (w/v) biotin 
The listed chemicals were carefully mixed and sterile-filtered through a filter with 0.45µm 
pores  
o 1 liter Methanol feed:   
986 ml 100 % (v/v) methanol 
12 ml PTM 
2 ml 0.02% (w/v) biotin 
100% (v/v) methanol was autoclaved and PTM and biotin were filter-sterilized into the 
methanol. 
o Fermentation basal salts medium:  
18.2 g Potassium sulphate 
3.0 g Magnesium sulphate- 7 H2O 
4.13 g Potassium hydroxide 
26.7 ml Phosphoric acid, 85% (w/v) 
40.0 g Glycerol 
0.93 g Calcium sulphate 
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All chemicals were dissolved in listed order in dH2O to a total volume of 2 liters and 
autoclaved. 
o 0.02 % (w/v) biotin, filter-sterilized through a 0.45 µm pored filter. 
o Buffered complex glycerol medium (BMGY, see section 2.2.1) 
o Buffered complex methanol medium (BMMY, see section 2.2.1) 
2.13.5.1 Procedure 
Both the thermometer and the dissolved oxygen tension polarographic electrode were calibrated 
and disinfected in 96% (v/v) ethanol.  Air supply, gas mixer and water cooler were checked 
before autoclaving.  All connection-tubes were clogged and wrapped in foil and, along with the 
Biostat B plus 5L fermenter (Sartorius Stedim biotech) containing 2 liter fermentation basal salts 
medium, sterilized by autoclaving.  All equipment and solutions used in the fermentation were 
sterilized either by filter-sterilization or autoclavation.  After connecting all the tube-connections 
between the devices and the steering console, the fermenter was cooled to 28°C.  Prior to 
inoculation, 1 ml 0.02 % (w/v) biotin and 8.7 ml PTM trace salts were added aseptically to the 
fermenter.  The P. pastoris transformant showing best expression of AtCBM33A during 
screening (2.13.4) was grown overnight at 30°C in 1 liter BMGY.  The overnight culture was 
centrifuged and resuspended in 250 ml BMGY, having an OD600=50, and was used for 
inoculation of the fermenter.  Growth on glycerol was performed at 28°C; the temperature being 
maintained by water cooling.  Continuous addition of 28 % aqueous ammonia served both as a 
nitrogen source, and to maintain the pH at 5.5 throughout the whole fermentation.   After 
complete consumption of glycerol from the BMGY medium, indicated by an increase in the 
dissolved oxygen to 100 %, a glycerol feed was initiated.  Glycerol feeding was carried out at 
28°C with automated control of parameters listed in Table 2.15 for about 4 hours until the culture 
had reached a cellular yield of 160 g/liter, measured by wet weight of cells from 1 ml cell 
culture.    
Before induction of the AOX1 promoter, the glycerol in the medium was completely consumed 
(dissolved oxygen concentration reached ∼100%) and the temperature was decreased to 22°C.  
Induction was initiated with a methanol feed at slow rate to adapt the culture to growth on 
methanol.  The rate was then slowly increased to a final feed rate of 11 g/h/L.  Fermentation on 
methanol was continued for 4 days.  After 4 days, the cells were harvested and the supernatant, 
containing secreted proteins, was separated from the cells by centrifugation at 12,000 x g for 30 
minutes at 4°C.  During harvesting, cells were kept at 4°C at all times to hinder cell lysis and 
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proteolysis.  The supernatant was sterilized by
then concentrated by use of Pellicon ultra
2.13.6  Ultrafiltration 
The Pellicon ultra-filtration system 
in the fermentation broth. The system 
filter holder with a Biomax 10 kDa cut
filtration (see Figure 2.1) where the fluid is pumped along the surface of the membrane.  The 
material that does not pass through the membrane (retentate
interest) is recycled while the permeate, the material that passes through the membrane, is 
thrown away. This results in an up-concentration of the macromolecules retained in the retentate.
 
Figure 2.1. Principle of tangential flow filtration. The fluid flows over and parallel to the semipermeable membrane 
and under pressure, some of the fluid is forced through the filter. The 
(http://encyclopedia2.thefreedictionary.com/tangential+flow+filtration
 
Materials 
o Pellicon cassette acrylic holder and assembly (
- Pellicon 2 Cassette filter  
- Biomax® Ultrafiltration Membrane
o Peristaltic pump, 4-13 litre/min  
o dH2O 
o 5 L 0.1 M NaOH, room temperature
o 300 ml 10 mM MES buffer pH 6.5
o 1 litre 20 % ethanol 
 
 
 filtration through a 0.22 µm filter (Millipore) and 
-filtration (see section 2.13.6). 
from Millipore was used for concentrating secreted proteins 
comprises a peristaltic pump and a Pellicon 2 cassette 
-off membrane- filter.  The system uses tangential flow 
, which contains the prote
 
Figure is from “the free 
). 
Millipore) with: 
  
 
 
in of 
 
dictionary” 
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Procedure 
All tubes in the pump head were fastened, all three valves opened and the tube ends placed in 
dH2O.   After washing the filter with 2 liters of dH2O, 2 liter of 0.1 M NaOH was circulated 
through the filter to remove any bound proteins.  Following this cleaning step, 5 liter dH2O was 
used to neutralize the pH in the system (checked using pH indicator paper).   Both feed and 
retentate tubing were placed in the filtrated fermentation supernatant and the permeate outlet 
placed in a collection flask.  The retentate side was slowly clamped so the sample was circulating 
through the filter system and thereby concentrated by the use of tangential flow.  After 
concentrating the supernatant 10 times (to a total volume of 500 ml), the filter was washed with 
100 ml buffer by recirculation, to extract all remaining proteins.  To clean the filter, 0.1 M NaOH 
was run through the system, followed by a neutralization of the pH with dH2O.  Finally, the 
system was washed with 20 % ethanol and stored. 
2.14  Periplasmic extracts of E. coli 
All Cfcbm33-genes were cloned into pRSET-B subsequent to a CBP21 signal peptide.  This 
signal peptide drives the translocation of all expressed CfCBM33 proteins to the periplasmic 
space in E. coli and can be extracted by lysing the cells using cold osmotic shock as described 
below. 
Materials 
o Spheroplast buffer:  
50 µl 0.5 M EDTA, pH 8.0  
5 ml 1 M Tris, pH 8.0 
8.55 g sucrose 
125 µl 50 mM PMSF  
All ingredients were carefully mixed and dissolved in dH2O to a final volume of 50 ml, 
and kept on ice. 
o Sterile dH2O 
o 20 mM MgCl2 
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Procedure 
150 ml overnight culture was transferred to 250 ml centrifuge bottles and placed on ice for 20 
minutes before centrifuging at 5500 x g for 10 minutes, using Beckman coulter Avanti J-25 
centrifuge with a JA-14 rotor, at 4°C.  After centrifugation the pellet was resuspended in 15 ml 
ice-cold spheroplast buffer and kept on ice for 5 minutes.  After another centrifugation, this time 
at 10,000 x g, the pellet was resuspended in 12.5 ml ice-cold dH2O and left on ice for 45 
seconds.   625 µl 20 mM MgCl2 was added to the suspension, followed by another centrifugation 
as above.  The final supernatant, the periplasmic extract, was filtered through a 0.22 µm sterile 
filter and stored at 4°C. 
2.15  Protein purification 
For protein characterization it is important to work with purified proteins.  In this study, different 
techniques for protein separation and purification were used, depending on the protein.  
Chitinases (ChiA, ChiB, ChiC from S. marcescens) and the chitin monooxygenase CBP21from 
S. marcescens, were all purified by use of chitin beads (affinity chromatography), while 
CfCBM33A-N and CfCBM33B-N was purified by a combination of ion exchange 
chromatography and gel-filtration.  His-tagged AtCBM33AHis was purified by the use of a His-
trap column. 
2.15.1  Ion Exchange Chromatography 
Ionic exchange chromatography is frequently used for separation and purification of proteins, 
polypeptides, nucleic acids and other charged biomolecules.  The technique separates proteins 
based on their surface ionic charge, using beads modified with positively or negatively charged 
groups.  Proteins with low binding-affinity to the column material are washed off the column by 
using low-salt buffer.  To elute the proteins that bind strongly to the column, a high-salt buffer is 
used.  The salt masks the charged groups on the column material allowing the protein to be 
eluted.  Since each protein has a different charge on the surface, proteins are eluted at varying 
salt concentrations and may thus be separated in different elution fractions. 
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Materials 
o Purification of CfCBM33A-N (pI=5.1) and CfCBM33B-N (pI= 5.2) 
- Binding buffer: 50 mM Tris- HCl pH 7.5 
- Elution buffer: 1 M NaCl in 50 mM Tris- HCl pH 7.5 
All buffers were filtrated through a 0.45 µm sterile- filter 
o 10 mM Tris-HCl pH 7.5 
Procedure 
The ion exchange column, HiTrap™ DEAE FF, 5 ml (GE Healthcare), was connected to an Äkta 
purifier chromatographic system (GE Healthcare), a fully automated liquid chromatography 
system, and washed with elution buffer to remove any contamination on the column and 
equilibrated using the binding buffer.  The pH of the sample was adjusted to 7.5 by addition of 
50 mM Tris-HCl and the sample (50 ml) was loaded onto the column.  To remove unbound 
proteins, a wash with 2 column volumes of binding buffer was performed.  The protein of 
interest was eluted by a gradient from 0 % to 50 % elution buffer, during 200 minutes at 4 
ml/min flow.  Eluted proteins were detected by online monitoring absorption at 280 nm and 
collected using a fraction collector (1 ml per fraction). Fractions were analyzed using SDS-
PAGE (see section 3.18).  Fractions containing the (partially purified) protein of interest were 
pooled and concentrated to 1 ml using Amicon Ultra-15 Centrifugal Filter Units with a 3 kDa 
cut-off cellulose membrane (Millipore), while at the same time changing the buffer to 10 mM 
Tris-HCl pH 7.5.  Further purification was done using size exclusion chromatography (see 
section 2.15.2).    
2.15.2  Size Exclusion Chromatography 
Size exclusion chromatography separates proteins on the basis of size and shape.  The column 
matrix is composed of beads with pores in different sizes, where small proteins enter all the 
pores, thereby using longer time passing through the column and eluting after the larger proteins.   
Materials 
o Running buffer (50 mM Tris-HCl, pH 7.5; 200 mM NaCl): 
50 ml 1 M Tris-HCl, pH  8.0 
11.6 g NaCl 
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Dissolved in 900 ml dH2O, regulated to pH 7.5 with 6 M HCl before the volume was brought 
up to 1 liter by addition of dH2O. 
Procedure 
A HiLoad 16/60 Superdex G-75 column (GE Healthcare) was connected to an Äkta purifier 
chromatographic system (GE Healthcare).  Concentrated protein (1 ml) obtained from the first 
step of purification (ion exchange chromatography; see section 2.15.1) was applied through a 2 
ml loading loop at 0.3 ml/min flow rate, followed by application of 3 column volumes of running 
buffer.  The eluate was collected in fractions of 5 ml.  Fractions putatively containing the protein 
of interest were analyzed bySDS-PAGE according to section 2.18 to visualize the purity of the 
protein and compared with the periplasmic extract.  Since CfCBM33B-N was clearly 
overexpressed and yielded a highly visible band in the starting material, we considered it 
sufficient to determine protein identity in the chromatographic fractions by comparison with the 
periplasmic extract.  
2.15.3 Protein purification by immobilized metal ion affinity chromatography  
HisTrap™ HP is a ready-to-use column for preparative purification of His-tagged recombinant 
proteins by immobilized metal ion affinity chromatography (IMAC).  The column is pre-packed 
with charged Ni Sepharose™ High Performance beads.  Histidines form complexes with nickel 
ions and the (His)
 6- tag on the N- terminus of AtCBM33AHis will bind strongly to the column 
material.   
Materials 
o Binding buffer (10 mM Hepes, 15 mM imidazole, 500 mM NaCl)  
2.38 g Hepes 
1.02g Imidazole 
29.2 g NaCl 
117.6 ml 85% (w/v) glycerol  
All chemicals were mixed in dH2O to a final volume of 1 liter.  The pH was adjusted to 7.5 
with 6 M HCl and the buffer was sterile-filtered through a 0.22 µm membrane and degassed 
by sonication for 30 minutes. 
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o Elution buffer (10 mM Hepes, 15 mM Imidazole, 500 mM NaCl, 10 % (w/v) glycerol):  
2.38 g Hepes 
27.2 g Imidazole 
29.2 g NaCl 
117.6 ml 85% (w/v) glycerol 
All chemicals were mixed and dissolved in dH2O to a total volume of 1 liter.  The pH was 
adjusted to 7.5 with 6 M HCl and the buffer was sterile-filtered through a 0.22 µm membrane 
and de-gassed by sonication for 30 minutes. 
o Stripping buffer (0,02 mM sodium phosphate, 500 mM NaCl, 50 mM EDTA):   
3.28 g sodium phosphate 
29.2 g NaCl 
100 ml 0.5 M EDTA, pH 8.0 
All ingredients were mixed and dissolved in 500 ml dH2O and the pH was adjusted to 7.4 
with 6 M HCl before dH2O was added to a final volume of 1 liter.  The buffer was sterile-
filtered through a 0.22 µm membrane and degassed by sonication for 30 minutes. 
o dH2O 
o 1 M NaCl 
o 20 % Ethanol 
Procedure 
The pH of 30 ml of the secreted proteins, concentrated according to section 2.13.6, was adjusted 
to 7.5 through a buffer exchange with 3 x the sample volume of binding buffer using an Amicon 
Ultra-15 Centrifugal Filter Units with a 10 kDa cut-off (Millipore).  Prior to loading the sample 
was filtered through a 0.22 µm filter, to remove any particles that could clog the column. 
A His-Trap™ HP 1 ml (GE Healthcare) pre-packed column was connected to an Äkta purifier 
chromatographic system (GE Healthcare).  The column was prepared for binding by washing 
with 5 column volumes of distilled water before equilibration using 5 column volumes of 
binding buffer.  The sample 30 ml was then loaded onto the column and binding buffer was run 
until the baseline was stable at a low UV signal (i.e. all non-binding proteins had passed through 
the column).  The binding buffer contained imidazole at a low concentration to prevent 
unspecific binding.  The protein of interest was eluted by applying a linear gradient of 20 column 
volumes from 0% to 100% elution buffer.  His-tagged protein was eluted at approximately 10 % 
of elution buffer and collected in fractions of 1 ml.  Elution and fraction collection were 
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continued until the absorbance at 280 nm had reached the baseline.   After elution, the column 
was washed with 20 column volumes of 1 M NaCl to remove all bound proteins, followed by 
washing 20 column volumes of dH2O and application of 20 % ethanol for storage. The purified 
protein was analyzed by SDS-PAGE according to section 2.18 and stored at 4°C. 
If the column was to be used for purification of other proteins, a “stripping” step was performed 
to remove all bound molecules.  The column was washed with 10 column volumes of stripping 
buffer, followed by 10 column volumes of binding buffer and, finally, 10 column volumes of 
dH2O.  The column was recharged using 0.5 ml 0.1 M NiSO4 solution followed by a 5 column 
volume wash with dH2O and application of 20 % ethanol before storage. 
2.15.4  Chitin-affinity chromatography 
ChiA, ChiB, ChiC and CBP21 all bind specifically to chitin and were purified by affinity 
chromatography using chitin beads as a chromatographic material.    
Materials 
o Binding buffer:  
- In purification of CBP21: 
132 g Ammonium sulphate 
Dissolved in 50 mM Tris-HCl, pH 8.0, yielding a 1 M solution 
- In purification of ChiA, ChiB and ChiC: 
50 mM Tris-HCl, pH 8.0 
o Elution buffer:   
20 mM Acetic acid 
o 20% (v/v) ethanol 
o Tris-HCl pH 7.0, 1 M and 5 mM 
o Chitin beads (New England Biolabs) 
Procedure 
For optimal CBP21 binding to the chitin beads, the periplasmic extract was adjusted to 1 M 
ammonium sulphate (by carefully adding 4 M ammonium sulphate) and 50 mM Tris-HCl pH 
8.0.  Periplasmic extracts containing ChiA, -B or C were all adjusted to 20 mM Tris-HCl pH 8.0 
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prior to purification. Aside from the differences in binding buffer, purifications of CBP21, ChiA, 
ChiB and ChiC were identical (described below). 
To prepare the column, 20 ml of chitin bead suspension was transferred to a 10 cm glass econo-
column with an inner diameter of 1.5 cm, yielding a bed volume of approximately 8 ml.  The 
column was inserted into a BioLogic LP (BioRad) system and washed with 20% ethanolat a flow 
of 2.5 ml/min before equilibrating the column using binding buffer.  An UV-reader was used for 
monitoring the baseline.  When the baseline was stable, the UV was reset to zero and adjusted 
periplasmic extract was loaded onto the column at a flow rate of 1 ml/min.  For removal of any 
unbound proteins, the system was washed with binding buffer until the baseline had stabilized 
again (approximately 45 minutes).    
To elute the bound protein, elution buffer was applied using a flow rate of 1 ml/min and fractions 
were collected.  When all the bound protein was eluted (and collected) the column was washed, 
first with binding buffer, then with 20% ethanol.  The washed column was stored in 20 % 
ethanol at 4°C.  Fractions containing purified protein were pooled and adjusted to pH 7 by adding 
1 M Tris-HCl pH 7.0 to a final concentration of 5 mM, followed by a wash with 3 volumes of 5 
mM Tris-HCl pH 7.0 and then concentrated using an Amicon Ultra, cellulose filter with 10 kDa 
cut-off (Millipore).  Protein concentration was measured using theBradford method (see section 
2.16) and SDS-PAGE (see section 2.18) was performed to verify the purification. 
2.16  Protein concentration measurement 
Quick Start ™ Bradford Protein Assay is a method for determining the concentration of proteins 
in a sample, which is based on the binding of Coomassie Brilliant Blue G-250 dye to proteins 
(Bradford 1976).  When the dye binds to protein it is converted from the cationic form (Amax = 
470 nm) to the stable unprotonated blue form (Amax = 595 nm), which can be detected using a 
spectrophotometer.  Protein concentration is calculated by using a standard curve. 
Materials 
o 5x Dye Reagent, Protein Assay (BioRad) 
o BSA Standard (2 mg/ml) 
o Polystyrene cuvettes, 1 ml (Brand) 
o Sample buffer 
o Bovine serum albumin (BSA) for calibration 
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Procedure 
From each sample, 2 µl concentrated protein was diluted in 798µl sample buffer and mixed with 
200 µl 5x Dye Reagent.  After 5 minutes incubation, the sample absorbance at 595 nm was 
measured by using the Bradford micro program.   
The spectrophotometer, Bio Photometer (Eppendorf), was calibrated with bovine serum albumin 
(BSA) as standard with the concentrations 2, 1.5, 1, 0.75, 0.5, 0.25 and 0.125 mg/ml (“Bradford 
micro”).  Triplicates of the standards incubated in 5x Dye Reagent for 5 minutes were analyzed 
and the standard curve used had a standard error less than 10 %. 
When measuring samples, a reference containing 800 µl sample buffer was mixed with 200 µl 5x 
Dye Reagent and incubated for 5 minutes.  After the photometer was zeroed using the reference, 
samples were analyzed in triplicates.  The sample concentration was calculated as the mean 
value of the three replicates.    
2.17  Deglycosylation of proteins using EndoH 
AtCBM33A was expressed and secreted by P. pastoris.  For optimal expression of eukaryotic 
genes, the host’s ability to perform posttranslational modifications is important.  For example, 
some eukaryotic proteins become unstable if they are not glycosylated. P. pastoris sometimes 
hyperglycosylates recombinant proteins, which may have negative effects, including marking 
them for degradation.  Although glycosilation may be necessary to obtain stable proteins, it is not 
a priori known how much glycosilation is needed and hyperglycosilation is not desirable. 
Therefore, and since improper glycosylation may interfere with enzyme activity and some 
biochemical assay techniques (see below), it is common to remove most of the glycosylations.   
One of the post-translational processing performed in P. pastoris is N-glycosylation of the amide 
nitrogen of asparagine residues in the Asn-Xaa-Thr/Ser consensus sequence.  The bacterium also 
O-glycosylates some proteins, however, the bacterium does not seem to have a preferred amino 
acid for O glycosylation (no consensus glycosylation sequence is known) and is thus difficult to 
predict (Cregg et al. 2000).  N-glycosylations, on the other hand can easily be predicted by using 
web-based prediction tools like NetNGlyc (http://www.cbs.dtu.dk/services/NetNGlyc/).   
The AtCBM33A-sequence contains two possible N-glycosylation sites (found by using 
NetNGLyc) and if glycosylation occurs, the protein may not be visible on the gel as one single 
band, and or the molecular weight 
Endoglucosidase H (EndoH), with a molecular weight of 29 kDa, is a recombinant glycosidase
which cleaves asparagine-linked mannose rich oligosaccharides from N
cleaves the glycosidic bond in the diacetylchitobiose core of the oligosaccharide, between two 
N-acetylglucosamine (GlcNAc) subunits, leaving one GlcNAc 
residue (Figure 3.3).   
Figure 3.3.  Action of EndoH. Endoglucosidase H (EndoH) cleaves the
protein between two core N-acetylglucosamine (GlcNAc)
and Y=H and in low-mannose structures, n=2, X and/or Y = AcNeu
Materials 
o dH2O 
o 10 x G5 Reaction Buffer (New England Biolabs)
o EndoH (New England Biolabs)
o Amicon Ultra 0.5 ml centrifuge tubes with cellulose filter and a cut
 
Procedure 
After purification, the protein did not appear as a clear band on the SDS
3.11), possibly because of glycosylations of the protein.  EndoH treatment was performed on 1
µl of the concentrated purifie protein 
µl dH2O.  Following 2 hour incubation at 37
for 20 min.  The samples were analysed
may be increased in a somewhat unpredictable manner
-linked glycoproteins.  It 
remaining on the asparagine 
 glucan moiety covalently bound to the 
 units in high-mannose structures, n= 2
-Gal-GlcNAc.   
 
 
-off of 10 kDa
-PAGE gel (see 
mixed with 2 µl 10x G5 Reaction buffer, 1 µl EndoH and 7 
°C, the EndoH was inactivated by incubation at 65
 by SDS-PAGE according to section 2.18
71 
.  
, 
 
-150, X=(Man)1-2 
 (Millipore) 
Figure 
0 
°C 
. 
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2.18  Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE)  
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) is a widely used 
technique for separation of proteins according to their mass.  The addition of anionic detergents 
like SDS or LDS (lithium dodecyl sulphate) and a reducing agent like β-mercaptoethanol (for 
reducing disulphide bridges) in the sample denatures the protein and provides each protein with a 
uniform negative charge.  The proteins are then separated based on size only by using 
electrophoresis and can be visualized by protein specific staining, i.e. with Coomassie brilliant 
blue.  A molecular marker containing proteins with known masses is used to estimate the mass of 
the sample proteins.   
Materials 
o NuPage® LDS sample buffer 4x (Invitrogen) 
o NuPage Sample reducing agent 10x (Invitrogen) 
o 20x MES SDS Running buffer pH 7.3:  
97.6 g MES 
60.6 g Tris Base 
10 g SDS 
3.0 g EDTA 
All chemicals were dissolved in dH2O added to a final volume of 500 ml. Before use, the 
buffer was diluted 20 times in dH2O. 
o 1x Wash solution: 
23.5 ml 85% (w/v) Phosphoric acid  
Diluted in 976.5 ml dH2O 
o 1x fixer solution:  
300 ml 96% (v/v) Ethanol 
23.5 ml 85% w/v) Phosphoric acid  
Diluted in dH2O to a final volume of 1 liter 
o Coomassie staining solution:  
200 ml 96% (v/v) Ethanol 
117.6 ml 85% (w/v) Phosphoric acid 
100 g Ammonium sulphate 
1.2 g Coomassie Brilliant Blue R 250 
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All ingredients were dissolved in dH2O to a final volume of 1 litre. 
o Bench Mark™ Protein Ladder (Invitrogen) 
Procedure 
To 18 µl protein sample, 2 µl NuPage® LDS sample buffer was added and the sample was 
boiled for 10 minutes.  A NuPage® polyacrylamide gel, Bis-Tris 10 % (Invitrogen) was installed 
in the XCell SureLock™ Mini-Cell Electrophoresis System (Invitrogen) and the chamber was 
filled with 1x MES SDS running buffer.  In the first well, 5 µl protein ladder was applied, 
followed by application of 15 µl of each sample in the remaining wells.  After running the gel 
using a Power supply (BioRad) for 35 minutes at 200V, the gel was released from the plastic 
plates and fixed in 1x fixer solution for 1 hour and washed in 1x washing solution for 2 x 10 min.  
For visualization of proteins, the gel was treated with the Coomassie Brilliant Blue R-250 
staining solution for 2 hours.  Coomassie blue binds non-specifically to all proteins.  Destaining 
of the gel was done by washing in dH2O for 3 hours.   
2.19  Matrix-Assisted Laser Desorption and Ionization Time of 
Flight mass spectrometry (MALDI-TOF MS) 
MALDI-TOF MS is a non-quantitative analysis method used to determine and identify the 
molecular weight of small molecules and proteins. The method implies that the analytes are 
ionized and brought into gas phase in vacuum, using a laser.  Ionized molecules are accelerated 
by a strong magnetic field through an analysing tube with a mass analyser in the end, with ions 
being separated based on their mass to charge ratios (m/z).  The Time-of- flight (TOF) analyser 
measures the time the ions use to reach the detector, reflecting the molecular mass of the ions.  
Smaller ions travel at the highest speed (Walsh 2002). 
2.19.1   In-gel trypsin digestion of Coomassie-stained protein spots 
MALDI-TOF MS is a convenient method for identifying or verifying proteins separated by SDS-
PAGE. The most common way of analysis is to excise the spot/band of interest in the SDS-
PAGE gel and subject the gel piece to in-gel trypsination in order to release peptides that can be 
analysed by the mass spectrometer (see section 2.19.2). 
Materials 
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o 40% (v/v) Ethanol 
o Acetonitrile, 100% (v/v) and 50% (v/v) 
o 100 mM NH4HCO3 
o 10 mM DL-Dihiothreitol (DTT)-solution: 
- 15.42 mg DTT dissolved in 100 µl 100 mM NH4HCO3 
o 55 mM iodoacetamide: 
- 1.5 mg iodoacetamide dissolved in 150 µl 100 mM NH4HCO3  
o Trypsin solution (12.5 ng/µl final concentration): 
- 10 µl sequencing grade modified trypsin (0.1 µg/µl in 10 mM HCl) diluted in 70 µl 
25 mM NH4HCO3 
Procedure 
The protein of interest was digested enzymatically (e.g. by trypsin) prior to MALDI- TOF MS 
analyzes.  All chemicals used had a purity grade for HPLC and the procedure was carried out in 
a laminar air flow (LAF)-bench to keep a dust-free environment. 
The desired protein-band was cut out of the SDS-gel using a clean scalpel and transferred to a 
pure micro centrifuge tube.  The gel piece was distained by washing in 100 µl 40 % (v/v) 
Ethanol.   After complete removal of the ethanol by suction, 300 µl 100 % (v/v) acetonitrile was 
added, and the sample was incubated for 30 minutes with vigorous shaking to dehydrate the gel.  
After completely removing the acetonitrile, 50 µl DTT-solution was added, and the sample was 
incubated at 56°C for 45 minutes.   DTT reduces disulphide-bridges in proteins.  The DTT-
solution was discarded and replaced by 50 µl iodoacetamide-solution.  The sample was 
incubated for 30 minutes with vigorous shaking; it was wrapped in foil to protect iodacetamine 
from exposure to light.   Iodoacetamide is an alkyl acting agent used to modify reduced cysteine 
residues thus hindering reformation of disulphide bonds.  Iodacetamine was removed, and the gel 
washed in 50 % (v/v) acetonitrile for 10 minutes with shaking.  The 50 % (v/v) acetonitrile was 
then replaced by 100 % (v/v) acetonitrile and the gel was incubated for 15 minutes with vigorous 
shaking for complete dehydration.  After removing all acetonitrile, 10 µl trypsin-solution was 
added and the sample incubated on ice.  Trypsin is a serine protease thatcleaves peptide chains at 
the carboxyl site of the amino acids lysine or arginine.  After 45 minutes, 10 µl 25 mM 
NH4HCO3 was added to the sample and the sample incubated overnight at 37°C.  The next day, 
the sample was centrifuged and the supernatant containing tryptic peptides was transferred to a 
clean tube and stored at -20°C.   
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2.19.2  Protein identification by MALDI-TOF MS/MS 
Materials 
o Matrix stock solution:  
100 µg α-cyano-hydroxy-cinnamic acid (CHCA)  
700 µl 100  % (v/v) Acetonitrile 
100 µl 1 % (w/v) Trifluoro acetic acid (TFA) 
200 µl dH2O 
All ingredients were mixed by thoroughly vortexing. 
o Acetonitrile, 100 % (v/v) 
o TFA, 0.5 % and 1 % (v/v) 
o MALDI-TOF/TOF Mass spectrometer, Ultraflex 
Procedure 
Prior to use, the MALDI sample plate was washed with dH2O, dried off with soft tissues and 
sonicated in 50 % methanol in a water bath for 15 minutes to remove all bound particles.  The 
methanol was washed off with dH2O and the plate was cleaned with small amounts of 100 % 
acetone.  Finally, the plate was dried with a soft tissue. 
For protein identification, 1µl trypsin digested sample (see section 2.19.1) was applied to a 
MALDI plate and left to dry before 1 µl photoactive matrix, obtained by diluting the stock 
solution 20 times in freshly made 90 % acetonitrile and 0.1 % TFA, was applied on top of the 
sample and air-dried.  Trypsin digested β-lactoglobulin with known tryptic fragments was used 
as standard and for this purpose 0.5 µl of a 5 pmol/µl solution of trypsinated β-lactoglobulin was 
applied to the plate and dried.  Then 0.5 µl matrix was added on top of the standard and left to 
dry.  The plate was inserted into the MALDI-TOF and a vacuum was introduced.  All 
instrumental analysis was performed using the program Flexcontrol version 3.3. The programme 
Biotools was used for interpretation of the data from MS and tandem mass spectrometry 
(MS/MS) analysis.  MS/MS employs multiple MS analysis stages with a fragmentation in 
between the steps.  
First a simple MS-analysis was performed using 30% of the laser intensity to irradiate the 
samples, resulting in ionized polypeptides that were accelerated through the magnetic field and 
captured by the TOF analyser.  A computationally generated database with predicted peptide-
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fragments from trypsin treated proteins was used to search for peptide identification.  If no 
identical sequences were retrieved during MS, MS/MS was used to generate sequence 
information for the peptides.  The largest peak from the MS analysis was captured, and the 
sample was irradiated again with higher laser intensity to fragment the peptides into a series 
short oligopeptides from which sequence information could be derived using the Biotools 
programme.  
2.19.3  MALDI-TOF MS analysis for testing enzyme activity 
The activity of CfCBM33B-N towards different carbohydrate substrates was analysed using 
MALDI-TOF MS for product analysis.  The different reaction conditions tested are summarized 
in Table 3.2. 
Materials 
o Matrix:   
4.5 mg DHB (2,5-Dihydroxybenzoic acid) 
150 µl acetonitrile 
350 µl dH2O 
DHB and acetonitrile were vortexed until the DHB was completely dissolved before dH2O 
was added.  The DHB solution was stored at 4°C for no more than a week. 
o MALDI target- plate 
o Substrates, all substrates listed in section 2.1.2 
o Buffers: 
- 100 mM Sodium acetate, pH 3.0, 4.0 and 5.0 
- 100 mM Bis-Tris, pH 6.0 
- 100 mM Tris HCl, pH 7.0, 7.5, 8.0 and 9.0 
o 1 mM copper chloride  
o MALDI-TOF/TOF Mass spectrometer, Ultraflex 
Procedure 
All reactions were set up with 1 mM reducing agent, 20 mM buffer, 1µM enzyme and 2mg/ml 
substrate (except for β-chitinE which was tested at 1 mg/ml) in cryo-tubes and incubated 
horizontally in a shaker for 16 hours at 37°C with shaking at 220 rpm.  Different reaction 
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conditions were tested: different substrates, different reaction pH, different buffers, with or 
without 1 µM copper2+ in the reaction, and different reducing agents. 
For every reaction set up, a negative control, i.e. a reaction without added enzyme was set-up to 
account for the presence of carbohydrate products in the substrate solution. A positive control 
was generated by incubating β-chitinA with CBP21, in a reaction with 1 mM ascorbic acid as 
reducing agent in Bis-Tris buffer pH 7.0 at room temperature. 
Of each sample, 1 µl was applied to a spot on the pre-cleaned MALDI plate (as described in see 
section 3.17.2) and 2 µl DHB-matrix was applied on top of the sample.  The sample/DHB-
matrix- spot was completely dried by a warm stream of air before the MALDI plate was placed 
on a MALDI target-plate and inserted into the MALDI-TOF analyzer.  The software FlexControl 
version 3.3 was used for controlling the system and FlexAnalysis version 3.3 was used for 
analysis and processing of data.  Most samples were analyzed using laser beam intensities 
between 20% - 30% of maximum capacity.  Addition of Cu2+ to the reaction decreases the 
activity (see results section 3.6.1, table 3.2) and, therefore, copper was not used in further 
enzyme activity assays. 
2.20  Binding assays 
Binding efficiencies and affinities of CfCBM33A-N and CfCBM33B-N were examined by 
incubation with various carbohydrate substrates. 
Materials 
o Substrates (see section 2.1.2)  
- Xylan 
- CelluloseC 
-
 α-chtinA 
- β-chitinA 
o Binding buffers 
- 100 mM Sodium acetate, pH 3.0, 4.0 and 5.0 
- 100 mM Bis-Tris, pH 6.0 
- 100 mM Tris HCl, pH 7.0, 7.5, 8.0 and 9.0 
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Procedure 
All substrates were pre-washed in 3 x 1 ml binding buffer, and the buffer was removed by 
pipetting.   For studies of the binding of proteins in the periplasmic extracts, 100 µl extract was 
used, whereas purified proteins were diluted to 2 µM in buffer with the appropriate pH prior to 
addition of substrate.  100 µl protein sample was mixed well with 100 µl followed by a 3 hour 
incubation at room temperature with shaking at 1,200 rpm.  Following the incubation, samples 
were centrifuged at 10,000 x g for 5 minutes. The supernatant, carrying the unbound protein, was 
separated from the substrate.  For all samples except xylan, the pelleted substrate was washed in 
3 x 1 ml buffer and then boiled for 10 minutes in 30 µl SDS-PAGE sample buffer.  From xylan-
samples, the supernatant, containing unbound protein, was analyzed instead of the pellet.  As a 
control, pure protein samples or periplasmic extracts were used.  For SDS-PAGE, 20 µl of 
sample was mixed with 20 µl 2 x sample buffer and boiled for 10 minutes.  Samples and a 
standard protein ladder were then subjected to SDS-PAGE analysis according to section 2.18. 
2.21 High-performance liquid chromatography (HPLC) 
HPLC is a chromatographic technique applied for separation of different compounds in a 
sample, with the aim to identify, quantify or purify the individual compounds.  An HPLC 
apparatus usually consist of a stationary phase (contained in a column), one or more pumps to 
drive the mobile phase and the samples through the column and a detector (in this case a UV-
detector). The column can contain different stationary phases. The retention time is calculated as 
the time it takes from the sample is injected until the compound is detected. HPLC delivers high 
performance (high resolution) because the systems are run at high pressure, which again allows 
the use of stationary phases with very low particle sizes. 
CfCBM33B-N activity on various substrates was analysed both by examining oxidized products 
released by CfCBM33B-N alone (see section 2.21.1) and by determining synergy obtained when 
combining this enzyme with chitinases and CBP21 derived from S. marcescens. After optimizing 
reaction conditions, synergy experiments were conducted on β-chitinA (highly crystalline) and β-
chitinE (less crystalline nano-fiber particles), as described in section 2.21.2. 
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2.21.1 Analysis of oxidized oligomeric products by UHPLC 
Materials 
o Reaction buffer 
- 100 mM Bis-Tris pH 6.0 
- Other buffers used during optimization (stock solutions): 
 100 mM Sodium acetate, pH 3.0, 4.0 and 5.0 
 100 mM Tris HCl, pH 7.0, 7.5, 8.0 and 9.0 
o Reducing agents (stock solutions) 
- 0.1 M ascorbic acid 
- Other reducing agents used during optimization: 
 0.1 M gallic acid 
 0.1 M reduced glutathione 
 0.1 M glucosamine 
o Substrate 
- β- chitinA, squid pen 
o Tris-HCl 15 mM, pH 8.0 
o 100 % (v/v) Acetonitrile 
o dH2O 
o Standard: A mix of oxidized GlcNAcs with a degree of polymerization (DP) between 3 and 8 
(produced in-house; Vaaje-Kolstad et al., 2010). 
o Column: HELIC,  Acquity UPLC® BEH Amide 1.7 µm, 150 x 2.1mm  
- Pre column: BEH Amide VanGuard, 1.7 µm, 5 x 2.1 mm 
Procedure 
Reactions (100 µl) were set up in triplicates in cryo-tubes with 10 mg/ml substrate, 1 µM 
enzyme in 20 mM buffer, with or without reducing agents at different concentrations (1 mM, 2.5 
mM, 5 mM and 10 mM).  All samples were incubated at 37°C with shaking at 990 rpm.  At given 
time points, 40 µl of the reaction was sampled and added acetonitrile to a final concentration of 
70 % (v/v).  After centrifuging the samples at max speed to sediment all insoluble substrate, 40 
µl of each supernatant (containing solubilized products) was transferred to HPLC-tubes and 
stored at -20°C.  Samples were analyzed on an Agilent 1290 Infinity UHPLC system set up with 
a Waters Acquity UPLC BEH amide column and a BEH Amide pre column.  The amount of 
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sample applied to the column was 5 µl was injected and oligosaccharides were separated using a 
column temperature 30°C and a flow rate of 0.4 ml/min. The gradient was started by running 72 
% acetonitrile and 28 % 15 mM Tris-HCl pH 8.0 for 4 minutes, followed by an 11 minute 
gradient ending on 62 % acetonitrile, 38 % 15 mM Tris-HCl pH 8.0, followed by reconditioning 
of the column was obtained by a gradient back to initial conditions which was run for 5 minutes 
at initial conditions before next injection.  An “in-house” produced mix of oxidized GlcNAcs 
with a degree of polymerization (DP) between 3 and 8 was used as standard.  
2.21.2 Analysis of chitin degradation in synergy experiments 
For analysis of mono- and disaccharides obtained upon degradation of chitin an HPLC method 
based on ion exclusion was used. The column used was a Rezex Fast Fruit column 
(Phenomenex) which was run isocratically with an acidic mobile phase (5 mM H2SO4).  The 
Rezex Fast Fruit column separates ionic and non-ionic analytes, repelling the ionic molecules so 
they elute early, and retaining the non-ionic molecules (i.e. sugars).  
Materials 
o Buffers 
- 0.1 M Bis-Tris pH 6.0 
o Reducing agent 
- 0.1 M ascorbic acid 
o Substrates (see section 2.1.2) 
- β-chitinA 
- β-chitinE 
o Tris-HCl 15 mM, pH 8.0 
o dH2O 
o Standard: N-acetyl-D-glucosamine (GlcNAc; Alfa Aesar) and di-acetyl chitobiose 
((GlcNAc)2); Megazyme) 
o H2SO4, 50 mM and 5 mM solutions 
o Rezex RFQ_Fast fruit H+, 100 x 7.8 mm column 
o Purified ChiA, ChiB, ChiC and CBP21 from S. marcescens 
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Procedure 
Reactions (300 µl) were set up in triplicates in 50 mM BisTris pH 6.0 with 2.5 mM ascorbic acid 
as electron donor and substrate and enzyme concentrations according to table 2.16, in cryo-tubes 
that were incubated horizontally at 37°C with shaking at 990 rpm.  At given time points, 50 µl 
was sampled and mixed with 50 µl 50 mM H2SO4 to stop the enzymatic reaction.  Prior to HPLC 
analysis, the sample was centrifuged at maximum speed and 20 µl supernatant was transferred to 
a HPLC- tube.  At regular intervals during the sample series, GlcNAc and (GlcNAc)2 were run 
as standards for quantification, using the  following concentrations: 0, 62.5, 125, 250, 500, 1000 
and 2000 µM. Standard samples were diluteded with 50 mM H2SO4 to a final concentration of 
25 mM. 
To analyse degradation of the substrate to mono- and disaccharides, a Dionex Ultimate 3000 
RSLC HPLC system was set up with a Rezex RFQ Fast Fruit column,using Chromeleon version 
7.1.1.1127 to record, integrate and analyse chromatograms.  Before use, the Rezex column was 
heated to 85°C while 5 mM H2SO4 was run through the system with a flow of 0.3 ml/min.  Then 
the flow rate was set to 1 ml/min, which was the rate used throughout the analyses.  Of each 
sample and standard, 8 µl was injected and separated during the first 4 minutes of a 6 minutes 
run with 5 mM H2SO4 as mobile phase.  Eluted oligosaccharides were monitored by measuring 
absorption at 195 nm. 
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Table 2.16.  Concentrations of enzymes and substrates in reactions set up to analyze the effect of CfCBM33B-N on 
the degradation of β-chitin by chitinases. 
 Enzyme concentration 
ChiA ChiB ChiC CfCBM33B-N CBP21 
β
-
ch
iti
n
A
 
2 
m
g/
m
l 
0.2 µM - - - - 
0.2 µM - - 1 µM - 
0.2 µM - - 0.5 µM 0.5 µM 
0.2 µM - - - 1 µM 
- 0.2 µM - - - 
- 0.2 µM - 1 µM - 
- 0.2 µM - 0.5 µM - 
- 0.2 µM - 0.5 µM 0.5 µM 
- 0.2 µM - - 0.5 µM 
- 0.2 µM - - 1 µM 
- - 0.2 µM - - 
- - 0.2 µM 1 µM - 
- - 0.2 µM 0.5 µM 0.5 µM 
- - 0.2 µM - 1 µM 
β
-
 
ch
iti
n
E  
1 
m
g/
m
l 
0.2 µM - - - - 
0.2 µM - - 1 µM - 
0.2 µM - - 0.5 µM - 
0.2 µM - - 0.5 µM 0.5 µM 
0.2 µM - - - 0.5 µM 
0.2 µM - - - 1 µM 
- 0.2 µM - - - 
- 0.2 µM - 1 µM - 
- 0.2 µM - 0.5 µM - 
- 0.2 µM - 0.5 µM 0.5 µM 
- 0.2 µM - - 0.5 µM 
- 0.2 µM - - 1 µM 
- 0.04 µM - - - 
- 0.04 µM - 1 µM - 
- 0.04 µM - 0.5 µM - 
- 0.04 µM - 0.5 µM 0.5 µM 
- 0.04 µM - - 0.5 µM 
- 0.04 µM - - 1 µM 
- - 0.2 µM - - 
- - 0.2 µM 1 µM - 
- - 0.2 µM 0.5 µM - 
- - 0.2 µM 0.5 µM 0.5 µM 
- - 0.2 µM - 0.5 µM 
- - 0.2 µM - 1 µM 
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3 RESULTS 
3.1 Bioinformatics 
For all 5 proteins described in this study, theoretical data were calculated using the ExPASy 
ProtParam tool (http://web.expasy.org/cgi-bin/protparam/protparam, (Gasteiger E. 2005)).  
Results are shown in table 3.1. 
Table 3.1. Summary of key properties of the five different proteins described in this study. The Table shows IDs in 
UniProt and GenBank as well as the molecular properties of both the full-length proteins and the  isolated N-
terminal CBM33-domain. See text for more details on domain structures. 
      Full-length protein N-terminal CBM33 domain 
Protein UniProt GenBank bp aa 
Mw 
(kDa) pI bp aa 
Mw 
(kDa) pI 
CfCBM33A D5UGA8 ADG73091 984 327 35.0 5.26 569 190 21.1 5.13 
CfCBM33B D5UGB1 ADG73094 1104 367 39.0 5.22 591 197 21.6 5.22 
CfCBM33C D5UH31 ADG73234 999 332 34.4 4.62 551 187 20.9 4.93 
CfCBM33D D5UHY1 ADG73405 714 271 29.1 6.56 429 146 16.4  5.91 
AtCBM33A Q0CGA6 EAU32670 1203 400 42.7 4.75         
 
3.1.1 CBM33s from C. flavigena 
Cfcbm33A, Cfcbm33B, Cfcbm33C, and Cfcbm33D all code for two-domain proteins with similar 
architectures.  A sequence alignment of the four proteins is shown in Figure 3.1 wherethe two 
histidines are highlighted in pink and the domain arrangement, found in InterPro 
(http://www.ebi.ac.uk/interpro), is indicated by coloured lines above the sequence.  All four 
CfCBM33s have an N-terminal signal peptide (between 32 and 43 amino acids in length) 
followed by a CBM33-domain which is connected to a C-terminal CBM2-domain through a low 
complexity linker as illustrated in Figure 3.1 and 3.2.   
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Figure 3.1. Sequence alignment of the full-length CBM33 proteins from C. flavigena (see table 3.1 for more 
details).  The four CfCBM33s share a similar domain architecture, presented in Figure3.2 and indicated by coloured 
lines above the alignment, with an N-terminal signal peptide (yellow) followed by a CBM33-domain (pink) 
connected though a low complexity linker (purpel) to a C-terminal CBM2 domain.  One of the conserved histidines 
in the active site is highlighted in pink (the corresponding histidines in CBP21 and GH61E are shown in Figure 1.8). 
 
 
Figure 3.2. Modular scheme of a CfCBM33
(yellow), a CBM33-domain (pink) and a
linker (purple) 
The four CfCBM33s all have a C
CBM2s are classified in two groups, CBM2a and CBM2b, referring to a binding affinity towards 
either cellulose or xylan, respectively.
CBM2a and CBM2b may be
bin/prosite/prosite-search-ac?PDOC00485
shows a sequence alignment of the CBM2 
domain of Cellulomonas fimi endoglucanase A (CfiCenA; UniProt ID: P07984) and the CBM2b
domain of C. fimi xylanase D (CfiXylD; UniProt ID: P54865
Figure 3.3. Sequence characteristics of 
CBM2a and CBM2b derived from Prosite
indicated by the representative letters, x indicates any amino acid
CBM2a and that makes up an extra β-
panel: Alignment of CfCBM33-CBM2
1.11, left) and a CBM2b (Cfixyn11A, 
surface-located tryptophans are marked in yellow 
specificity by affecting the rotation of the first tryptophan
pink.  The area of the CBM2a-sequence pattern
.  All CfCBM33s have the same modules: an N-terminal 
 C-terminal CBM2-domain (blue) connected through a 
-terminal CBM2-domain.  As mentioned in section 1.3.
  Sequence patterns illustrating the differe
 derived from Prosite (http://prosite.expasy.org/cgi
) and are shown in Figure 3.3 (top). 
domains of the four CfCBM33s with the CBM2a
).   
CfCBM33s CBM2 domains. Top panel: schematic consensus patterns for 
.  Surface exposed tryptophan residues and conserved residues are 
.  The sequence pattern that is characterist
sheet in the structure (see section 1.3.5.1) is indicated by asterisks.  Bottom
 sequences with representative sequences of a CBM2a (
Figure 1.11 right).  All uniprot IDs are indicated in brackets. 
while the amino acids supposed to contribute to substrate 
 (graphically illustrated in Figure 1.12) 
 is indicated by a box. 
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signal peptide 
low complexity 
6.1, 
nces between 
-
The Figure also 
-
-
ic for 
 
Cfixyn10A, Figure 
 Conserved 
is highlighted in 
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Figure 3.3 shows that all four CfCBM33
most-likely are of the cellulose-binding
well as a glycine in the position that steers the orientation of the first tryptophan. 
noted that the few CBM2 modules for which binding to chitin has been demonstrated also belong 
to the CBM2a family (i.e. Tfu1665, 
3.1.2 CBM33 from A. terreus
3.1.2.1 Domain architecture  
Atcbm33A (ATEG_07286, Uniprot ID: Q0CGA6
protein containing 400 amino acids (aa) with an N
CBM33-domain (aa 18-117) followed by an unknown domain
terminal CBM20-domain (aa 298-383) through a low complexity linker (composed of mostly 
threonine and serine) as illustrated in
express the full length protein. 
Figure 3.4. Domain organization of AtCBM33A
CBM33-domain (pink) followed by an unknown domain
(green) through a serine/threonine linker (blue).
. 
3.1.2.2 Codon optimization 
To optimize the expression of a protein, efficient DNA transcription
protein production the expression rate
availability of tRNAs with the matching anti
multiple codons and the preferred 
Codon optimization implies that single nucleotide mu
DNA sequence to optimise the codon usage without affecting the protein sequence.  
Atcbm33A was optimized according to the codon usage bias in 
OptimumGene™ Gene Design software (
- CBM2-domains belong to the CBM2a family and 
 type, since all have the third conserved tryptophan 
Bacillus thuringiensis chitinase). 
 
) from A. terreus encodes a multidomain 
-terminal signal peptide (aa 1-17) 
 which is connected to a C
 Figure 3.4.  In the present study attempts were 
. The protein consists of an N-terminal signal peptide (yellow), a 
 (red) which is connected to a C-terminal CBM20
 
 alone is not sufficient
 also depends on the translation efficiency and the 
-codon.  Most amino acids can be coded for by 
codon usage varies between organisms (codon usage bias)
tations are introduced into 
P. pastoris by 
http://www.genscript.com/codon_opt.html
as 
 It should be 
preceding a 
-
made to 
 
-domain 
, since 
.  
the wild-type 
 
GenScript’s 
) prior to 
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gene synthesis.  The codon optimized nucleotide sequence (Appendix B) shares 75 % sequence 
identity with the original sequence.   
3.1.2.3 Homology modeling and sequence alignments 
In order to explore whether the CBM20 of AtCBM33A would be structurally compatible with 
binding starch, a homology model was made using the solution structure of the granular starch 
binding domain of glucoamylase 1 (G1) from A. niger (PDB: 1KUL; (Sorimachi et al. 1996)) as 
a template.  The model was made by use of Modeller (http://salilab.org/modeller/; (Eswar et al. 
2006; Sali et al. 1995)), based on sequence alignments generated by ClustalW2, and is presented 
in Figure 3.5.  The sequences share 56 % sequence identity, without insertions and deletions (see 
below), so the model may be expected to be reasonably accurate.  
 
Figure 3.5.  Homology model of the CBM20-domain of AtCBM33A.  The model is shown with two bound 
substrates shown in grey stick representation and oxygen coloured red, one substrate is bound in binding site 1 (in 
focus in the left model) and one in binding site 2 (in focus in the right model) (see section 1.3.6.3.1 for more 
details).  The right model is rotated 90° to the left and tilted 45° in respect to the left model.  An oligomannose is 
attached to Asn379 (coloured blue) to illustrate a possible N-glycosylation made by P. pastoris (see section 3.1.2.4).   
To position the two bound substrates, the model was superimposed onto the crystal structure of A. niger 
glucoamylase 1 (G1) when bound to β-cyclodextrin (PDB ID: 1AC0).  Protein structure graphics were made using 
PyMol (Schrodinger 2010). 
 
3.1.2.4 Analysis of putative N-glycosylation sites 
P. pastoris both O- and N- glycosylates proteins and both modifications could affect the protein 
expression and function.  However, since less is known about the O-glycosylations compared to 
N-glycosylations, and as no consensus glycosylation sequence is known for O-glycosylations in 
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P. pastoris, their prediction is not possible.  N-glycosylation, on the other hand, is known to 
occur on asparagine residues which occur in the sequence Asn-Xaa-Ser/Thr, where Xaa is any 
amino acid except proline with some exceptions depending on the surrounding sequence.  For 
prediction of possible N-glycosylation sites in AtCBM33 the NetNGlyc 
(http://www.cbs.dtu.dk/services/NetNGlyc/) server, was used.  NetNGlyc is a web-tool for 
predicting plausible N-glycosylation sites in proteins that based on the surrounding sequence.  
Analyses show that there is 68% possibility for N-glycosylation to occur at residue 119 and a 
51.5 % possibility at residue 379 (see output file in Appendix C) based on the assumption that 
these amino acids are located on the protein surface.   
One of these putative N-glycosylation sites, Asn 379, is located within the CBM20 domain.  For 
illustration purposes, an oligomannose was computationally attached to Asn379 in the homology 
model shown in Figure 3.5 by the use of the GlyProt 
(http://www.glycosciences.de/modeling/glyprot/php/main.php) with default settings (see 
Appendix C).  GlyProt is a web-based tool for attaching various N-glycans to potential N-
glycosylation sites of a known three-dimensional protein structure.   
 
3.1.2.5 Conserved residues 
As stated in section 1.3.4.3, both binding sites of the CBM20-domain have conserved residues 
proven important for substrate binding.  The binding sites of the two proteins were compared by 
aligning both the sequence and the structures/models of AtCBM33A_CBM20 and G1_CBM20 
(Figure 3.6).  The results of these comparisons show that in binding site 1, all residues involved 
in substrate binding are conserved, while binding site 2 shows more variation.   
 
 
 
Figure 3.6.  Concerved residues in the CBM20
AtCBM33A. (Top) Structure based sequence alignment of the CBM20
AtCBM33A.  Conserved residues in binding site 1 
2 are highlighted in green.  Residues in binding site 2 that differ between G1 and AtCBM33A are colored in blue 
and yellow, respectively.  (Bottom) Superimposition of the conserved residues in binding site 1 (left) and in binding 
site 2 (right) of AtCBM33A (pink) and G1 (light blue). 
binding is visible in the upper left corner.   The numbering of residues 
Alignments and protein structure graphics were made using PyMol (Schrodinger 2010
3.2 Cultivation, cloning and transformation
3.2.1 Cultivation of C. flavigena
C. flavigena’s ability to utilize different carbon sources 
bacterium with minimal medium containing 
The carbon sources used were cellulose
at 0.2 % w/v.  We observed no growth on 
SDS-PAGE of supernatant proteins 
2.18. No further attempts were made to analyze the susbtrate preferences of the bacterium
 
    
 domains of A. niger glucoamylase 1 (PDB ID: 
-domains of A. niger glucoamylase 1 
are highlighted in pink, while conserved residues in binding site 
 In the right picture the flexible loop involved in substrate 
is according to the numbering in 1KUL.  
). 
 
 
were examined by cultivation of the 
distinct different carbon sources (see section
A
, xylan, α-chitinA, β -chitinA, all at 1% w/v
these media, and no secreted proteins were detected 
performed according to the procedure described in section 
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, and glucose 
in 
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3.2.2 Cloning of CfCBM33s 
Chromosomal DNA was extracted from a 
(see section 2.4) and all four cbm33
and Cfcbm33D) were amplified by PCR using Phusion
according to section 2.5.1.  For each protein, two DNA fragments were generated, one encoding 
the full length protein and one containing only
leader sequence, using primer set s
concerning the truncation points). 
name (e.g. Cfcbm33A) whereas constructs comprising only the
ending at “-N” (e.g. Cfcbm33A-N). PCR fragments of appropriate size were obtained for 
constructs. Figure 3.7 shows the eight
Figure 3.7.  PCR amplification of Cfcbm33
where the left lane show a 100 bp ladder.  The size (bp) of all marker
PCR products. The predicted sizes of the PCR 
CfCBM33B 1117 bp, CfCBM33B-N 607 bp, 
CfCBM33D-N 445 bp.   
The cloning strategy for the Cfcbm33
Appendiks C, figure C.2 for plasmid details) that had the 
2 ml culture of C. flavigena grown over night 
-genes from C. flavigena (Cfcbm33A, Cfcbm33B, Cfcbm33C 
™ High-Fidelity DNA polymerase 
 the N-terminal CBM33 domain without its natural 
pecific for each gene (Table 2.2; see Figure3.1
Full length constructs are indicated by the gene or protein 
 N-terminal domain have names 
 PCR fragments that were successfully cloned (see below).
 genes. The left lanes show a 1 kb DNA ladder, except for 
-fragments is labeled.  The right lanes show 
products are: CfCBM33A 999 bp, CfCBM33A
CfCBM33C 1014 bp, CfCBM33C-N 573 bp, CfCBM33D 931 bp, 
 genes was based on the use of a variant of pRSET
cbp21 gene from S
on LB 
 for details 
all eight 
 
 
Cfcbm33B-N 
-N 585 bp, 
-B (see 
. marcescens 
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inserted within its multiple cloning site (Vaaje-Kolstad et al. 2005a), referred to as pRSET-
B/cbp21.  The cbp21 gene includes a signal peptide and it has been shown in previous studies 
that this pRSET-B construct leads to accumulation of considerable amounts of correctly 
processed CBP21 in the periplasmic space of the E. coli host cells.  In the cloning strategy used 
here the gene fragment encoding mature CBP21 was replaced (by cleaving with HindIII and 
BsmI) with Cfcbm33 gene fragments lacking their natural signal peptide.  Thus, vector constructs 
were generated in which mature CfCBM33s were fused to the leader peptide of CBP21.   
All eight amplified gene fragments (shown in Figure 3.7) were attempted cloned into pRSET-B 
using the In-Fusion™ cloning procedure described in section 2.10.1 and illustrated in Figure 2.1.  
Ligation mixes were transformed into competent E. coli TOP10 according to section 2.11 and 
transformants were obtained for four of the constructs: Cfcbm33A, Cfcbm33A-N, Cfcbm33B-N 
and Cfcbm33C.  Each of the four transformants was inoculated overnight in 5 ml LB-medium 
supplemented with 50 µg/ml ampicillin.  The plasmids were isolated from 2 ml of each culture 
according to section 2.6.1 and the genes sequenced by the use of BigDye version 3.1 according 
to section 2.8.1 with both forward and reverse sequencing primers (pRSET_B SeqF, RSET- 
SeqR in addition to the gene-specific forward and revers primers annealing in the middle of the 
genes, listed in table 2.3).  Sequencing results were analysed using GENtle (Manske 2003) and 
indicated a successful cloning of Cfcbm33A-N and Cfcbm33B-N while the sequencing results of 
Cfcbm33A and Cfcbm33C were incomplete and no further attempts were made to make positive 
transformants carrying these genes.  For protein expression, purified plasmids of Cfcbm33A-N 
and Cfcbm33B-N were transformed into BL21 Star (DE3) competent E. coli (see section.  
Transformants containing CfCBM33A-N and CfCBM33B-N were obtained and cultivated for 
protein expression, as described further below. 
3.2.3 Cloning of Atcbm33A 
The expression vector used for expression of AtCBM33A in P. pastoris was pPICZα-A (see 
Appendix D for plasmid map of pPICZα-A).  pPICZα-A was ligated with the codon optimized 
synthetic gene encoding AtCBM33A, both flanked by XhoI and XbaI, according to section 
2.10.2.  This strategy would result in the AtCBM33A gene replacing the multiple-cloning site 
preceding the c-myc epitope and ending with a stop codon (TGA) prior to the XbaI restriction 
site. The ligation mix was transformed into XL10-Gold competent E. coli.  Plasmids extracted 
from positive transformants, selected by growth on Zeocin™, were sequenced by using forward 
or reverse sequencing primers according to section 2.8.  Sequencing results revealed a deletion 
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of guanine in the stop-codon (TGA) of the 
but, by coincidence, this mutation led 
gene and a strech of nucleotides encoding
histidine tag directly followed by a stop codon
Figure 3.8.  Alignment of the 3’ end of the codon optimized Atcbm33A 
pPICZα-A derivative used for AtCBM33A 
a terminally extended protein with a c-myc epitope and a polyhistidine tag.  
used for cloning (TCTAGA) and the stop
made using GENtle (Manske 2003). 
Because of this deletion, the protein was extended with 23 amino acids and the molecular weight 
of the protein increased with 2788 Da.  This p
histidine tag could be beneficial for purification and identification and it was decided to continue 
using this plasmid throughout the present
were obtained (results not shown). 
3.3 Protein expression and purification
3.3.1 CfCBM33 expression 
For optimal expression of CfCBM33A
media were tested.  IPTG, which induce the allegedly inducible T
both previous studies (G. Vaaje-Kolstad,
carried out in the present study had indicated that induction had no effect on protein expression.
Expression of CfCBM33B-N was success
used.  Cultivation in TB-medium supplemented with 50 µg/ml 
shaking at 180 rpm for 3 days gave high expression
under the same conditions (Figure
however in lower amounts than CfCBM33B
synthetic gene.  As a result, the stop-codon was los
to an in-frame C-terminal fusion between the 
 a C-terminal c-myc epitope followed by 
 (Figure 3.8). 
gene and the Atcbm33A gene 
expression.   Deletion of one G in the stop-codon of Atcbm33A
Additionally, the XbaI restriction site 
-codon subsequent to the polyhistidine tag is marked. Alignments were 
rotein is further annotated as AtCBM33A
 study.  Later, transformants with the correct sequence 
 
-N and CfCBM33B-N, different cultivation conditions and 
7 promoter, was not used since 
 personal communication) and initial experiments 
ful but expression levels depended on the conditions 
ampicillin at 25°C and with 
, as compared to cultivation on 
 3.9).  Expression of CfCBM33A-N was also 
-N (Figure 3.9).   
Stop
t, 
AtCBM33A 
a hexa-
 
present in the 
 results in 
His
.  A 
  
e.g. BHI 
observed, 
-codon 
 Figure 3.9.  Expression of CfCBM33. 
marker (left lane) and periplasmic extracts from CfCBM33 producing strains, as indicated. Two of the marker 
proteins are lebeled by their molecular weight and the approximate position of the expressed proteins (21 kDa for 
both) is indicated by an arrow.  The gel shows tha
of E. coli BL21 Star™ (DE3) in Terrific broth (
also shows that cultivation in brain heart infusion (BHI) 
to a less extent than cultivation on TB
with shaking at 180 rpm).  Expression of CfCBM33A
conditions, however to a less extent than for CfCBM33B
For the larger scale production and subsequent purifcation of 
coli were cultivated in 150 ml TB
three days of cultivation, the proteins secreted into the periplasm of the bacterial cells were 
extracted according to section 2.14
3.3.2 Expression of AtCBM33A
For protein expression, linearized pPICZ
transformed into P. pastoris strain 
2.12.  Transformed cells were selected by cultivation on YPDS
µg/ml Zeocin™ for four days.  This gained approximately 20 transformants, and those carrying 
the gene of interest were identified by PCR (see section 2.5.1) using the clo
section 2.1.3).  80 % of the transformants had 
small-scale expression was conducted according to section 2.14.
transformants able to grow on methanol as sole carbon source and secrete 
Approximately 1.5*108 transformed cells were cultivated in 25 ml BMMY containing 0.5 % 
(v/v) methanol for 96 hours.  Secreted proteins were 
secreting AtCBM33AHis (~45.5 kDa) were included in a large
see section 2.13.4) to determine 
was monitored by measuring OD
 The picture shows a Coomassie-stained SDS-PAGE gel with a protein 
t optimal expression of CfCBM33B-N was achieved by cultivation 
TB)-medium for 3 days at 25°C with shaking at 180 rpm.  
medium gave good expression of CfCBM33B
 medium (under otherwise same conditions, i.e. 3 days incubation at 25°C 
-N was also achieved after cultivation under the same 
-N.    
CfCBM33 genes, transformed 
-medium for three days at 25°C with shaking at 180 rpm.  After 
.   
His 
α-A/ Atcbm33AHis (approximately 8 µg) was 
X-33 (7*107 cells) by electroporation according to section 
-plates supplemented with 100 
ning primers (see 
Atcbm33A incorporated in their genomes and a 
3 to screen for positive 
analyzed on SDS-PAGE and transformants 
-scale expression (5
which transformant to proceed with for fermentation.  Growth 
600 during the four day growth phase with induction by 
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The gel 
-N, however, 
E. 
AtCBM33AHis.  
00 ml cultures; 
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methanol.  The growth curve is shown in Figure 3.10.  Out of the 16 transformants carrying the 
gene, only four could metabolize methanol as sole carbon source and secrete AtCBM33AHis 
(determined by SDS-PAGE).  Out of these four, one was selected for fermentation. 
 
 
Figure 3.10. Growth of P. pastoris X-33 producing Atcbm33A. Growth of P. pastoris X-33 with Atcbm33A 
integrated in the genome during large scale expression (500 ml cultivation medium containing 0.5 % (v/v) methanol 
as sole carbon source) was monitored by measuring OD600 every 24 hours after start of the induction phase (see 
section 2.13.4 for details on the large-scale expression).  The cell density is calculated by multiplying the OD600 by 
5x107, the approximately cell density/ml when OD600=1 (M. Abou Hachem, personal communication).  The graph 
represents the mean growth of 4 transformants, and the error-bar indicates the standard deviation of the mean. 
The selected P. pastoris X-33 transformant for expression of secreted AtCBM33AHis was grown 
in a 5 liter fermentor as described in section 2.13.5.  During fermentation, a similar growth-curve 
as in the large-scale expression was observed, however, with a much higher cell density.  The 
fermentor, containing 2 liter basal salt medium, was inoculated with 250 ml BMGY containing 
2.5*109 cells and cultivated with a constant, however minimal, feed of glycerol until the culture 
reached a cellular yield of 160 g/liter.  The glycerol feed was stopped and the culture induced 
with methanol.  Fermentation on methanol was carried out for four days with a more or less 
constant feed of methanol at 11 g/h/L.  After four days the cells were harvested by centrifugation 
and the supernatant, containing the secreted proteins, were sterile filtered and concentrated 10 
times using the Pellicon ultra-filtration system according to section 2.13.6. 
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3.3.3 Protein purification 
Protein purification of CfCBM33A-N and CfCBM33B-N was performed in two steps.  First, an 
ion exchange chromatography was conducted according to section 2.15.1 to exclude molecules 
with a different isoelectric point than the two CfCBM33s (pI= 5.1/5.2).  The periplasmic extract, 
containing either CfCBM33A-N or CfCBM33B-N retrieved from a 150 ml culture, was pH 
adjusted to 7.5 by addition of 50 mM Tris-HCl and the sample (50 ml) was loaded onto the 
column.  Elution of CfCBM33s and fraction collection (1 ml/fraction) was performed as 
described in section 2.15.1 and analyzed on SDS-PAGE (Figure 3.11 Left; chromatograms are 
shown in Appendix D, Figure D.1).  Fractions containing the highest amount of the desired 
protein (CfCBM33A-N fractions 33-39 and CfCBM33B-N fractions 11-17) were concentrated 7 
times and the buffer changed to 10 mM Tris-HCl pH 7.5.  The concentrated sample (1 ml) was 
further purified by size exclusion chromatography according to section 2.15.2 and collected in 
fractions of 5 ml.  Fractions putatively containing CfCBM33A-N (fractions 53-56) or 
CfCBM33B-N (fractions 53-62) were analyzed by SDS-PAGE (Figure 3.11, Right; 
chromatograms are shown in Appendix D, Figure D.2-3).   
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Figure 3.11. Purification of CfCBM33A-N and 
fractions from the two-step purification of 
exchange chromatography (Left) followed by
applied in the left lane in all four gels and the
approximate position of the expressed proteins (
CfCBM33A-N and CfCBM33B-N were not completely purified
size exclusion chromatography using fractions 33
CfCBM33B-N, pure CfCBM33B-N was obtained from fractions 56 
purified. 
CfCBM33A-N was not completely purifie
molecular weight of the largest contaminating protein is a
intermolecular reformation of cysteine bonds during SDS
using reducing agents in the SDS
discussion. 
CfCBM33B-N, on the other hand, contained purified protein in
fractions (5 ml/fraction) were pooled and concentrated
concentration according to section 2.16.  T
approximately 1 mg. 
CfCBM33B-N. The picture shows SDS-PAGE analysis of 
CfCBM33A-N (Top) and CfCBM33B-N (Bottom)
 size exclusion chromatography (Right).  A protein marker was 
 marker proteins are labeled by their molecular weight
21 kDa for both) is indicated by arrows.  The gels show that both 
 by ion exchange chromatography.  
-39 containing CfCBM33A-N and fractions 11
– 62.  CfCBM33A-N was not completely 
d, possibly because of dimerization of protein
pproximately 40 kDa)
-PAGE.  If so, this could be solved by 
-PAGE running buffer.  This is discussed further in the 
 fractions 58 to 62
 25 times before determining the protein 
otal yield of pure CfCBM33B-N was calculated to be 
different 
, first by ionic 
.  The 
However, after 
-17 containing 
s (the 
 due to 
.  These 
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AtCBM33AHis was purified from 30 ml of the secreted proteins (concentrated according to 
2.13.6) from the fermentation of transformed P. Pastoris (section 2.13.5) using a HisTrap™ HP 
column according to section 2.15.3.  The chromatogram is shown in Appendix E, Figure E.4.  
Fractions A15 to B3 were pooled, concentrated 10 times and run on an SDS-PAGE for analyzing 
the purity.  The purified protein appeared as a “smear” on the gel (Figure 3.12).  Since the 
protein has known N-glycosylation sites (shown in section0) a treatment of the purified protein 
with EndoH was performed to remove N-glycosylations (see section 2.18).  EndoH-treatment 
removed some of the glycosylations (visualized by SDS-PAGE; Figure 3.12); however, it did not 
result in a clear band as should be the case if the protein only were N-glycosylated.  
 
 
Figure 3.12. Purified AtCBM33AHis.  The picture shows a Coomassie-stained SDS-PAGE gel with a protein 
marker in the left lane and AtCBM33AHis (Mw: ~45 kDa) first (1) purified by immobilized metal ion 
chromatography followed by (2) incubation with EndoH (mw: 29 kDa) at 37°C for two hours.  EndoH treatment 
should remove any N-glycosylations (see section 2.17 and Figure 2.3).  Although the gel shows a narrowing of the 
smear after EndoH treatment, a clear protein band was not achieved.  All marker proteins are labelled. 
3.3.4 Expression and purification of ChiA, ChiB, ChiC and CBP21 
Previously constructed vectors for expression of CBP21 (pRSET-B/cbp21) and the three 
chitinases from S. marcescens (chiA was cloned in expression vector pMAY20-1, chiB in 
pMAY2-10, chiC in pRSET-B) had been transformed into E. coli BL21 Star (DE3) for 
expression (Brurberg et al. 1994; Brurberg et al. 1995; Brurberg et al. 1996; Vaaje-Kolstad et al. 
2005b).  From these transformants, CBP21, ChiA, ChiB and ChiC were expressed as described 
in section 2.13.1 in overnight cultures in 300 ml LB-medium supplied with 50 µg/ml ampicillin.  
ChiC expression was induced by 0.5 mM IPTG when the culture had reached an OD600 of 0.6 
according to section 2.13.2 while ChiA and ChiB were produced under control of their original 
promoters.  Proteins secreted to the periplasmic space were extracted after lysis of the cells by 
cold osmotic shock (section 2.14).  Following, the three chitinases and CBP21 were purified 
1 2 
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from the extract by affinity chromatography with chitin beads according to section 
Chromatograms for these one-step purifications are shown 
Figure 3.13 shows SDS-PAGE gels illustrat
that the three chitinases and CBP21 were completely purified. 
ChiC only consist of the GH18-domain and 
fibronectinIII.  This truncated version of the protein is referred to as 
protein is known as ChiC1.  
        
Figure 3.13.  Purified chitinases and CBP21 derived from 
show a protein marker (left lane), the protein contents in the periplasmic extract from witch 
ChiB (mw: 55.5 kDa), ChiC (ChiC1 mw: 52 kDa, ChiC2: 36 kDa) and CBP21 (mw: 18.8 kDa
finally the purified proteins.  All proteins were completely purified
(section 2.15.4).  Note that purified ChiC results in two protein, one full
variant (ChiC2) lacking the substrate binding modules, CBM12 and 
3.4 Determination of protein identity
Since EndoH treatment of AtCBM33A
gel (Figure 3.12) protein identification was carried out by 
gel with analyzed purified AtCBM33A
was cut out and trypsin digested according to section
analyzed using MALDI-TOF MS (
against the NCBI-database for AtCBM33A with protein sequence coverage of 30 % and a score 
of 124 (see Appendix E for output from Mascot;
analysis).  
in Appendix D, Figure
ing the purity of the purified proteins.  The data show 
 Note that part of the purified 
lack the two extra binding domains, CBM12 and 
ChiC2, while the full
 
S. marcescens.  The coomassie-stained SDS
ChiA (mw: 61 kDa), 
) was 
 by affinity chromatography using
-length protein (ChiC1) and one truncated 
fibronectin III-domain. 
 
His
 did not result in a clear protein bond on the 
MS-analysis.  From the SDS
His
 a piece of the protein-smear (at approximately
 2.19.1.  The trypsin digested 
see section 2.19.2) and gave a positive match 
 the protein is named ATEG_07286
2.15.4.  
 D.5-D.8 and 
-length 
 
-PAGE gels 
purified and 
 chitin beads 
SDS-PAGE 
-PAGE 
 55 kDa) 
protein was 
in search 
 in this 
3.5 Binding assays 
3.5.1 Substrate binding of 
Binding properties of the non
periplasmic extracts of the production strains, were 
chitinA, xylan and filter paper; see table 2.1 for 
at pH 7.5 (Figure 3.). 
Figure 3.14.  Binding of non-purified
extracts to α-chitinA, β- chitinA, xylan and 
amount of substrate) were analysed on SDS
1200 rpm.  Note that the lanes with 
(pelleted by centrifugation), whereas the 
after pelleting xylan).  A protein marker (left lane in both gels) was used for size
marker proteins in between 20 and 40 kDa are labelled.  
shown as control.  The band representing
Weak binding to α-chitinA was observed 
CfCBM33A-N did not show detectable binding 
binding affinity to this substrate.  
could not be analyzed for technical reasons.  Analysis of the unbound material (Fig. 3.13) did 
indicate that binding to xylan is weak or absent for both proteins (
concentrations were observed between the periplasmic extract an
Neither of the proteins bound to cellulose
The binding properties of 0.7 µM purified 
further examined at varying pH, ranging from 3
temperature with shaking (1200 rpm).
substrate-free sample (÷) were visualized by SDS
CfCBM33B-N visualized by SDS-page
-purified CfCBM33A-N and CfCBM33B-N, as 
tested with different substrates (
details on the substrate) according to section 
 
 CfCBM33A-N (left) and CfCBM33B-N (right) as present in
celluloseC at pH 7.5.  Samples (100 µl periplasmic extract and an equal 
-PAGE after incubation for 3 hours at room temperature with shaking at 
α-chitinA, β-chitinA and celluloseC show proteins bound to the substrates 
xylan lanes show the unbound proteins (proteins left in the supernatant 
-determination of the proteins.  All 
Periplasmic extract containing the expressed protein is 
 the respective proteins (~21 kDa) is marked with an arrow.
for both CfCBM33A-N and CfCBM33B
to β-chitinA, while CfCBM33B-N showed strong 
Data for xylan are not conclusive, because, the bound fract
no differences in protein 
d the unbound protein sample
C
.  
CfCBM33B-N towards 50 mg/ml 
 to 9, when incubated for 3 hours at room 
  Protein bound to the substrate (+) and protein in the 
-page (Figure 3.15Figure 3.12).  
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α-chitinA, β-
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 periplasmic 
 
-N.  
ion 
).  
β-chitinA were 
 
100  
Figure 3.12. Binding of CfCBM33B-N to β
added to samples containing 50 % buffer and 50 % 
concentration 50 mg/ml) or with 100 % buffer (indicated by ÷) and incubated at 37°C with shaking
3 hours.  The gels show protein bound to the substrate 
were tested to check for pH-induced effects on the soluble protein.
The results indicate that binding is clearly pH
the pH range below 5 and above 9, while optimal binding i
At pH 5, which is close to the proteins 
shown by the absence of protein in the
pellet upon centrifugation (not shown).
3.5.2 Binding of AtCBM33A
titration calorimetry 
Isothermal titration calorimetry (ITC) experiments 
by Maher Abou Hachem and colleagues at the department of syste
protein chemistry, Denmark Technical University
not known).  ITC is a technique that measures the released or absorbed heat from a biomolecular 
binding event.   From the measured data, dis
(average number of binding sites per mole of protein, N), enthalpy (
calculated.  AtCBM33AHis was titrated with 
of seven glucose units, and the results are shown in 
0.5 and the calculated dissociation constant 36 µM, indicating a moderate binding affinity 
towards β-cyclodextrin.   
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Figure 3.16.  ITC experiment of AtCBM33His titrated with β-cyclodextrin.  The Figure shows the raw data (black), 
the fitted line (red) and thermodynamic data derived from the experiment.  See Appendix F for raw data. 
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3.6 Activity assays 
3.6.1 Enzyme activity profiling by MALDI-TOF MS 
To determine the substrate specificities and the optimal reaction conditions for polysaccharide 
degradation by CfCBM33B-N, reactions were set up according to Table 3.2 and analyzed by 
MALDI-TOF MS according to section 2.19.3.  The MALDI-TOF analysis was used to detect 
native and oxidized oligosaccharide products. 
Table 3.2. Activity of CfCBM33B-N towards different carbohydrate substrates under different reaction conditions. 
In addition to the listed variable conditions, all reactions included 1.0 µM CfCBM33B-N, 1.0 mM ascorbic acid and 
2.0 mg/ml substrate.  See Table 2.1 for detailed information on the various substrates. Reactions were incubated at 
37°C with shaking at 900 rpm for 20 hours.  Degradation of β-chitinA by CBP21 was used as a positive control, and 
reactions in absence of enzyme were set up as negative controls.  Activity was monitored by MALDI-TOF analysis 
of oligosaccharide products and detected oligosaccharide products were marked by a + in the table (see section 3.6.2 
including Figure 3.6.2 for an example of the interpretation of MALDI-TOF results).  The raw data from the 
MALDI-TOF analyses are provided in Appendix H.  Empty boxes mean not determined. The positive controls were 
done with 1 µM CBP21, 2 mg/ml β-chitinA, 1 mM ascorbic acid in 20 mM Tris-HCl pH 8  and all yielded previous 
identified oligosaccharides with a degree of polymerization of 4, 6, 8 and 10.  No oligomeric products were detected 
in the negative controls (not shown). The two substrates that were used in further analyses are highlighted in yellow. 
Buffer 20 mM Na-acetate  20 mM Bis-Tris  20 mM Bis-Tris  20 mM Bis-Tris  20 mM Tris-HCl  
pH 5.0 6.0 7.0 7.0 8.0 
Metal - - - Cu(II)Cl2 1.0  µM - 
α-chitinA - - - - - 
α-chitinB - - - - - 
α-chitinC - - - - - 
α-chitinD - - - - - 
α-chitinE + + + - + 
β-chitinA + + + + - 
β-chitinB + + + - + 
β-chtiinC + + + - + 
β-chitinD + + + - + 
β-chitinE + + +   
Xylan 
  
-   
Avicel 
  
-   
PASC 
  
-   
 
The data in table 3.2 and the binding data presented above show that CfCBM33B-N is active on 
β-chitin in a wide pH range.  Table 3.2 also shows some activity towards α-chitinE, which is semi 
crystalline nanofiber α-chitin.  Addition of copper (II) seemed to inhibit the degradation (Table 
3.2) and this effect of Cu2+ was also seen for the positive control
G.2).  β-chitinA and β-chitinE (highlighted in yellow in 
3.6.2 A closer view on the 
A closer view at product profiles obtained 
orCfCBM33B-N revealed similarities and differences. The two enzymes are similar in that their 
product profiles show the same periodicity, with a dominance of even numbered products 
(Figure 3.17). This indicates cleavage 
further comments). Most importantly,  the product profiles obtained with
more peaks than those obtained with CBP21 and the m/z values for these peaks  indicated that 
they represent partially  deacetylated 
atomic mass of 42 from the corresponding 
deacetylated oligosaccharide products seem to be a recurring tendency and were generated from 
the oxidation of β-chitin with varying 
G.11 for zoom-ins of DP4, DP8 and DP10, respectively)
Figure 3.17. MALDI-TOF MS analysis of products detected after treating 2.0 mg/ml 
CfCBM33B-N and 1.0 mM ascorbic acid in Bis
oxidized hexameric products obtained by CfCBM33B
under the same reaction conditions in reactions carried out at the same time and analyzed in
, CBP21 (Appendix 
Table 3.2) were used in further analy
activity of CfCBM33B-N towards β-chitin
with upon incubating β-chitin
at every second glycosidic bond (see 
 CfCBM33B
oligosaccharides of chitin (Figure 3.1), differing with an 
completely acetylated products
crystallinity (see Appendix G and Figure G.
.    
β-chitinA
-Tris buffer pH 6.0.  The upper right corner shows a zoom in of 
-N (red spectrum) and by CBP21 (control; 
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G, Figure 
ses. 
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A
 with CBP21 
Discussion for 
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.  These partly 
9, G.10 and 
 
 with 0.1 µM 
blue spectrum) 
 the same analysis 
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session.  In the overview spectrum peaks are labelled by the degree of polymerization (DP) i.e. the number of sugar 
moieties, including one oxidized sugar. In the zoom in pictures peaks are labelled by the observed atomic mass and 
the predicted compostion of the oligomer. Abbreviations used: GlcNAc; GlcN, deacetylated GlcNAc; GlcNLa, 1-5 d 
lactone of GlcNAc; GlcNAcA, aldonic acid of GlcNAc.  For similar zoom in pictures (showing similar features) for 
DP4, DP8 and DP10 see Appendix G, Figure G.9-11. 
3.6.3 Optimization of β-chitin oxidation by CfCBM33B-N 
Results from MALDI-TOF MS indicated that CfCBM33B-N degrades β-chitin. Therefore, 
synergy assays with chitinases and CBP21 from S. marcescens were performed with β-chitin as 
substrate.  To investigate to what extent substrate crystallinity affects the enzymatic degradation, 
both the highly crystalline β-chitinA and the less crystalline β-chitinE were used in synergy 
assays. 
Prior to synergy experiments, different posisble conditions for degradation of β-chitinA by 
CfCBM33B-N and chitinases were screened in a truly quantitative matter,  using UHPLC for 
quantitative product detection according to section 2.21.1. Several parameters were tested. 
The buffer capacity of BisTris was tested with 2.5 mM ascorbic acid as reducing agent. 
Reactions with 10 mg/ml β-chitinA (pre-washed in Bis-Tris with the appropriate pH), 2.5 mM 
ascorbic acid and 1 µM enzymes (CfCBM33-N, CBP21, ChiA, ChiB or ChiC in separate 
reactions) were set up in 5, 10, 20 and 50 mM Bis-Tris. The pH of the reactions was measured 
before and after 24 hours incubation at 37°C with shaking at 900 rpm.  A reaction concentration 
of 20 mM Bis-Tris was necessary to maintain the pH at 6 for all enzymes tested.  When analyzed 
by HPLC using the Rezex column (described in section 2.21.2) a buffer-concentration of 50 mM 
was used without interfering with the analysis of soluble sugars, as all buffer components eluted 
prior to mono- and oligosaccharide products. 
To determine the optimal pH-conditions for the oxidation of 10 mg/ml β-chitinA by 1 µM 
CfCBM33B-N, an experiment with 20 mM buffers in the pH-range from 2 to 9 was conducted 
with specific quantitative detection of oxidized oligomeric products as previously described by 
Vaaje-Kolstad et al. (2010) and according to section 2.21.1.  In this experiment various 
reductants (ascorbic acid, gallic acid, glucosamine and reduced glutathione) were also tested, all 
at a final concentration of 2.5 mM. The results are shown in Figure 3.18. 
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Figure 3.18.  Oxidation of β-chitin by CfCBM33B-N 
and CBP21 varies with pH and the reducing agent. 
Quantitative analysis of oxidized (GlcNAc)2 products 
detected upon incubation of 10 mg/ml β-chitinA with 1 
µM CfCBM33B-N (A,C) or 1 µM CBP21 (B; positive 
control) in 20 mM buffers with pH ranging from 5 to 
8.  The reaction mixtures contained 2.5 mM ascorbic 
acid (A,B)  or 2.5 mM gallic acid as reducing agents.  
Reactions were incubated for 24 hours at 37°C with 
shaking at 900 rpm.  For each sample, calculated peak 
areas (mAU*min) for the major product peaks are 
shown. Sample sizes were identical.  No oxidized 
products were detected in reactions with pH 2, 3, 4 and 
9.  Reactions containing reduced glutathione and 
glucosamine as reducing agents resulted in less 
oxidized products and higher levels of background 
compared to gallic acid (results not shown). 
 
The data in Figure 3.18 show that CfCBM33B-N has a pH optimum for activity around pH 6.0 
and that this optimum is rather  “sharp”.  No oxidized (GlcNAc)2 products were detected at pH 2, 
3, 4 and 9; affirming the observations from binding assays (Figure 3.15).  The data also show 
differences between the reducing agents.  Use of ascorbic acid as the reducing agent (Figure 3.8, 
A) gave a more even distribution of the oxidized products and less noise in the spectra during 
analysis compared to gallic acid (Figure 3.18 C), reduced glutathione and glucosamine.   
Finally, different concentrations of ascorbic acid were tested.  The degradation of 10 mg/ml  β-
chitinA by 1 µM CfCBM33B-N reactions required a concentration of ascorbic acid between 2.5 
and 10 mM (Figure 3., leftpanel).  The degradation of 10 mg/ml  β-chitinA  by 1 µM CBP21 
showed much higher activity, at lower cocnentration ascrobic acid (1 mM) and in this case, 
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increasing the ascobric acid concentration to 2.5 mM or higher had a clear negative effect on 
activity (Figure 3.19, right panel). At 2.5 mM ascorbic acid, both enzymes showed an 
approximately equal activity. Therefore, ascorbic acid was used for all experiments at a 
concentration of 2.5 mM. 
 
 
Figure 3.19.  Quantitative analysis of oxidized (GlcNAc)2 products detected upon treating 10 mg/ml β-chitin with 1 
µM CfCBM33B-N (left) or CBP21 (right) with various concentrations of ascorbic acid (1, 2.5, 5 and 10 mM) as the 
reducing agent.  Reactions were incubated for 24 hours at 37°C with shaking at 900 rpm and oxidized (GlcNAc)2. 
Products were detected by UHPLC.  For raw data see Appendix H, Figure H.1 and H.2. 
3.6.4 Testing for synergism: Combining CfCBM33B-N and CBP21 with 
chitinases to degrade β-chitin 
To examine whether or not CfCBM33B-N boosts the degradation of β-chitinA and β-chitinE by 
the S. marcescens chitinases ChiA, ChiB or ChiC and to verify whether the CBM33 from S. 
marcescens, CBP21 could work together with CfCBM33B-N synergy experiments were 
conducted according to section 2.21.2.  Reactions (300 µl) set up according to table 2.16 were 
incubated at 37°C with shaking at 900 rpm for 22-30 hours.  Sampling (50 µl) was done at given 
time points (indicated by points in Figure 3.20) and the amount of (GlcNAc)2 in the sample was 
measured by UHPLC.  The results are presented in Figure 3.3 where the percent conversion 
equals the fraction of β-chitin in the sample converted to (GlcNAc)2.  Data are only based on the 
levels of generated (GlcNAc)2. Production of the second major product, GlcNAc, was also 
measured and GlcNAc levels showed the same tendencies.  However, since GlcNAc levels were 
less than 5 % of the (GlcNAc)2, for the sake of simplicity, GlcNAc levels were not taken into 
account.
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Figure 3.3. Synergy effects of CfCBM33B
Degradation of 10 mg/ml β-chitinA at pH 6 by 0.2 µM ChiA (A), ChiB (B) and ChiC (C) in 
of 0.5 µM or 1.0 µM CfCBM33B-N, 0.5 or 1.0 µM CBP21 and equimolar amounts (0.5µM each)
CfCBM33B-N, with 2.5 µM ascorbic acid as external electron donor.  (D) Degradation of 
µM ChiB with the same reaction conditions as in B.  
shaking at 900 rpm.  Degradation is presented as 
UHPLC. The lines are only drawn between points for illustration.  Data 
quantification are shown in Appendix H, Figure H.3.
All Figures indicate an increased degradation rate by addition of 
CBP21 also appears to increase the degradation rate of the three chitinases towards 
does not have any effect on the degradation
added to the reactions with β-chitin
Nevertheless, the turnover rate to (GlcNAc)
data presented above, CfCBM33B
or ChiB, whereas the opposite is the case for ChiC. 
to further be able to test if these al
A 
C 
-N and CBP21 on the degradation of β-chitin by ChiA, ChiB, ChiC. 
the 
2 mg/ml 
Reactions were set up in triplicates and incubated at 37°C with 
the mean conversion of β-chitin to (GlcNAc)
for the standard curve used for 
 
CfCBM33B-N to the reaction.  
 of β-chitinE by ChiB.  Note that the amount of ChiB 
E
 is a fifth the amount added to reactions with 
2 remains high.  Remarkably, partly in contrast to 
-N seems more active than CBP21 when combined with ChiA 
A statistical model was fitted to the raw data 
leged synergies are significant (see section 3.6.5). 
D 
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absence or presence 
 of CBP21 and 
β-chitinE by 0.04 
2, as measured by 
β-chitinA but 
β-chitinA.  
 
108  
 
3.6.5 Estimated regression models for the conversion of β-chitin over time 
and the effect of synergy 
Synergy experiments (section 3.6.2 and Figure 3.20) indicate a boosting activity of CfCBM33B-
N on the degradation of β-chitin by ChiA, ChiB and ChiC.  However, the graphs in Figure 3.10 
is only displaying the experimental results, but is not sufficient for claiming a significant effect 
of these synergisms.  To further analyze the results and test for significance on the observed 
synergies, a second order regression model was fitted to the observed data presented in section 
3.6.4.  The model described below, including interactions of enzyme-mix and time of incubation, 
was adapted to the data using the statistical program R version 2.14.0 
(R_Development_Core_Team 2008) with R-commander (Liland 2012) installed.   
Model: 
Yijk= µ + Ei + (β1 + β1i)Tj + (β2 + β2i)Tj2 + eijk where: 
eijk~N(0,σ), ∑   0, ∑ 	  0, ∑ 	
  0  
Yijk is the per cent conversion of the substrate by enzyme-mix i, at time j and in replicate k.  
i=1,2,3,4, j=1,…,6 and k=1,2,3 
µ is a constant. 
Ei is the effect of enzyme-mix i on the conversion of the substrate. 
β1 and β2 is the general effect of time (hours) on the substrate conversion   
β1i and β2i is the synergistic effect on the conversion of the substrate of time (hours) 
Tj is the time j, measured in hours, for sampling 
eijk represents each sample’s discrepancy from the mean.  All eijk are independent. 
For all models, an analysis of variance (ANOVA) was conducted, and the results showed that all 
interaction terms included in this model are significant for the estimation of β-chitin conversion 
over time. 
Using this model, the time-dependent conversion of the substrates was calculated (estimated) for 
each enzyme-mix and plotted in Figure 3.4.  The output from the estimation of all model 
parameters using R is shown in Appendix J along with the model-diagnostic plots.  All p-values 
(p) lower than 0.05 (p<0.05) are considered significant.  A p-value of 0.05 entails that it is a 5 % 
possibility to observe this high interaction in the data, assuming there is no real interaction.  
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Figure 3.4. Effect plots showing the estimated models of per cent conversion over time for each synergy experiment 
including degradation of β-chitinA by ChiA (A), ChiB (B) and ChiC (C), and degradation of β-chitinE by ChiB (D).  
A second order model was fitted to the data presented in Figure 3.19 for the time period from 1 to 24 hours.  
Detailed results from the statistical analysis of all models and model-diagnostic plots are shown in Appendix I.  
Effect plots were made using the statistical software R. 
To further analyze differences between the different enzyme treatments a post hoc pairwise test, 
the Tukey test, was conducted (results are shown in Appendix I).  From the Tukey test it is clear 
that the degradation rate over time of most synergies differ from each other.  The degradation of 
β-chitinA by ChiA and ChiC is significantly (p<0.01) increased by both CfCBM33B-N and 
CBP21.  Interestingly, while CfCBM33B-N increases the degradation of β-chitinA by ChiA more 
than CBP21, the opposite is observed in the degradation by ChiC, where addition of CBP21 
gains a higher degradation rate compared to addition of CfCBM33B-N.  In both cases, equimolar 
amounts of the two LPMs in combination give a degradation rate that is in between the rates 
obtained with each of the single LPMs.  On the degradation of β-chitinA by ChiB there is a 
significant effect (p<0.01) of addition of CfCBM33B-N and AtCBM33A, but in this case they 
A 
D C 
B 
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increase the degradation rate equally.  Conversely, on the degradation of β-chitinE by ChiB there 
is a major difference.  While CBP21 has no effect on the degradation, CfCBM33B-N most 
significantly (p<0.01) boosts the degradation rate.  In total, CfCBM33B-N and AtCBM33A show 
different effect on the degradation of β-chitin by ChiA, ChiB and ChiC.  This is very interesting 
and will be further discussed in the following section. 
 
4 DISCUSSION 
The objective of this study was to clone, express, purify and characterize CBM33s from two 
different species, C. flavigena and A. terreus, primarily to determine whether or not the enzymes 
possess a lytic polysaccharide monooxygenase activity and secondly to understand C. 
flavigena’s need for as many as four CBM33s. 
Despite the fact that the genome of S. marcescens encodes only one CBM33, the LPM CBP21, 
this bacterium is considered one of the most efficient chitin degraders (Fuchs et al. 1986) 
indicating that CBP21 alone is adequate to complement its chitinases.  Many organisms, 
including C. flavigena, encode multiple CBM33s, all with similar domain architecture.  The 
reasons for having several CBM33s are unknown and remain a matter of speculation.  Do they 
complement each other in the degradation of complex biomasses such as lignocellulosic 
materials comprising both cellulose and hemicellulose?  Do they target different substrates or 
different types of surfaces within the same substrate?  Answers to these questions could 
hopefully give more insight into carbohydrate degradation performed by microorganisms in the 
soil and could possibly be used for optimization of industrial biomass conversion.  
Cloning and expression of all four CBM33s from C. flavigena, both in the full length version and 
in the truncated version lacking the CBM2-domain (Figure 3.1), was attempted.  However, due 
to a desire to at least characterize a few of these enzymes, attempts to clone and express them 
were not exhaustive. Four of the eight cloning steps failed for reasons that were not further 
investigated (cloning was attempted only once).  Two of the four protein variants that were 
successfully cloned were not expressed. As is commonly observed for CBM33 proteins (MSC 
thesis Torfinn Nome; G Vaaje-Kolstad, personal communication) expression is difficult and 
often fails, especially for multi-domain proteins.  
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Two CfCBM33s, CfCBM33A-N and CfCBM33B-N, i.e. both in truncated forms, were 
successfully cloned and expressed.  CfCBM33B-N was produced at high levels; it was 
completely purified and studied in detail further. CfCBM33A-N was produced at lower levels 
and appeared not to be completely purified after size exclusion chromatography (Figure 1.10).  
This impurity was unexpected, since the proteins in the starting material differ highly in 
molecular mass. It is thus plausible that some of the other proteins expressed have an affinity for 
the column material that is not blocked by the salt concentration in the buffer.  A possible 
solution would be to increase the salt concentration, lower the flow and increase the length of the 
column.  Another possible explanation is that the protein has formed dimers after purification, as 
the size of one of the contaminating bands is about 40 kDa.  If this is the case, this might be 
because of intermolecular reformation of cysteine bonds during SDS-PAGE, resulting in 
dimerization (CfCBM33A-N contains four cysteins).  A possible solution would then be to use 
reducing agents also in the running buffer. 
C. flavigena is known to be a cellulose and xylan degrading bacterium (Abt et al. 2010).  The 
presence of a CBM2a-domain at the C-terminus of all CfCBM33s indicates binding affinity 
towards cellulose (Simpson et al. 2000) but binding to chitin is also possible, as seen for the 
CBM2 domain of chitinase C from Streptomyces lividans (Fujii & Miyashita 1993).  From both 
binding experiments and activity assays, CfCBM33B-N shows no specificity towards xylan or 
cellulose, only for chitin.  Obviously, since these domains lack their CBM2s it cannot be 
excluded that the complete proteins bind to and cleave e.g. cellulose.  The genome of C. 
flavigena DSM 20109 contains no identified chitinases (GH18 or GH19) or known chitosanases 
but it encodes four proteins belonging to family four of the carbohydrate esterases (CE4).  The 
family of CE4 includes acetyl xylan esterases, chitooligosaccharide deacetylases and 
peptidoglycan GlcNAc deacetylases, all with a deacetylase activity.  While three of the four 
CE4s are linked to CBM- and GH-domains, indicating xylan-specific activity, the fourth CE4 
found in C. flavigena (Uniprot ID: D5UC80) has no auxiliary domains.  A search through the 
databases using the basic local alignment search tool (BLAST) revealed sequence similarities 
with polysaccharide deacetylases, among them chitin deacetylases.   
Although speculative, it is possible that one role of the CfCBM33s is to make chitin more 
accessible to deacetylation.  Such an effect, which could be part of an otherwise not yet known 
alternative chitin degradation route, has indeed been observed for CBP21 (Z. Liu et al., 
manuscript in preparation). Moreover, intriguingly, in addition to generating oxidized acetylated 
chitin oligosaccharides as observed in the degradation of β-chitinA by CBP21 (Vaaje-Kolstad et 
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al. 2010), CfCBM33B-N also generates partly deacetylated products from the oxidation of the 
same substrate.  These partly deacetylated products are also observed from the degradation of 
other, less crystalline, β-chitin substrates by CfCBM33B-N (Appendix H), displaying a recurring 
tendency, and possibly a new function or binding specificity compared to CBP21.  Nevertheless, 
both CBP21 and CfCBM33B-N tend to cleave every second glycosidic bond in the chitin chain, 
thereby generating even-numbered oligosaccharides reflecting the periodicity seen in the 
structure (Figure 1.6).    
A possible difference in function between CBP21 and CfCBM33B-N was also observed in the 
synergy experiments (Figure 3.3).  Previous studies have demonstrated that CBP21 from S. 
marcescens promotes hydrolysis of crystalline β-chitinA by ChiA and ChiC, and is essential for 
full chitin degradation by ChiB (Vaaje-Kolstad et al. 2010).  This is consistent with the 
observations found in this study and presented in Figure 3.3 and Figure 3.21.  Interestingly, on 
the less crystalline nanofiber chitin (β-chitinE) CBP21 did not affect the degradation by ChiB.  
CfCBM33B-N, on the other hand, demonstrates the same increase of ChiB’s degradation of all 
β-chitin substrates.  This further indicates a difference in substrate binding between CBP21 and 
CfCBM33B-N. 
The production of partially deacetylated products suggests that CfCBM33B-N has a preference 
for deacetylated regions of the substrate. Combined to the opposing activities observed in the 
synergy experiments, this leads to the hypothesis that  CfCBM33B-N has a new type of 
specificity or a possible loss of specificity; i. e. CfCBM33B and CBP21 may target different 
substrates or have activity on different surfaces or regions on the same substrate.  
The activity of CfCBM33B compared to that of CBP21 is clearly different as shown by the 
difference in synergy obtained when combined with ChiA and ChiC.  This difference may result 
from inequalities in the surface targeting.  Such dissimilarities in surface targeting have 
previously been described for cellulose binding proteins (Carrard et al. 2000; Lehtiö et al. 2003).  
Furthermore, as elaborated on in section 1.3.3, the three chitinases from S. marcescens show 
different, but complementary activities.  ChiB and ChiC show little synergy in degradation of 
chitin, while ChiA shows strong synergy with both ChiB and ChiC on the same substrate 
(Suzuki et al. 2002; Vaaje-Kolstad et al. 2005a).  Taken into consideration that these three 
chitinases have different auxiliary domains (ChiA contains a fibronectinIII–like domain, ChiB 
contains a CBM5 and ChiC contains a CBM12 and an fibronectin III-like domain), Horn et al. 
(2006b) postulated that auxiliary carbohydrate binding domains potentiate the catalytic activity 
113 
 
or directs it to different parts of the substrate.  One possible explanation is the competitiveness 
regarding substrate binding as CBM5 and CBM12 are classified in the same family in the protein 
family database, Pfam (http://pfam.sanger.ac.uk/) (Finn et al. 2008), as “distantly related”.  All in 
all, it might seem that both chitinases and CBM33s vary in their affinity for specific types of 
chitinous substrates.  Notably, considering the lack of chitinases in the genome of C. flavigena, it 
remains to be seen what the natural substrate of CfCBM33B actually is. 
Considering the possibility of LPMs to be surface specific, it is likely that while CBP21 only acts 
on surfaces with protruding N-acetyl groups, CfCBM33B-N can oxidize chitin chains on 
multiple surfaces (illustrated in Figure 4.1).  If also the chitinases display differences in surface 
targeting and the target surface of CBP21 is the same as the target surface of ChiB, it does not 
matter whether LPM is added to the reaction; they both make the substrate available for ChiB.  
This is consistent with the observations presented in Figure 3.3 (B) and the tukey tests 
(Appendix J) showing that CBP21 and CfCBM33B-N increase the β-chitin degradation by ChiB 
equally.  If ChiA then targets another surface than ChiB and CBP21, its β-chitin degradation will 
be greatly affected by which LPM is added to the reaction.  Addition of CfCBM33B-N would 
increase the substrate degradation rate by ChiA, while addition of CBP21 would have a lower 
impact, as observed in the presented data (Figure 3.4(A)) and proven significant by tukey testing 
(Appendix I).   
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Kolstad et al., 2010; Westereng et al., 2011; Forsberg et al., 2011; Quinlan et al. 2011). For some 
fungal LPMs it has been shown that they oxidize C4 (Phillips et al., 2011; Beeson et al. 2012), 
and perhaps even C6 in what may be a side reaction (Horn et al. 2012; Quinlan et al. 2011).  
Although alternative oxidations could take place, this has not been emphasized in our study.  The 
MS data presented do not permit easy discrimination between the various types of oxidation.  
Since  C4- or even C6-oxidation seems much less common than C1 oxidation, and since only C1 
oxidation has been found for by LPMs working on chitin, through the rest of the discussion we 
suppose that all chain breaks are made by C1-oxidation.   
It would be of great interest to further study the differences in surface targeting and substrate 
oxidation among the different CBM33s and LPMs.  Additionally, as CBM33s previously have 
been shown to degrade crystalline substrates like chitin (Vaaje-Kolstad et al. 2010) and cellulose 
(Forsberg et al. 2011) it would also be interesting to explore to which extent CBMs are active on 
other crystalline substrates, like starch.  Finding an enzyme streamlining the starch degradation 
would target a whole new area in the use of LPMs, namely the food-industry, as well as, 
possibly, production of first generation bio-ethanol from corn starch.  Therefore, the CBM33 of 
the starch degrading yeast A. terreus, anticipated to have starch binding properties as it is linked 
to a CBM20, was included in the present study.  AtCBM33A was expressed in P. pastoris (work 
performed at the group for enzyme and protein chemistry lead by Birte Svensson at the 
Department of systems biology, Technical university of Denmark) with the intention to express 
the protein with all its natural features, foremost glycosylations.  
AtCBM33A has two possible sites for N-glycosylations (Appendix C, Figure C.1.).  Whether 
such glycosylations are essential for functionality is not easy to predict. It is interesting to note 
that in a recent study, Taylor et al (2012) claim that N-glycosylations improve the binding of 
CBM1 towards cellulose.  The study implies that glycosylations function to lead the substrate 
into the binding site.  This may also be the case for other CBMs and as the glycosylation site in 
the homology model of the CBM20 domain (Figure 3.5.) is near binding site 2 it is likely to have 
an impact on the substrate binding of AtCBM33A. In addition to N-glycosylations of the amide 
nitrogen of asparagine residues in the Asn-Xaa-Thr/Ser consensus sequence, P. pastoris also 
adds O-linked oligosaccharides made up of mannose residues (Daly & Hearn 2005).  P. pastoris 
does not seem to have a preferred amino acid for O-glycosylation, in other words, no consensus 
glycosilation sequence is known (Cregg et al. 2000).  From studies on other fungal carbohydrate 
degrading enzymes, it is well known that Serine/Threonine rich interdomain linkers tend to be O-
glycosylated (Letourneur et al. 2001),  and this could also be the case for the CBM20 domain of 
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AtCBM33A. In a review on glycosylation of P. pastoris-derived proteins, Bretthauer and 
Castellino (Bretthauer & Castellino 1999)point out that N-glycosilation may be demonstrated by 
shong that treatment with enzymes such as EndoH leads to clear band shifts in SDS-PAGE gels. 
EndoH treatment removed some of the glycosylations on AtCBM33A (Figure 3.1).  
Nevertheless, if these simply were N-glycosylations, treatment with EndoH would have resulted 
in a clearer and sharper band.  This might indicate that the protein is also O-glycosylated.    
In comparison to CBM20 from glucoamylase 1 from A. niger, the predicted model of the 
AtCBM33A CBM20 shows only small differences in conserved residues at binding site 2, while 
binding site 1 is completely conserved (Figure 3.5).   As the CBM20 of glucoamylase 1 has two 
substrate-binding sites (Figure 3.5) and the similarities with the predicted binding sites of 
AtCBM33A are high, AtCBM33A was expected to have a binding stoichiometry of 2 (i.e. 
binding two β-.cyclodextrins per enzyme).  Contradictory, results from the ITC experiments 
showed a binding stoichiometry of 0.5 for β-cyclodextrin (Figure 3.).  As discussed previously, it 
is possible, however doubtful, that the glycosylation near the second binding site could be of 
steric hindrance for substrate binding.  Also unlikely is the possibility that the CBM33-domain 
conflicts with the binding as the domains are separated by a long linker.  Nonetheless, it is a 
possibility.  It is also possible that the histidine-tag at the C-terminus interferes with the binding. 
Importantly, the ITC experiments did yield a binding constant lower than expected, but still large 
enough to confirm the functionality of the CBM20 domain.   
Time-limitations prohibited further functional analysis of AtCBM33AHis, such as analyses of the 
proteins possible contribution to starch degradation by amylases. Obviously, such experiments 
need to be done and will be of great interest. 
4.1.1 Concluding remarks and Future work 
The present study has revealed functional differences between CfCBM33B-N and CBP21.  
However, this study does not explain why C. flavigena encodes four CBM33s, neither deos it 
explain the structural basis and the in vivo functional implications of the differences between 
CfCBM33B-N and CBP21. To better understand C. flavigena’s substrate specificities and 
substrate degrading properties, cloning, expression and characterization of the remaining 
CfCBM33s, both in the truncated variant (lacking the C-terminal CBM2-domain) and in full-
length would be of considerable interest.  This was attempted; however, due to time-limitations, 
no further efforts were made to clone and express the remaining CfCBM33s. A deeper 
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understanding of these proteins will also require deeper functional and structural analysis of each 
individual protein. Studies like this could be complemented by transcriptional data showing 
which CBM33s are expressed when C. flavigena is cultivated with different carbon sources.  
This was attempted during this study, but with no success. 
The generation of partly deacetylated products from the oxidation of β-chitin by CfCBM33B-N 
was not further investigated.  Future work should endeavour to characterize these products in 
detail and further understand the function of CfCBM33B. This may reveal a new function in the 
group of LPMs.  The most likely explanation for the present observation is that CfCBM33B 
oxidizes the substrate in deacetylated areas and would then increase the degradation rate in 
synergy with deacetylases. 
An interesting approach would also be to investigate the difference in degradation rates observed 
when adding CBP21 and CfCBM33B-N, alone or in synergy, to reactions with various 
chitinases.  As the crystalline β-chitin displays different surfaces available for the enzymes, the 
possibility of chitinases and or various CBM33s to target these different surfaces for optimal 
degradation should be considered in future studies.   
Making the statistical model (section 3.6.5), one assumption was that the variance was constant.  
From the residual plots in Appendix J it is clear that this assumption was wrong.  The variance is 
increasing by the time of incubation and a model with weighted regression, weighting the 
variances differently according to the time of the reaction.  However, this would not affect the 
results remarkably, as all interactions are highly significant. 
Regarding AtCBM33A, the present work was only the start of a big study on CBM33s with 
putative starch affinity.  ITC experiments were only conducted on glycosylated proteins and to 
exclude the possibility of interference by N-glycosylations, it would be preferable to also 
perform the analysis on deglycosylated proteins.  Although glycosylations have proven to be of 
great importance of the binding affinity of other CBMs, a glycosylation near the starch binding 
domain could possibly be of steric hindrance for substrate binding.  Also unknown is the effect 
of the extended C-terminal His-Tag on the binding affinity. Native AtCBM33A, lacking this His-
tag, was also expressed and further work should be conducted on this variant of the protein.  
Clearly, functional studies, with the aim of detecting possible oxidative cleavage in starch need 
to be conducted. 
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While much further work needs to be done, the present work on AtCBM33A does lead to two 
important conclusions.  Firstly, the protein does indeed show affinity for starch that is lower than 
expected but still in the same range as e.g. the affinity of CBP21 for chitin (Vaaje_Kolstad et al, 
første 2005 paper i JBC).  Secondly, the data show that it is in fact possible to produce a 
complete recombinant version of this potentially complicated multi-domain protein. 
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Appendix A 
 
Codon optimized Atcbm33A.  Atcbm33A was codon optimized according to the codon usage bias in Pichia pastoris and synthesized by GenScript’s 
OptimumGene™ Gene Design software (http://www.genscript.com/codon_opt.html). Following is the codon optimized sequence. 
 
ATGTTGCTGACTGTATTGGCGGTCGTCGGTTGTTTCACGGCTGTAAATGGTCACGGCTACTTGACTATTCCTGCGTCCAGAACTCGCCTGGGTTTTGAAACCGGCATTGACACTTGTCCGGAATGC
AGCATCCTGGAACCTGTTACCGCTTGGCCAGATCTGGAAGCTGCACAAGTGGGCCGCTCAGGTCCTTGTGGCTATAATGCACGTGTTTCCGTGGATTATAACCAGCCGTCGGAATACTGGGGTAA
TGAACCTGTTGTGACATACACGTCTGGCGAAGTCGTAGAAGTTCAATGGTGTGTGGATGCCAACGGTGACCATGGTGGCATGTTTACCTATGGCATTTGCCAAAACCAGACTTTAGTGGATAAGT
TCTTGACACCAGGTTACCTGCCGACGAACGAAGAAAAGCAAGCCGCGGAAGATTGCTTCTTGGACGGCGAACTGAAGTGTAAGGATGTCTCTGGTCAGACATGTGGCTATAACCCAGACTGCAC
GGAAGGTGCTGCATGTTGGAGAAATGATTGGTTTACTTGCAATGCTTTCCAAGCAAACACAGCACGTGCATGTCAGGGTGTCGATGGTGCTAGTTTAAACTCCTGCAAAACCACTATCGCAGGTG
GCTATACCGTAACTAAACGTATTAAGATCCCGGATTACTCTTCAGACCATACCCTGTTACGTTTTAGATGGAATAGTTTCCAAACTGCCCAGGTTTACCTGCACTGTGCGGATATTGCTATCGCAG
GTTCCGGTGGCGGTACAACGTCCAAATCGACCACTTCGACAACGTCTACCACTTCTACCTCAAGAAGCACAAGTACGTCCGCCCCTACAACGACCAGCAGTGCCTCAACCGCGACTCCTATTTGC
ACTACACAAGCGAGCCTGATCCCAGTCACTTTTCAGGAATTCGTAACGACCATGTGGGGTGAAAACGTCTTTGTAACAGGTTCGATTTCTCAGTTGGGCTCATGGAGCACTGACAAAGCCGTGGC
GCTGTCCGCTACAGGTTATACGGCATCTAATCCATTATGGACTACAACGATTGATTTGCCGGCTGGTACCACTTTCGAATACAAGTTCATCAAAAAGGAAACCGATGGCTCAATTATCTGGGAAA
GCGACCCGAATCGCAGTTACACCGTCCCGACTGGTTGTTCTGGCACTACCGCTACCGCAGCCGCTTCTTGGCGTTGA 
  
Appendix B 
 
Name:  cfcbm33A  Length:  400 
MLLTVLAVVGCFTAVNGHGYLTIPASRTRLGFETGIDTCPECSILEPVTAWPDLEAA
QVGRSGPCGYNARVSVDYNQPSE      80  
YWGNEPVVTYTSGEVVEVQWCVDANGDHGGMFTYGICQNQTLVDKFLTPGYLPTN
EEKQAAEDCFLDGELKCKDVSGQTC     160  
GYNPDCTEGAACWRNDWFTCNAFQANTARACQGVDGASLNSCKTTIAGGYTVTKR
IKIPDYSSDHTLLRFRWNSFQTAQV     240  
YLHCADIAIAGSGGGTTSKSTTSTTSTTSTSRSTSTSAPTTTSSASTATPICTTQASLIPV
TFQEFVTTMWGENVFVTGS     320  
ISQLGSWSTDKAVALSATGYTASNPLWTTTIDLPAGTTFEYKFIKKETDGSIIWESDP
NRSYTVPTGCSGTTATAAASWR     400  
................................................................................      80 
......................................N.........................................     160 
................................................................................     240 
................................................................................     320 
..........................................................N.....................     400 
 
(Threshold=0.5) 
---------------------------------------------------------------------- 
SeqName      Position  Potential   Jury    N-Glyc 
     agreement result 
---------------------------------------------------------------------- 
cfcbm33A     119 NQTL   0.6798     (9/9)   ++     
cfcbm33A     379 NRSY   0.5152     (5/9)   +      
 
 
 
 
Figure B.1. Output from prediction of N-glycosylations in AtCBM33A from NetNGlyc (http://www.cbs.dtu.dk/services/NetNGlyc/; left) and the selections made when using GlyProt 
(www.glycoscience.de/modeling/glyprot/php/main.php) to predict the connection of an oligomannose to Asn379 in the homologymodel of the CBM20 domain in AtCBM33A 
(right). 
Appendix C 
 
Figure C.1. Summary of the pPICZα-A, B and C vectors (left) and the specific sequence of the multiple cloning site in pPICZα-A with labeled restriction sites and functions in or near the 
cloning site (right).  Both figures are retrieved from Invitrogen (www.invitrogen.com).  
 Figure C.2. Summary of the pRSET A, B and C vectors (left) and the specific sequence of the multiple cloning site in pPICZα-A with labeled restriction sites and functions in or near the 
cloning site (right).  Both figures are retrieved from Invitrogen (www.invitrogen.com).  
 
 
 
 
Appendix D  
Chromatograms from protein purification using ion exchange chromatography, size exclusion chromatography, 
immobilized metal affinity chromatography or affinity chromatography with chitin beads. 
E  
Figure D.1. Ion exchange chromatography used for purification of CfCBM33B-N.  Fraction numbers are 
shown in red. The chromatogram for the purification of CfCBM33A-N by ion exchange chromatography 
showed a similar elution pattern.  Both CfCBM33s were purified using a HiTrap™ 5 ml column.  Sterile-
filtered periplasmic extract CfCBM33s (50 sample volume) was applied to the column at pH 7.5 with a flow of 
1 ml/min, followed by 2 column volumes of 50 mM Tris-HCl pH 7.5 and the protein was eluted during a 
gradient from 0 % to 50 % elution buffer during 200 minutes at 0.4 ml/min flow rate.  Eluted proteins were 
detected by online monitoring  of the absorption at 280 nm and collected in 1 ml fractions. 
 
 
Figure D.2. Size exclusion chromatography used for further purification of CfCBM33B-N, after ion exchange 
chromatography.  Fraction numbers are shown in red.  Fractions containing the protein of interest from ion 
exchange chromatography was pooled and concentrated 7 times.  The sample (1 ml) was applied through a 2 ml 
loading loop to a HiLoad 16/60 Superdex G-75 column at a 0.3 ml/min flow rate, followed by application of 3 
column volumes of running buffer to elute the protein (collected in fractions of 5 ml). 
 
 
CfCBM33B-N 
CfCBM33B-N 
 Figure D.3. Size exclusion chromatography used for purification of CfCBM33A-N, semi-purified by ion 
exchange.  Fraction numbers are shown in red.  Fractions containing the protein of interest from ion exchange 
chromatography was pooled and concentrated 7 times.  The sample (1 ml) was applied through a 2 ml loading 
loop to a HiLoad 16/60 Superdex G-75 column at a 0.3 ml/min flow rate, followed by application of 3 column 
volumes of running buffer to elute the protein (collected in fractions of 5 ml). 
 
  
Figure D.4. Chromatogram from the purification of AtCBM33AHis using a His-Trap™ HP column.  
AtCBM33AHis was purified from 30 ml of the secreted proteins, concentrated 10 times using a HisTrap™ HP (1 
ml) column.  The sample was loaded onto the column and binding buffer was run until the baseline was stable 
at a low UV signal.  The protein was eluted through a linear gradient from 0 % to 100 % by 20 column volumes 
elution buffer.  The His-tagged protein was eluted at approximately 10% elution buffer and was collected in 
fractions of 1 ml. 
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 Figure D.5. Chromatogram from the purification of CBP21 by affinity chromatography using chitin beads. 
CBP21 was purified from periplasmic extract adjusted to 1 M ammonium sulphate and 50 mM Tris-HCl (both 
final concentration) at pH 8.0 (according to section 2.15.4).  The sample was loaded onto the column at a flow 
rate of 1 ml/min, followed by 3 column volumes of binding buffer (50 mM Tris-HCl and 1 M ammonium 
sulphate pH 8.0).  CBP21 was then eluted (and collected) by during application of one column volume of 20 
mM acetic acid. 
 
Figure D.6. Chromatogram from the purification of ChiAby affinity chromatography using chitin beads. ChiA 
was purified from periplasmic extract adjusted to 20 mM Tris-HCl (both final concentration) at pH 8.0 
(according to section 2.15.4).  The sample was loaded onto the column at a flow rate of 1 ml/min, followed by 3 
column volumes of 50 mM Tris-HCl pH 8.0.  CBP21 was then eluted (and collected) by during application of 
one column volume of 20 mM acetic acid. 
CBP21 
ChiA 
  
Figure D.7. Chromatogram from the purification of ChiB by affinity chromatography using chitin beads. ChiB 
was purified from periplasmic extract adjusted to 20 mM Tris-HCl (both final concentration) at pH 8.0 
(according to section 2.15.4).  The sample was loaded onto the column at a flow rate of 1 ml/min, followed by 3 
column volumes of 50 mM Tris-HCl pH 8.0.  CBP21 was then eluted (and collected) by during application of 
one column volume of 20 mM acetic acid. 
 
Figure D.8. Chromatogram from the purification of ChiC by affinity chromatography using chitin beads.  ChiC 
was purified from periplasmic extract adjusted to 20 mM Tris-HCl (both final concentration) at pH 8.0 
(according to section 2.15.4).  The sample was loaded onto the column at a flow rate of 1 ml/min, followed by 3 
column volumes of 50 mM Tris-HCl pH 8.0.  CBP21 was then eluted (and collected) by during application of 
one column volume of 20 mM acetic acid. 
ChiB
 
ChiC
 
Appendix E: Protein identification by fragment analysis 
 
 
 
 
 
Figure E.1.  Output from the Mascot-search towards the NCBI database after MALDI-.TOF MS analysis 
of trypsinated  AtCBM33A.  The results show a positively match against AtCBM33A (ATEG_07286) 
 
Appendix F: Results from ITC. 
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Figure F.1.  Raw data from ITC experiment showing the released heat upon binding of AtCBM33AHis to β-cyclodextrin.  This work 
was performed by M. Abou Hachem, Technical University of Denmark.
Appendix G: Results from MALDI
Figure G.1. MALDI-TOF analysis of oligomeric products rele
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 Figure G.3.  The degradation of β-chitinA by 1 µM CfCBM33B-N varies with pH and is affected by the presence of Cu2+.  MALDI-TOF analysis of 
oligomeric products released upon incubation of 2 mg/ml  β-chitinA with 1 µM CfCBM33B-N in 20 mM Na-acetate pH 5 ( middle panel) and Bis-
Tris  pH 7.0 (to upper panels) pH 6 (second lowest panel) and pH 8 (lower panel) with 1 mM ascorbic acid as reducing agent.  The upper panel show 
a reaction incubated in the presence of 1 µM Cu2+. The peaks are labeled by the degree of polymerization (DP, shown in upper panel), and for 
corresponding m/z-values, see Figure G.1. 
 
Figure G.4.  The degradation of β-chitinB by 1 µM CfCBM33B-N varies with pH, and is affected by the presence of Cu2+.  MALDI-TOF analysis of 
oligomeric products released upon incubation of 2 mg/ml  β-chitinB with 1 µM CfCBM33B-N in 20 mM Na-acetate pH 5 ( middle panel) and Bis-
Tris  pH 6.0 (second lowest panel) pH 7.0 (second upper and lower panels) and pH 8 (upper panel) with 1 mM ascorbic acid as reducing agent.  The 
second upper panel show a reaction incubated in the presence of 1 µM Cu2+. The peaks are labeled by the degree of polymerization (DP, shown in 
upper panel), and for corresponding m/z-values, see Figure G.1. 
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 Figure G. 5.  The degradation of β-chitinC by 1 µM CfCBM33B-N varies with pH, and is affected by the presence of Cu2+.  MALDI-TOF analysis of 
oligomeric products released upon incubation of 2 mg/ml  β-chitinC with 1 µM CfCBM33B-N in 20 mM Na-acetate pH 5 ( middle panel) and Bis-
Tris  pH 6.0 (second lower panel) pH 7 (upper and lower panels) and pH 8 (second upper panel) with 1 mM ascorbic acid as reducing agent.  The 
upper panel show a reaction incubated in the presence of 1 µM Cu2+. The peaks are labeled by the degree of polymerization (DP, shown in upper 
panel), and for corresponding m/z-values, see Figure G.1. 
 
Figure G.6. The degradation of β-chitinD by 1 µM CfCBM33B-N varies with pH, and affected by the presence of Cu2+ .  MALDI-TOF analysis of 
oligomeric products released upon incubation of 2 mg/ml  β-chitinD with 1 µM CfCBM33B-N in 20 mM Na-acetate pH 5 ( middle panel) and Bis-
Tris  pH 6.0 (second lower panel) pH 7 (upper and lower panels) and pH 8 (second upper panel) with 1 mM ascorbic acid as reducing agent.  The 
upper panel show a reaction incubated in the presence of 1 µM Cu2+. The peaks are labeled by the degree of polymerization (DP, shown in upper 
panel), and for corresponding m/z-values, see Figure G.1. 
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 Figure G.7.  The degradation of β-chitinE by 1 µM CfCBM33B-N varies with pH, and is affected by the presence of Cu2+.  MALDI-TOF analysis of 
oligomeric products released upon incubation of 2 mg/ml  β-chitinE with 1 µM CfCBM33B-N in 20 mM Na-acetate pH 5 ( middle panel) and Bis-
Tris  pH 6.0 (second lower panel) pH 7 (upper and lower panels) and pH 8 (second upper panel) with 1 mM ascorbic acid as reducing agent.  The 
upper panel show a reaction incubated in the presence of 1 µM Cu2+. The peaks are labeled by the degree of polymerization (DP, shown in upper 
panel), and for corresponding m/z-values, see Figure G.1. 
 
 
Figure G.8. The degradation of α-chitinE by 1 µM CfCBM33B-N varies with pH, and is affected by the presence of Cu2+.  MALDI-TOF analysis of 
oligomeric products released upon incubation of 2 mg/ml  α-chitinE with 1 µM CfCBM33B-N in 20 mM Na-acetate pH 5 ( middle panel) and Bis-
Tris  pH 6.0 (second lower panel) pH 7 (upper and lower panels) and pH 8 (second upper panel) with 1 mM ascorbic acid as reducing agent.  The 
upper panel show a reaction incubated in the presence of 1 µM Cu2+.  For labeleling corresponding m/z-values, see Figure G.1. 
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Figure G.9. Zoom in of DP4.  MALDI-TOF MS analysis of products detected after treating 2.0 mg/ml 
CfCBM33B-N and 1.0 mM ascorbic acid in Bis-Tris buffer pH 6.0.  The 
obtained by CfCBM33B-N (red spectrum) and by CBP21 (control; 
carried out at the same time and analyzed in the same analysis session.
of polymerization (DP) i.e. the number of sugar moieties, 
the observed atomic mass and the predicted composition
GlcNLa, 1-5 d lactone of GlcNAc; GlcNAcA, aldonic acid o
Figure G.10. Zoom in of DP8.  MALDI-TOF MS analysis of products detected after treating 2.0 mg/ml 
CfCBM33B-N and 1.0 mM ascorbic acid in Bis-Tris buffer pH 6.0.  The 
obtained by CfCBM33B-N (red spectrum) and by CBP21 (control; 
carried out at the same time and analyzed in the same analysis session.
of polymerization (DP) i.e. the number of sugar moieties, 
the observed atomic mass and the predicted composition
GlcNLa, 1-5 d lactone of GlcNAc; GlcNAcA, aldonic acid o
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f GlcNAc.   
 
β-chitinA
figure shows a zoom in of oxidized hexameric products 
blue spectrum) under the same reaction conditions
  In the overview spectrum peaks are 
including one oxidized sugar. In the zoom in pictures
 of the oligomer. Abbreviations used: GlcNAc; GlcN,
f GlcNAc.   
 
 with 0.1 µM 
 in reactions 
labeled by the degree 
 peaks are labeled by 
 deacetylated GlcNAc; 
 with 0.1 µM 
 in reactions 
labeled by the degree 
 peaks are labeled by 
 deacetylated GlcNAc; 
  
Figure G.11. Zoom in of DP10. MALDI-TOF MS analysis of products detected after treating 2.0 mg/ml 
CfCBM33B-N and 1.0 mM ascorbic acid in Bis-Tris buffer pH 6.0.  The 
obtained by CfCBM33B-N (red spectrum) and by CBP21 (control; 
carried out at the same time and analyzed in the same analysis session.
of polymerization (DP) i.e. the number of sugar moieties, 
the observed atomic mass and the predicted composition
GlcNLa, 1-5 d lactone of GlcNAc; GlcNAcA, aldonic acid o
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Appendix H: Results from HPLC
Figure H.2.  HPLC- analysis of oxidized products from degradation of 10 mg/ml 
acetate pH 5.  Reactions were set up with varying concentration
line), 5 mM (pink line), 10 mM (brown line).  An 
polymerization between 3 and 8 was used for comparison
Figure H.3.  HPLC- measurements of the oxidized products from the degradation of 10 mg/ml 
acetate pH 5 as buffer.  The reactions were set up with varying concentration of ascorbic acid as reducing agent; 
2.5 mM (blue line), 5 mM (pink line), 10 mM (brown line)
polymerization between 3 and 8 was used for comparison
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 Figure H.4.  Overlay of the chromatograms of the standard curve used for determination of the concentration of GlcNAc and (GlcNAc)
(black), 62.5 (blue), 125 (pink), 250 (brown), 500 (green), 1000 (cyan) and 2000 (grey) µM of each GlcNAc and (GlcNAc)
sample-run.   
  
2 
2. All standards were run in triplicates evenly distributed through the 
 
.  All standards were set up with concentrations of  
Appendix I: 
 Statistical analysis on the synergy effect of CfCBM33B-N and CBP21 on the degradation 
of β-chitin by chitinases from S. marcescens.  
A=ChiA, B=ChiA+CfCBM33B-N 1µM, C=ChiA+CfCBM33B-N 0.5µM+CBP21 0.5µM, D=ChiA+CBP21 
0.5µM 
ChiA, β-chitinA 
Estimation of the coefficients and anova-analysis of the effect of degradation over time 
Call: lm(formula = Conversion ~ Enzyme + Time + Time2 + Enzyme * Time +     Enzyme * Time2, 
data = Dataset) 
Estimate Std. Error t value Pr(>|t|) 
(Intercept) 1.725883 1.729299 0.998 0.32228 
Enzyme[T.B] 4.705500 2.445598 1.924 0.05909 . 
Enzyme[T.C] 4.550369 2.445598 1.861 0.06770 . 
Enzyme[T.D] 0.967406 2.445598 0.396 0.69383 
Time 0.170357 0.503496 0.338 0.73628 
Time2 -0.005021 0.019024 -0.264 0.79273 
Enzyme[T.B]:Time 3.056005 0.712050 4.292 6.56e-05 *** 
Enzyme[T.C]:Time 1.228733 0.712050 1.726 0.08956 . 
Enzyme[T.D]:Time 0.548036 0.712050 0.770 0.44452 
Enzyme[T.B]:Time2 -0.076346 0.026904 -2.838 0.00619 ** 
Enzyme[T.C]:Time2 -0.030396 0.026904 -1.130 0.26306 
Enzyme[T.D]:Time2 -0.009246 0.026904 -0.344 0.73230 
--- 
Signif. codes:   0 '***'  0.001 '**'  0.01 '*'  0.05 '.'  0.1 ' ' 
Anova Table (Type II tests) 
Response: Conversion 
Sum Sq Df F value Pr(>F) 
Enzyme 3316.2 3 105.6711 < 2.2e-16 *** 
Time 313.7 1 29.9857 9.036e-07 *** 
Time2 133.8 1 12.79 0.0006961 *** 
Enzyme:Time 219.1 3 6.98 0.0004170 *** 
Enzyme:Time2 100.4 3 3.2 0.0295718 * 
Residuals 627.6 60   
> options(contrasts=c('contr.Treatment', 
'contr.poly')) 
 Tukey; multiple comparisons of the means  
    95% family-wise confidence level 
$Enzyme 
diff lwr upr p adj 
B-A 17.967072 15.1181789 20.815964 0.0000000 
C-A 9.916474 7.0675809 12.765366 0.0000000 
D-A 3.848663 0.9997699 6.697555 0.0038648 
C-B -8.050598 -10.8994907 -5.201705 0.0000000 
D-B -14.118409 -16.9673017 -11.269516 0.0000000 
D-C -6.067811 -8.9167037 -3.218918 0.0000030 
ChiB, β-chitinA 
A=ChiB, B=ChiB+CfCBM33B-N 1 µM, C= ChiB+CfCBM33B-N 0.5µM, D=ChiB+CfCBM33B-N 
0.5µM+CBP21 0.5µM, E=ChiB+CBP21 0.5µM, F=ChiB+CBP21 1µM 
Estimation of the coefficients and anova-analysis of the effect of degradation over time 
 
Call:lm(formula = conversion ~ Enzyme * Time + Enzyme * Time2, data = Dataset) 
Coefficients: 
Estimate Std, Error t value Pr(>|t|) 
(Intercept) 1,2533 1,0785 1,162 0,24737 
Enzyme[T,B] 0,4493 1,5252 0,295 0,76878 
Enzyme[T,C] 0,3713 1,5252 0,243 0,80808 
Enzyme[T,D] 1,1941 1,5252 0,783 0,43514 
Enzyme[T,E] 0,4152 1,5252 0,272 0,78591 
Enzyme[T,F] 1,9622 1,5252 1,287 0,20062 
Time 0,8387 0,3389 2,475 0,01467 
Time2 -0,0195 0,0139 -1,409 0,16123 
Enzyme[T,B]:Time 2,0466 0,4793 4,270 3,81E-05 
Enzyme[T,C]:Time 0,7215 0,4793 1,505 0,13473 
Enzyme[T,D]:Time 2,3055 0,4793 4,810 4,22E-06 * 
Enzyme[T,E]:Time 0,3160 0,4793 0,659 5,11E-01 
Enzyme[T,F]:Time 1,622315 0,479281 3,385 9,50E-04 *** 
Enzyme[T,B]:Time2 -0,044391 0,019606 -2,264 0,02527 
Enzyme[T,C]:Time2 -0,018448 0,019606 -0,941 0,34854 *** 
Enzyme[T,D]:Time2 -0,062842 0,019606 -3,205 0,00171 
Enzyme[T,E]:Time2 -0,009108 0,019606 -0,465 0,64306 *** 
Enzyme[T,F]:Time2 -0,044127 0,019606 -2,251 0,02614 * 
--- 
      Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1  
Anova Table (Type II tests) 
Response: conversion 
Sum Sq Df F value Pr(>F) 
Enzyme 1824,55 5,00 32,75 < 2,2e-16 
Time 2345,01 1,00 210,49 < 2,2e-16 
Time2 847,22 1,00 76,05 <1,38e-14 
Enzyme:Time 442,48 5,00 7,94 0,0000015580 
Enzyme:Time2 171,29 5,00 3,08 0,0118400000 *** 
Residuals 1403,73 126,00 
  
*** 
 
Tukey; multiple comparisons of the means 
    95% family-wise confidence level 
$Enzyme 
diff lwr upr p adj 
B-A 8,45 5,67 11,24 0,000000 
C-A 2,93 0,14 5,72 0,033197 
D-A 9,01 6,22 11,80 0,000000 
  E-A 1,44 -1,35 4,23 0,667888 
F-A 7,47 4,68 10,26 0,000000 
C-B -5,52 -8,31 -2,73 0,000001 
  D-B 0,56 -2,23 3,35 0,992225 
E-B -7,01 -9,80 -4,23 0,000000 
F-B -0,98 -3,77 1,81 0,910775 
D-C 6,08 3,29 8,87 0,000000 
E-C -1,49 -4,28 1,30 0,634223 
F-C 4,54 1,75 7,33 0,000092 
E-D -7,57 -10,36 -4,78 0,000000 
F-D -1,54 -4,33 1,25 0,601103 
F-E 6,0321608 3,2436458 8,820676 0,0000001 
ChiC, β-chitinA 
A=ChiC, B=ChiC+CfCBM33B-N 1µM, C= ChiB+CfCBM33B-N  0.5 µM + CBP21 0.5µM, D= ChiB+CBP21 
1µM 
 
Estimation of the coefficients and anova-analysis of the effect of degradation over time 
Call:lm(formula = Conversion ~ Enzyme * Time + Enzyme * Time2, data = Dataset3) 
Coefficients: 
Estimate Std. Error t value Pr(>|t|) 
(Intercept) 0.78669 1.74353 0.451 0.65347 
Enzyme[T.B] 2.74384 2.46572 1.113 0.27024 
Enzyme[T.C] 4.63736 2.46572 1.881 0.06486 . 
Enzyme[T.D] 3.09766 2.46572 1.256 0.21388 
Time 0.44966 0.47889 0.939 0.35151 
Time2 -0.01087 0.01462 -0.743 0.46010 
Enzyme[T.B]:Time 1.91285 0.67725 2.824 0.00642 ** 
Enzyme[T.C]:Time 3.62825 0.67725 5.357 1.41e-06 *** 
Enzyme[T.D]:Time 4.88718 0.67725 7.216 1.07e-09 *** 
Enzyme[T.B]:Time2 -0.04854 0.02067 -2.348 0.02217 * 
Enzyme[T.C]:Time2 -0.08899 0.02067 -4.305 6.26e-05 *** 
Enzyme[T.D]:Time2 -0.11940 0.02067 -5.776 2.90e-07 *** 
Signif. codes:   0 '***'  0.001 '**'  0.01 '*'  0.05 '.'  0.1 ' ' 
Anova Table (Type II tests) 
Response: Conversion 
Sum Sq Df F value Pr(>F) 
Enzyme 5729.5 3 169.756 < 2.2e-16 *** 
Time 1833.5 1 162.968 < 2.2e-16 *** 
Time2 1188.0 1 105.599 7.546e-15 *** 
Enzyme:Time 663.3 3 19.652 5.420e-09 *** 
Enzyme:Time2 422.8 3 12.526 1.836e-06 *** 
Residuals 675.0 60 
Tukey; multiple comparisons of the means 
    95% family-wise confidence level 
Fit: aov.default(formula = LinearModel.10) 
$Enzyme 
diff lwr upr p adj 
B-A 10.251254 7.2967771 13.205731 0.000000 
C-A 19.391592 16.4371149 22.346069 0.000000 
D-A 23.050638 20.0961612 26.005116 0.000000 
C-B 9.140338 6.1858607 12.094815 0.000000 
D-B 12.799384 9.8449069 15.753861 0.000000 
D-C 3.659046 0.7045691 6.613523 0.009336 
ChiB, β-chitinE 
A=ChiB, B=ChiB+CfCBM33B-N 1 µM, C= ChiB+CfCBM33B-N  0.5µM, D=ChiB+CfCBM33B-N 
0.5µM+CBP21 0.5µM, E=ChiB+CBP21 0.5µM, F= ChiB+CBP21 1µM 
Estimation of the coefficients and anova-analysis of the effect of degradation over time 
Call:lm(formula = conversion ~ Enzyme * Time + Enzyme * Time2, data = J145_162) 
Coefficients: 
Estimate Std, Error t value Pr(>|t|) 
(Intercept) 2,2385 1,3465 1,6620 0,09890 , 
Enzyme[T,B] 2,4167 1,9043 1,2690 0,20670 
Enzyme[T,C] 1,8987 1,9043 0,9970 0,32060 
Enzyme[T,D] 1,6540 1,9043 0,8690 0,38670 
Enzyme[T,E] 0,3537 1,9043 0,1860 0,85300 
Enzyme[T,F] 0,0268 1,9043 0,0140 0,98880 
Time 0,1784 0,4821 0,3700 0,71200 
Time2 -0,0064 0,0210 -0,3030 0,76250 
Enzyme[T,B]:Time 5,1560 0,6818 7,5620 <1e-05 *** 
Enzyme[T,C]:Time 3,7637 0,6818 5,5200 <1e-05 *** 
Enzyme[T,D]:Time 4,7534 0,6818 6,9720 <1e-05 *** 
Enzyme[T,E]:Time 0,3457 0,6818 0,5070 0,61310 
Enzyme[T,F]:Time 0,2240 0,6818 0,3290 0,74310 
Enzyme[T,B]:Time2 -0,1570 0,0297 -5,2870 <1e-05 *** 
Enzyme[T,C]:Time2 -0,1241 0,0297 -4,1780 <1e-05 *** 
Enzyme[T,D]:Time2 -0,1514 0,0297 -5,0970 <1e-05 *** 
Enzyme[T,E]:Time2 -0,0123 0,0297 -0,4140 0,67980 
Enzyme[T,F]:Time2 -0,0071 0,0297 -0,2390 0,81160 
--- 
Signif, codes:  0 '***' 0,001 '**' 0,01 '*' 0,05 ',' 0,1 ' ' 1  
 
Anova Table (Type II tests) 
Response: conversion 
Sum Sq Df F value Pr(>F) 
Enzyme 7836,2 5 99,604 < 2,2e-16 *** 
Time 2645,6 1 168,138 < 2,2e-16 *** 
Time2 1427,7 1 90,738 < 2,2e-16 *** 
Enzyme:Time 2010,9 5 25,559 < 2,2e-16 *** 
Enzyme:Time2 1039,5 5 13,213 2,39E-10 *** 
Residuals 1982,6 126 
--- 
Signif, codes:  0 '***' 0,001 '**' 0,01 '*' 0,05 ',' 0,1 ' ' 1 
Tukey; multiple comparisons of the means 
    95% family-wise confidence level 
$Enzyme 
diff lwr upr p adj 
B-A 17,63536 14,3214 20,94932 <1e-05 
C-A 12,31338 8,999424 15,62734 <1e-05 
D-A 15,19845 11,88449 18,51241 <1e-05 
E-A 1,244626 -2,06933 4,558585 0,886 
F-A 0,668039 -2,64592 3,981999 0,992 
C-B -5,32197 -8,63593 -2,00801 <1e-05 
D-B -2,4369 -5,75086 0,877057 0,280 
E-B -16,3907 -19,7047 -13,0768 <1e-05 
F-B -16,9673 -20,2813 -13,6534 <1e-05 
D-C 2,88507 -0,42889 6,199029 0,126 
E-C -11,0688 -14,3827 -7,7548 <1e-05 
F-C -11,6453 -14,9593 -8,33139 <1e-05 
E-D -13,9538 -17,2678 -10,6399 <1e-05 
F-D -14,5304 -17,8444 -11,2165 <1e-05 
F-E -0,57659 -3,89055 2,737373 0,996 
 
 Basic diagnostic plots; residual plots and normal distribution plots for the four
models. 
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